{"text": "Common symptoms include alternating diarrhea and constipation , excess intestinal gas , intestinal cramping , uncomfortable bowel movements , abdominal discomfort following meals , and excessive awareness of the presence of stool in the colon .", "label": "", "metadata": {}, "score": "29.786018"}
{"text": "Common symptoms include alternating diarrhea and constipation , excess intestinal gas , intestinal cramping , uncomfortable bowel movements , abdominal discomfort following meals , and excessive awareness of the presence of stool in the colon .", "label": "", "metadata": {}, "score": "29.786018"}
{"text": "Patients with diarrhea ( without typical IBS - symptoms ) had an impressive ratio of 5 responders out of 8 .The subgroup lower abdomen with predominant diarrhea complaints improved its symptoms by an average of about 66 % .", "label": "", "metadata": {}, "score": "30.192265"}
{"text": "Mean relative reduction was 30 % for upper abdominal symptom score and 42 % for lower abdominal symptom score .Patients then were categorized according to their primary complaint at the initial visit as either \" upper abdominal \" ( 34 patients ) or \" lower abdominal \" ( 32 patients ) .", "label": "", "metadata": {}, "score": "30.371992"}
{"text": "We can not exclude the results as mainly driven by unspecific placebo - effects .Thus the results of this prospective , observational pilot study form a valuable basis for conducting more comprehensive controlled studies in patients with functional gastrointestinal diseases , focusing on diarrhea , GERD , and IBS .", "label": "", "metadata": {}, "score": "30.956654"}
{"text": "Diarrhea without cramps was the single symptom which showed the most significant improvements .It is remarkable that responder rates of approximately 30 - 50 % were found in patients who have suffered for years from functional gastrointestinal disorders which might be regarded as therapy - refractory .", "label": "", "metadata": {}, "score": "31.568403"}
{"text": "Approximately two thirds of all subjects reported an improvement in symptoms after treatment , and there was a favorable shift in self - reported bowel pattern [ 18 ] .", "label": "", "metadata": {}, "score": "32.58463"}
{"text": "The symptom score system is introduced to quantify the degree of abdominal pain , diarrhea , stool consistency and other concomitant symptoms as shown in Figure 3 , following the Guidelines for Clinical Research of New Chinese Medicine [ 20 ] .", "label": "", "metadata": {}, "score": "32.61139"}
{"text": "Other subgroups ( with some overlap of patients attributed to several subgroups ) are shown in Figure 3 .In addition , patients with severe flatulence were separated nonexclusively into \" upper abdominal gas \" ( 29 patients ) and \" lower abdominal gas \" ( 22 patients ) subgroups .", "label": "", "metadata": {}, "score": "33.551476"}
{"text": "In these subgroup analyses , the effect of symptom reduction could be observed in patients with very different symptom patterns of functional gastrointestinal diseases from nonulcer dyspepsia to irritable bowel syndrome including even constipation - predominant IBS .", "label": "", "metadata": {}, "score": "33.872566"}
{"text": "Compared with patients in the placebo group , patients in the CHM groups showed a significant improvement in bowel symptom and global improvement scores as rated by patients and by gastroenterologists .", "label": "", "metadata": {}, "score": "34.103493"}
{"text": "Scores of 4 or more were associated to severe bloating .Symptomatic episodes with a score of 2 or more defined a significant flatulence .A \" physician 's overall evaluation \" was made by simple questions addressed to the child / parent \" How did you feel during the treatment as compare to the period before ? \" at the end of treatment and \" How did you feel as compared to the treatment period ? \" at the end of follow - up and asked to select a category response as follows : completed or marked improvement , mild improvement , unchanged or worse .", "label": "", "metadata": {}, "score": "34.561134"}
{"text": "Scores of 4 or more were associated to severe bloating .Symptomatic episodes with a score of 2 or more defined a significant flatulence .A \" physician 's overall evaluation \" was made by simple questions addressed to the child / parent \" How did you feel during the treatment as compare to the period before ? \" at the end of treatment and \" How did you feel as compared to the treatment period ? \" at the end of follow - up and asked to select a category response as follows : completed or marked improvement , mild improvement , unchanged or worse .", "label": "", "metadata": {}, "score": "34.561134"}
{"text": "Our study was carried out in children who predominantly had bloating and gas - related symptoms , with no significant abdominal pain .Consequently , the beneficial results obtained in this study can not be considered valid for children suffering from different variants of functional gastrointestinal disorder ( IBS - predominant constipation or IBS - predominant diarrhea ) .", "label": "", "metadata": {}, "score": "36.723064"}
{"text": "Our study was carried out in children who predominantly had bloating and gas - related symptoms , with no significant abdominal pain .Consequently , the beneficial results obtained in this study can not be considered valid for children suffering from different variants of functional gastrointestinal disorder ( IBS - predominant constipation or IBS - predominant diarrhea ) .", "label": "", "metadata": {}, "score": "36.723064"}
{"text": "Lea R , Whorwell PJ : Expert commentary - bloating , distension , and the irritable bowel syndrome .MedGenMed 2005 , 7 : 18 .", "label": "", "metadata": {}, "score": "36.892097"}
{"text": "There was a 20.7 % and 42.9 % loss of appetite in the TXNG and placebo groups , respectively .An observable improvement in IBS - related diarrhea was seen in 86.2 % of subjects in the TXNG group and 42.9 % of subjects in the placebo group .", "label": "", "metadata": {}, "score": "37.478146"}
{"text": "A total of 82.7 % of the patients reported a reduction in IBS - related pain in the TXNG group compared with 39.3 % in the placebo group .", "label": "", "metadata": {}, "score": "37.886463"}
{"text": "Other complaints were nausea ( 6 patients ) , epigastric pain ( 6 patients ) , and other symptoms ( 5 patients ) .8 patients were smokers , and 34 patients consumed alcohol more than once a week .", "label": "", "metadata": {}, "score": "37.912228"}
{"text": "However , the IBS - related pain alleviation time and the IBS - related diarrhea alleviation time in the TXNG group were markedly shorter than those in the placebo group [ 52 ] .", "label": "", "metadata": {}, "score": "38.48118"}
{"text": "For functional gastrointestinal symptoms relevant placebo effects are considered .A part of the effect observed in this study may be explained by placebo and regression - to - mean effects .", "label": "", "metadata": {}, "score": "38.601414"}
{"text": "And there were also no significant differences in GSRS symptom specific scores among three groups .The baseline age , gender , race , and the severity of IBS - D symptoms of the patients were listed in Table 2 and they were all similar among different groups .", "label": "", "metadata": {}, "score": "39.483482"}
{"text": "Subgroups with diarrhea , IBS and GERD presented highest responder rates .6 % of patients reported adverse reactions with probable or possible relationship to the test product .", "label": "", "metadata": {}, "score": "39.57853"}
{"text": "But , the probiotic did not seem to improve the actual symptoms of IBS .Two studies that pooled previous randomized trials on the use of probiotics for IBS came to similar conclusions : probiotics appear to offer some benefit , most notably for global symptoms and abdominal discomfort .", "label": "", "metadata": {}, "score": "39.58698"}
{"text": "But , the probiotic did not seem to improve the actual symptoms of IBS .Two studies that pooled previous randomized trials on the use of probiotics for IBS came to similar conclusions : probiotics appear to offer some benefit , most notably for global symptoms and abdominal discomfort .", "label": "", "metadata": {}, "score": "39.58698"}
{"text": "But , the probiotic did not seem to improve the actual symptoms of IBS .Two studies that pooled previous randomized trials on the use of probiotics for IBS came to similar conclusions : probiotics appear to offer some benefit , most notably for global symptoms and abdominal discomfort .", "label": "", "metadata": {}, "score": "39.58698"}
{"text": "But , the probiotic did not seem to improve the actual symptoms of IBS .Two studies that pooled previous randomized trials on the use of probiotics for IBS came to similar conclusions : probiotics appear to offer some benefit , most notably for global symptoms and abdominal discomfort .", "label": "", "metadata": {}, "score": "39.58698"}
{"text": "Finally , it is known that IBS - D had a severe impact on the quality of life [ 18 - 21 ] ( QOL ) , which is correlated with the appearance of symptoms , the protracted time , and severity of the disease .", "label": "", "metadata": {}, "score": "39.651596"}
{"text": "Out of 15 patients with lower - abdominal gas , 6 were responders with parallel relief for flatulence , abdominal cramps , and abnormal bowel habits .", "label": "", "metadata": {}, "score": "39.777107"}
{"text": "S1-S35 , 2009 .View at Google Scholar . E. A. Williams , J. Stimpson , D. Wang et al . , \" Clinical trial : a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double - blind placebo - controlled study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "39.850906"}
{"text": "Secondary Efficacy Endpoint .Secondary efficacy endpoints are the GSRS symptom specific scores of abdominal pain , rugitus , abdominal distension , increased flatus , increased passage of stools , loose stools , and urgent need for defecation .", "label": "", "metadata": {}, "score": "39.95326"}
{"text": "At the end of the screen period , IBS - D patients were randomized into one of the three groups if they exhibited diarrhea the occurred for at least 2 days / week .", "label": "", "metadata": {}, "score": "39.95817"}
{"text": "Seventy - nine percent of patients on Mentha capsule experienced an alleviation of the severity of abdominal pain , 83 % had less abdominal distension , 83 % showed a reduced stool frequency , 73 % had fewer borborygmi , and 79 % less flatulence .", "label": "", "metadata": {}, "score": "40.003944"}
{"text": "For example , a s6-week , double - blind study of 105 people with mild irritable bowel syndrome compared 5 g of fructo - oligosaccharides daily against placebo , and returned conflicting results .", "label": "", "metadata": {}, "score": "40.84449"}
{"text": "For example , a s6-week , double - blind study of 105 people with mild irritable bowel syndrome compared 5 g of fructo - oligosaccharides daily against placebo , and returned conflicting results .", "label": "", "metadata": {}, "score": "40.84449"}
{"text": "For example , a s6-week , double - blind study of 105 people with mild irritable bowel syndrome compared 5 g of fructo - oligosaccharides daily against placebo , and returned conflicting results .", "label": "", "metadata": {}, "score": "40.84449"}
{"text": "For example , a s6-week , double - blind study of 105 people with mild irritable bowel syndrome compared 5 g of fructo - oligosaccharides daily against placebo , and returned conflicting results .", "label": "", "metadata": {}, "score": "40.84449"}
{"text": "Improvement of heartburn mainly occurred later than other symptoms between week 3 and 6 of the study ; 14 out of 34 ( upper abdominal ) patients could be characterized as responders for both upper and lower abdominal scores .", "label": "", "metadata": {}, "score": "41.075024"}
{"text": "Each IBS patient could switch from one subgroup to another over time .Current medication approaches for IBS are based on symptom reduction , yet many patients remain undertreated ; meanwhile , many medication approaches are associated with side effects that result in less benefit to the patient , particularly in treatment for long - term relief of abdominal pain or discomfort .", "label": "", "metadata": {}, "score": "41.14441"}
{"text": "10 lower abdominal symptoms were asked analogously .Results .62 of 90 patients were evaluated per protocol .Upper and lower abdomen sum scores decreased already in the first three weeks ( .", "label": "", "metadata": {}, "score": "41.48291"}
{"text": "11 , pp .937 - 956 , 2001 .View at Google Scholar .N. J. Talley , E. H. Dennis , V. A. Schettler - Duncan , B. E. Lacy , K. W. Olden , and M. D. Crowell , \" Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "41.563126"}
{"text": "We added 10 analogous questions related to symptoms of the lower abdomen .Scores were calculated as the sum of the symptoms for upper abdomen or lower abdomen and total score as the sum of both scores .", "label": "", "metadata": {}, "score": "41.6378"}
{"text": "Discussion .Characterised by continuous or intermittent abdominal pain , bloating , changes of bowel habits or stool consistency , IBS is a disease lacking any changes of gastrointestinal structure and biochemical abnormalities .", "label": "", "metadata": {}, "score": "41.661545"}
{"text": "Vlieger AM , Menko - Frankenhuis C , Wolfkamp SC , Tromp E , Benninga MA .Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "41.911415"}
{"text": "Vlieger AM , Menko - Frankenhuis C , Wolfkamp SC , Tromp E , Benninga MA .Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "41.911415"}
{"text": "Vlieger AM , Menko - Frankenhuis C , Wolfkamp SC , Tromp E , Benninga MA .Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "41.911415"}
{"text": "Vlieger AM , Menko - Frankenhuis C , Wolfkamp SC , Tromp E , Benninga MA .Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "41.911415"}
{"text": "But PPIs might also induce gastrointestinal symptoms , especially after stopping therapy [ 7 ] .10 - 15 % of the western world is affected by IBS [ 8 , 9 ] and about 5 % seeks medical attention .", "label": "", "metadata": {}, "score": "42.048096"}
{"text": "Keywords .Gas - related symptoms Bloating \u03b1 - galactosidase Children .Background .Most patients with functional gastrointestinal disorders , including those with irritable bowel syndrome , complain of gas - related symptoms , e.g. bloating , abdominal distention , and flatulence [ 1 ] .", "label": "", "metadata": {}, "score": "42.053383"}
{"text": "The overall bowel symptom score ( BSS ) from baseline was decreased both in Hypericum and placebo groups whereas the placebo arm showed significantly lower scores at the end of treatment .", "label": "", "metadata": {}, "score": "42.15207"}
{"text": "Background .Most patients with functional gastrointestinal disorders , including those with irritable bowel syndrome , complain of gas - related symptoms , e.g. bloating , abdominal distention , and flatulence [ 1 ] .", "label": "", "metadata": {}, "score": "42.25835"}
{"text": "However , the diagnosis can be challenging particularly because of variability and overlap of symptoms [ 4 ] .Functional gastrointestinal complaints are often treated with drugs such as proton pump inhibitors ( PPIs ) or prokinetics .", "label": "", "metadata": {}, "score": "42.420303"}
{"text": "Out of the 90 participating patients , 29 reported 35 adverse events and 3 severe adverse events .The latter were exacerbations of known concomitant diseases without causal relation to the gastrointestinal gel but led to 1 dropout .", "label": "", "metadata": {}, "score": "42.70118"}
{"text": "No clinically significant differences among the three patient groups were detected in the analysis of laboratory values , vital signs , and physical examination either .", "label": "", "metadata": {}, "score": "42.978973"}
{"text": "Only 1 patient ( 1.3 % ) in Group HM and 1 patient ( 1.7 % ) in group PB reported the allergy .Both of them were mild - to - moderate and were considered to be related to the study treatment .", "label": "", "metadata": {}, "score": "43.018677"}
{"text": "However , in group FM , IBS specific symptoms of abdominal pain , abdominal distension , and increased passage of stools were more serious ( .", "label": "", "metadata": {}, "score": "43.182213"}
{"text": "69 After a 2-week \" wash - out \" period , the children were switched to the other treatment .VSL#3 was associated with a reduction in symptoms , including abdominal pain , bloating , and gas .", "label": "", "metadata": {}, "score": "43.381996"}
{"text": "69 After a 2-week \" wash - out \" period , the children were switched to the other treatment .VSL#3 was associated with a reduction in symptoms , including abdominal pain , bloating , and gas .", "label": "", "metadata": {}, "score": "43.381996"}
{"text": "69 After a 2-week \" wash - out \" period , the children were switched to the other treatment .VSL#3 was associated with a reduction in symptoms , including abdominal pain , bloating , and gas .", "label": "", "metadata": {}, "score": "43.381996"}
{"text": "69 After a 2-week \" wash - out \" period , the children were switched to the other treatment .VSL#3 was associated with a reduction in symptoms , including abdominal pain , bloating , and gas .", "label": "", "metadata": {}, "score": "43.381996"}
{"text": "15 adverse events had an improbable relationship to treatment , 7 referring to gastrointestinal symptoms explained by acute viral gastrointestinal infections .Some adverse drug reactions ( 20 patients ) were treated by reduction of dosage ( 9 patients ) or by discontinuing the therapy ( 11 patients ) .", "label": "", "metadata": {}, "score": "43.52674"}
{"text": "doi : 10.1038/ajg.2010.57 .[PubMed ] [ Cross Ref ] .Lea R , Whorwell PJ .Expert commentary - bloating , distension , and the irritable bowel syndrome .", "label": "", "metadata": {}, "score": "43.708084"}
{"text": "It contains seven items ( abdominal pain , rugitus , abdominal distension , increased flatus , increased passage of stools , loose stools , and urgent need for defecation ) .", "label": "", "metadata": {}, "score": "43.780247"}
{"text": "In the opinion of the authors , 2 less days of bloating over the week in the alpha - galactosidase group as compared to placebo would be clinically significant .", "label": "", "metadata": {}, "score": "44.0299"}
{"text": "In the opinion of the authors , 2 less days of bloating over the week in the alpha - galactosidase group as compared to placebo would be clinically significant .", "label": "", "metadata": {}, "score": "44.0299"}
{"text": "The prevalence of simple constipation is also as high as 15 % in North America [ 10 ] .Interpreting efficacy studies in functional dyspepsia is difficult since a variety of test instruments are used , many of which have not been validated .", "label": "", "metadata": {}, "score": "44.321396"}
{"text": "As the most common type of IBS , IBS - D is characterised by abdominal pain / discomfort and diarrhea , mainly accompanied with emotional instability , which is the exact indication of SQTX Granule in our study .", "label": "", "metadata": {}, "score": "44.332195"}
{"text": "IBS - related pain increased in the Curcuma group and decreased in the placebo group .IBS - related distension showed a greater reduction in the placebo group compared to the curcuma group .", "label": "", "metadata": {}, "score": "44.397892"}
{"text": "Reductions in straining , abdominal pain , bloating , flatulence , and global IBS symptoms were also demonstrated in patients using this formula .Subjects in the C - IBS group experienced a 20 % increase in bowel movement frequency and significant reductions in straining , abdominal pain , bloating , and global IBS symptom severity , as well as improvements in stool consistency .", "label": "", "metadata": {}, "score": "44.539715"}
{"text": "But it may have been insufficient to achieve maximum effect from HM , because IBS - D is often a lifelong condition typified by chronic and episodic symptoms [ 6 ] .", "label": "", "metadata": {}, "score": "44.845016"}
{"text": "Additionally , the global assessment of changes in IBS symptoms and psychological stress due to IBS did not differ significantly among the two treatment groups [ 19 ] .", "label": "", "metadata": {}, "score": "44.849136"}
{"text": "Nobaek S , Johansson ML , Molin G , et al .Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "45.211338"}
{"text": "Nobaek S , Johansson ML , Molin G , et al .Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "45.211338"}
{"text": "Nobaek S , Johansson ML , Molin G , et al .Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "45.211338"}
{"text": "Nobaek S , Johansson ML , Molin G , et al .Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "45.211338"}
{"text": "Change of other nongastrointestinal medications was reported in 1 patient after 1 week , in 8 patients after 3 weeks .During the course of the study , 23 patients dropped out .", "label": "", "metadata": {}, "score": "45.41147"}
{"text": "[ Epub ahead of print 2014 Mar].Ford AC , Quigley EM , et al .Efficacy of prebiotics , probiotics , and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "45.416985"}
{"text": "[ Epub ahead of print 2014 Mar].Ford AC , Quigley EM , et al .Efficacy of prebiotics , probiotics , and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "45.416985"}
{"text": "[ Epub ahead of print 2014 Mar].Ford AC , Quigley EM , et al .Efficacy of prebiotics , probiotics , and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "45.416985"}
{"text": "[ Epub ahead of print 2014 Mar].Ford AC , Quigley EM , et al .Efficacy of prebiotics , probiotics , and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "45.416985"}
{"text": "Introduction .About 20 - 30 % of people in the western world experience chronic gastrointestinal complaints relating to functional bowel disorders [ 1 ] , half of those seeking medical attention [ 2 , 3 ] .", "label": "", "metadata": {}, "score": "45.654423"}
{"text": "Ninety - six percent of patients rated this extract better than or at least equal to previous therapies administered for their symptoms .Furthermore , the tolerability of Cynara scolymus extract was very good [ 24 ] .", "label": "", "metadata": {}, "score": "45.739437"}
{"text": "References .L. J. Brandt , W. D. Chey , A. E. Foxx - Orenstein , et al . , \" An evidence - based position statement on the management of irritable bowel syndrome , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "45.953896"}
{"text": "243 - 247 , 2008 .View at Google Scholar . D. R. De Vries , M. A. Van Herwaarden , A. Baron , A.J. Smout , and M. Samson , \" Concomitant functional dyspepsia and irrritable bowel syndrome decrease health - related quality of life in gastroesophageal reflux disease , \" Scandinavian Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "45.9675"}
{"text": "PubMed View Article .Elsenbruch S : Abdominal pain in irritable bowel syndrome : a review of putative psychological , neural and neuro - immune mechanisms .", "label": "", "metadata": {}, "score": "45.975883"}
{"text": "Ford AC , Quigley EM , et al .Effect of antidepressants and psychological therapies , including hypnotherapy , in irritable bowel syndrome : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "46.0068"}
{"text": "Ford AC , Quigley EM , et al .Effect of antidepressants and psychological therapies , including hypnotherapy , in irritable bowel syndrome : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "46.0068"}
{"text": "Ford AC , Quigley EM , et al .Effect of antidepressants and psychological therapies , including hypnotherapy , in irritable bowel syndrome : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "46.0068"}
{"text": "Ford AC , Quigley EM , et al .Effect of antidepressants and psychological therapies , including hypnotherapy , in irritable bowel syndrome : Systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "46.0068"}
{"text": "However , only 5 of these ulcer - like patients could be considered responders according to total symptom scores .Patients with GERD ( 18 patients ) showed a greater decrease in reflux - related symptoms when compared with other patients-9/18 ( 50 % ) patients were responders .", "label": "", "metadata": {}, "score": "46.040466"}
{"text": "Over 54 % of patients receiving hypnotherapy had symptom improvement for up to 15 months compared to 25 % in the control group . 79In a review of 5 trials with 278 patients , hypnotherapy was associated higher levels of symptom improvement when compared to a control group or usual care .", "label": "", "metadata": {}, "score": "46.068375"}
{"text": "Over 54 % of patients receiving hypnotherapy had symptom improvement for up to 15 months compared to 25 % in the control group . 79In a review of 5 trials with 278 patients , hypnotherapy was associated higher levels of symptom improvement when compared to a control group or usual care .", "label": "", "metadata": {}, "score": "46.068375"}
{"text": "Over 54 % of patients receiving hypnotherapy had symptom improvement for up to 15 months compared to 25 % in the control group . 79In a review of 5 trials with 278 patients , hypnotherapy was associated higher levels of symptom improvement when compared to a control group or usual care .", "label": "", "metadata": {}, "score": "46.068375"}
{"text": "Over 54 % of patients receiving hypnotherapy had symptom improvement for up to 15 months compared to 25 % in the control group . 79In a review of 5 trials with 278 patients , hypnotherapy was associated higher levels of symptom improvement when compared to a control group or usual care .", "label": "", "metadata": {}, "score": "46.068375"}
{"text": "Course of Study .Inclusion of patients was based on individual case history and a physical examination .Patients completed questionnaires about gastrointestinal symptoms at the time of inclusion ( visit 0 ) , after 3 weeks ( visit 2 ) , and after 6 weeks ( visit 3 ) .", "label": "", "metadata": {}, "score": "46.09318"}
{"text": "Note : 1 ) Patients cured in a course of treatment are not regarded as cases for withdrawal .Patients withdrawn due to poor efficacy after a half course of treatment ( 14 days ) are regarded as not recovered but not withdrawn , and they would be included in the Full Analysis Set ( FAS ) and the Per Protocol Set ( PPS ) .", "label": "", "metadata": {}, "score": "46.200478"}
{"text": "Pre - publication history .References .Longstreth GF . et al .Functional bowel disorders .Gastroenterology .doi : 10.1053/j.gastro.2005.11.061 .[", "label": "", "metadata": {}, "score": "46.22568"}
{"text": "PubMed View Article .Francis CY , Morris J , Whorwell PJ : The irritable bowel severity scoring system : a simple method of monitoring irritable bowel syndrome and its progress .", "label": "", "metadata": {}, "score": "46.22953"}
{"text": "In this scale , each item was scored 0 ( absence of the symptom ) , 1 ( mild symptom ) , 2 ( moderate symptom ) , or 3 ( extreme degree of the symptom ) , rendering a total score between 0 and 21 .", "label": "", "metadata": {}, "score": "46.31546"}
{"text": "Talley NJ , Zinsmeister AR , Melton LJ 3rd : Irritable bowel syndrome in a community : symptom subgroups , risk factors , and health care utilization .", "label": "", "metadata": {}, "score": "46.355705"}
{"text": "( a ) Abdominal pain ; ( b ) rugitus ; ( c ) abdominal distension ; ( d ) increased flatus ; ( e ) increased passage of stools ; ( f ) loose stools ; ( g ) urgent need for defecation during study time .", "label": "", "metadata": {}, "score": "46.549366"}
{"text": "Results .No significant differences were found for abdominal spasms and abdominal distension .No adverse events were reported during treatment .Conclusions .Although larger and longer trials are needed to confirm this result , \u03b1 - galactosidase seems to be a safe , well tolerated and effective treatment for gas - related symptoms in the pediatric population .", "label": "", "metadata": {}, "score": "46.555576"}
{"text": "Results .No significant differences were found for abdominal spasms and abdominal distension .No adverse events were reported during treatment .Conclusions .Although larger and longer trials are needed to confirm this result , \u03b1 - galactosidase seems to be a safe , well tolerated and effective treatment for gas - related symptoms in the pediatric population .", "label": "", "metadata": {}, "score": "46.555576"}
{"text": "Gas - related symptoms are included in the functional gastrointestinal disorders ( FGID ) as there is no evidence of morphological or biochemical abnormalities .When the symptoms are mild or episodic , reassurance and dietary changes may be sufficient .", "label": "", "metadata": {}, "score": "46.584934"}
{"text": "Gas - related symptoms are included in the functional gastrointestinal disorders ( FGID ) as there is no evidence of morphological or biochemical abnormalities .When the symptoms are mild or episodic , reassurance and dietary changes may be sufficient .", "label": "", "metadata": {}, "score": "46.584934"}
{"text": "At the time of manuscript submission , patient recruitment for the trial is on - going .PSSR : . percentage of symptom score reduction .", "label": "", "metadata": {}, "score": "46.87494"}
{"text": "734 - 737 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . Y. A. Saito , P. Schoenfeld , and G. R. Locke III , \" The epidemiology of irritable bowel syndrome in North America : a systematic review , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "46.885357"}
{"text": "Palsson OS , Turner MJ , Johnson DA .Hypnotherapy for irritable bowel syndrome : symptom improvement and autonomic nervous system effects .Poster presented at : Digestive Disease Week 2000 ; May 21 - 24 , 2000 ; San Diego , CA .", "label": "", "metadata": {}, "score": "46.90289"}
{"text": "Palsson OS , Turner MJ , Johnson DA .Hypnotherapy for irritable bowel syndrome : symptom improvement and autonomic nervous system effects .Poster presented at : Digestive Disease Week 2000 ; May 21 - 24 , 2000 ; San Diego , CA .", "label": "", "metadata": {}, "score": "46.90289"}
{"text": "Palsson OS , Turner MJ , Johnson DA .Hypnotherapy for irritable bowel syndrome : symptom improvement and autonomic nervous system effects .Poster presented at : Digestive Disease Week 2000 ; May 21 - 24 , 2000 ; San Diego , CA .", "label": "", "metadata": {}, "score": "46.90289"}
{"text": "Palsson OS , Turner MJ , Johnson DA .Hypnotherapy for irritable bowel syndrome : symptom improvement and autonomic nervous system effects .Poster presented at : Digestive Disease Week 2000 ; May 21 - 24 , 2000 ; San Diego , CA .", "label": "", "metadata": {}, "score": "46.90289"}
{"text": "Treatment of diarrhea - predominant irritable bowel syndrome with traditional Chinese herbal medicine : a randomized placebo - controlled trial .Am J Gastroenterol .Vejdani R , Shalmani HR , Mir - Fattahi M , et al .", "label": "", "metadata": {}, "score": "46.938828"}
{"text": "Treatment of diarrhea - predominant irritable bowel syndrome with traditional Chinese herbal medicine : a randomized placebo - controlled trial .Am J Gastroenterol .Vejdani R , Shalmani HR , Mir - Fattahi M , et al .", "label": "", "metadata": {}, "score": "46.938828"}
{"text": "Treatment of diarrhea - predominant irritable bowel syndrome with traditional Chinese herbal medicine : a randomized placebo - controlled trial .Am J Gastroenterol .Vejdani R , Shalmani HR , Mir - Fattahi M , et al .", "label": "", "metadata": {}, "score": "46.938828"}
{"text": "Treatment of diarrhea - predominant irritable bowel syndrome with traditional Chinese herbal medicine : a randomized placebo - controlled trial .Am J Gastroenterol .Vejdani R , Shalmani HR , Mir - Fattahi M , et al .", "label": "", "metadata": {}, "score": "46.938828"}
{"text": "Scand J Gastroenterol .Dainese R , Galliani EA , De Lazzari F , et al .Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients .", "label": "", "metadata": {}, "score": "46.982582"}
{"text": "Scand J Gastroenterol .Dainese R , Galliani EA , De Lazzari F , et al .Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients .", "label": "", "metadata": {}, "score": "46.982582"}
{"text": "Scand J Gastroenterol .Dainese R , Galliani EA , De Lazzari F , et al .Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients .", "label": "", "metadata": {}, "score": "46.982582"}
{"text": "Scand J Gastroenterol .Dainese R , Galliani EA , De Lazzari F , et al .Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients .", "label": "", "metadata": {}, "score": "46.982582"}
{"text": "Patrick DL , Drossman DA , Frederick IO , DiCesare J , Puder KL : Quality of life in persons with irritable bowel syndrome : development and validation of a new measure .", "label": "", "metadata": {}, "score": "47.01916"}
{"text": "No changes in any of the dietary habits of the patients were allowed throughout the duration of the study .Children underwent follow - up 2 weeks after the end of treatment .", "label": "", "metadata": {}, "score": "47.208954"}
{"text": "No changes in any of the dietary habits of the patients were allowed throughout the duration of the study .Children underwent follow - up 2 weeks after the end of treatment .", "label": "", "metadata": {}, "score": "47.208954"}
{"text": "The changes from baseline to endpoint of treatment in scores will be assessed with the use of a paired t -test for measurement data and a signed rank test for enumeration data .", "label": "", "metadata": {}, "score": "47.221127"}
{"text": "[PubMed ] [ Cross Ref ] .Rippel SW . et al .Pediatric patients with dyspepsia have chronic symptoms , anxiety , and lower quality of life as adolescents and adults .", "label": "", "metadata": {}, "score": "47.449448"}
{"text": "According to some measures of symptom severity employed by the researchers , use of FOS led to an improvement in symptoms ; however , according to other measures , FOS actually worsened symptoms .", "label": "", "metadata": {}, "score": "47.662453"}
{"text": "According to some measures of symptom severity employed by the researchers , use of FOS led to an improvement in symptoms ; however , according to other measures , FOS actually worsened symptoms .", "label": "", "metadata": {}, "score": "47.662453"}
{"text": "According to some measures of symptom severity employed by the researchers , use of FOS led to an improvement in symptoms ; however , according to other measures , FOS actually worsened symptoms .", "label": "", "metadata": {}, "score": "47.662453"}
{"text": "According to some measures of symptom severity employed by the researchers , use of FOS led to an improvement in symptoms ; however , according to other measures , FOS actually worsened symptoms .", "label": "", "metadata": {}, "score": "47.662453"}
{"text": "2008 Feb 15 .Wilhelm SM , Brubaker CM , Varcak EA , et al .Effectiveness of probiotics in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.773537"}
{"text": "2008 Feb 15 .Wilhelm SM , Brubaker CM , Varcak EA , et al .Effectiveness of probiotics in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.773537"}
{"text": "2008 Feb 15 .Wilhelm SM , Brubaker CM , Varcak EA , et al .Effectiveness of probiotics in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.773537"}
{"text": "2008 Feb 15 .Wilhelm SM , Brubaker CM , Varcak EA , et al .Effectiveness of probiotics in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.773537"}
{"text": "The proposed pathophysiology of gas - related symptoms includes a variety of different and overlapping mechanisms , which are difficult to recognize in clinical practice [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "47.810783"}
{"text": "The proposed pathophysiology of gas - related symptoms includes a variety of different and overlapping mechanisms , which are difficult to recognize in clinical practice [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "47.810783"}
{"text": "Vlieger AM , Rutten JM , Govers AM , Frankenhuis C , Benninga MA .Long - term follow - up of gut - directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.942345"}
{"text": "Vlieger AM , Rutten JM , Govers AM , Frankenhuis C , Benninga MA .Long - term follow - up of gut - directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.942345"}
{"text": "Vlieger AM , Rutten JM , Govers AM , Frankenhuis C , Benninga MA .Long - term follow - up of gut - directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.942345"}
{"text": "Vlieger AM , Rutten JM , Govers AM , Frankenhuis C , Benninga MA .Long - term follow - up of gut - directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome .", "label": "", "metadata": {}, "score": "47.942345"}
{"text": "Drisko J , Bischoff B , Hall M , et al .Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics .", "label": "", "metadata": {}, "score": "48.144623"}
{"text": "Drisko J , Bischoff B , Hall M , et al .Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics .", "label": "", "metadata": {}, "score": "48.144623"}
{"text": "Drisko J , Bischoff B , Hall M , et al .Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics .", "label": "", "metadata": {}, "score": "48.144623"}
{"text": "Drisko J , Bischoff B , Hall M , et al .Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics .", "label": "", "metadata": {}, "score": "48.144623"}
{"text": "Keywords .Irritable bowel syndrome Diarrhea Traditional Chinese medicine Shun - Qi -Tong - Xie Granule Randomised controlled trial .Background .IBS refers to a clinical syndrome that presents as a common chronic gastrointestinal disorder .", "label": "", "metadata": {}, "score": "48.18184"}
{"text": "The ramp distension of the intestinal loop stimulated a rise in intestinal afferent nerve discharge that was lower in the STW 5 pretreated group compared to controls [ 47 ] .", "label": "", "metadata": {}, "score": "48.281994"}
{"text": "630 - 637 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. A. Koloski , N. J. Talley , S. S. Huskic , and P. M. Boyce , \" Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "48.374237"}
{"text": "No evidence of any pathological change is found .Current Western medicine provides limited symptomatic relief to IBS patients through pharmacological treatment ; however , TCM has a long history spanning thousands of years , dealing with abdominal pain and diarrhea .", "label": "", "metadata": {}, "score": "48.5726"}
{"text": "Sandler RS , Stewart WF , Liberman JN .et al .Abdominal pain , bloating and diarrhea in the United States : prevalence and impact .", "label": "", "metadata": {}, "score": "48.576977"}
{"text": "Authors ' Affiliations .Department of Integrated Traditional and Western Medicine , West China Hospital of Sichuan University .References .Agr\u00e9us L , Sv\u00e4rdsudd K , Nyr\u00e9n O , Tibblin G : Irritable bowel syndrome and dyspepsia in the general population : overlap and lack of stability over time .", "label": "", "metadata": {}, "score": "48.898354"}
{"text": "View Article .Dorn SD , Kaptchuk TJ , Park JB , Nguyen LT , Canenguez K , Nam BH , Woods KB , Conboy LA , Stason WB , Lembo AJ : A meta - analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "48.97489"}
{"text": "The disease is one of the most common functional gastrointestinal ( GI ) disorders with a reported prevalence of approximately 5 to 20 % worldwide [ 1 - 3 ] .", "label": "", "metadata": {}, "score": "49.035324"}
{"text": "PubMed .Rey E , Talley NJ : Irritable bowel syndrome : novel views on the epidemiology and potential risk factors .Dig Liver Dis 2009 , 41 : 772 - 780 .", "label": "", "metadata": {}, "score": "49.126312"}
{"text": "Intestinal gas - related symptoms are generally not considered to be a severe medical problem but can negatively affect quality of life , even in pediatric age [ 3 ] .", "label": "", "metadata": {}, "score": "49.15867"}
{"text": "Intestinal gas - related symptoms are generally not considered to be a severe medical problem but can negatively affect quality of life , even in pediatric age [ 3 ] .", "label": "", "metadata": {}, "score": "49.15867"}
{"text": "12 , pp .1770 - 1798 , 2008 .View at Google Scholar .S. Zakko , G. Barton , E. Weber , C. Dunger - Baldauf , and A. R\u00fchl , \" Randomised clinical trial : the clinical effects of a novel neurokinin receptor antagonist , DNK333 , in women with diarrhoea - predominant irritable bowel syndrome , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "49.264442"}
{"text": "Gastroenterology 2007 , 133 : 433 - 444 .PubMed Central PubMed View Article .Gulewitsch MD , Enck P , Schwille - Kiuntke J , Weimer K , Schlarb AA : Mental strain and chronic stress among university students with symptoms of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "49.339905"}
{"text": "This uncontrolled observational study showed a significant and relevant improvement in gastrointestinal symptom scores after 6 weeks of therapy with Silicea Gastrointestinal Gel .Major part of patients reported a marked improvement already after 3 weeks , but improvement continued throughout the second half of the 6-week treatment phase .", "label": "", "metadata": {}, "score": "49.392902"}
{"text": "[PubMed ] [ DOI ] .Barbara G , De Giorgio R , Stanghellini V , Cremon C , Salvioli B , Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome .", "label": "", "metadata": {}, "score": "49.664"}
{"text": "11 , pp .2454 - 2459 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Neumann , K. Monkem\u00fcller , A. Kanduski , and P. Malfertheimer , \" Dyspepsia and IBS symptoms in patients with NERD , ERD and barretts esopaghus , \" Digestive Diseases , vol .", "label": "", "metadata": {}, "score": "49.6748"}
{"text": "PubMed View Article .Lackner JM , Jaccard J , Krasner SS , Katz LA , Gudleski GD , Blanchard EB : How does cognitive behavior therapy for irritable bowel syndrome work ?", "label": "", "metadata": {}, "score": "49.9897"}
{"text": "Tolerability and compliance were recorded over this 6-week period .Stool behavior and gastrointestinal symptoms were recorded in a patient 's diary .Patients were informed about the test drug , its administration , and how to document consumption , gastrointestinal symptoms , and bowel habits in the diary .", "label": "", "metadata": {}, "score": "50.009857"}
{"text": "PubMed View Article .Rippel SW , et al .: Pediatric patients with dyspepsia have chronic symptoms , anxiety , and lower quality of life as adolescents and adults .", "label": "", "metadata": {}, "score": "50.02971"}
{"text": "When there would be at least one subgroup with much lower response , this group might serve as a pseudo - control - provided that these differences would not be explained by different placebo - responses according to subgroups .", "label": "", "metadata": {}, "score": "50.185722"}
{"text": "This effect tends to disappear in half of patients 2 weeks after treatment withdrawal .Conclusions .In conclusion , oral \u03b1 -galactosidase was effective and very well tolerated in the treatment of bloating and gas - related symptoms in children and adolescents aged 4 - 17 years .", "label": "", "metadata": {}, "score": "50.33355"}
{"text": "This effect tends to disappear in half of patients 2 weeks after treatment withdrawal .Conclusions .In conclusion , oral \u03b1 -galactosidase was effective and very well tolerated in the treatment of bloating and gas - related symptoms in children and adolescents aged 4 - 17 years .", "label": "", "metadata": {}, "score": "50.33355"}
{"text": "DN .References .Chang JY , Talley NJ .Current and emerging therapies in irritable bowel syndrome : from pathophysiology to treatment .Trends Pharmacol Sci .", "label": "", "metadata": {}, "score": "50.341423"}
{"text": "However , the quality of the sutdies may have influenced the outcomes .Researchers in all acupuncture trials listed above highlighted the need for more studies .", "label": "", "metadata": {}, "score": "50.353527"}
{"text": "However , the quality of the sutdies may have influenced the outcomes .Researchers in all acupuncture trials listed above highlighted the need for more studies .", "label": "", "metadata": {}, "score": "50.353527"}
{"text": "However , the quality of the sutdies may have influenced the outcomes .Researchers in all acupuncture trials listed above highlighted the need for more studies .", "label": "", "metadata": {}, "score": "50.353527"}
{"text": "However , the quality of the sutdies may have influenced the outcomes .Researchers in all acupuncture trials listed above highlighted the need for more studies .", "label": "", "metadata": {}, "score": "50.353527"}
{"text": "Patients will receive a 28-day treatment and a 2-month follow - up .The primary outcome measures include the scores of IBS - quality of life ( IBS - QOL ) rating scale and IBS - symptom severity scale ( IBS - SSS ) rating scale .", "label": "", "metadata": {}, "score": "50.369156"}
{"text": "As a secondary outcome , a Traditional Chinese medicine ( TCM ) symptom score system is introduced into this protocol .The treatment efficacy evaluation system is introduced to evaluate the improvement of symptoms using the percentage of symptom score reduction ( PSSR ) .", "label": "", "metadata": {}, "score": "50.42827"}
{"text": "2008 May 9 .McFarland LV , Dublin S. Meta - analysis of probiotics for the treatment of irritable bowel syndrome .World J Gastroenterol .", "label": "", "metadata": {}, "score": "50.432194"}
{"text": "2008 May 9 .McFarland LV , Dublin S. Meta - analysis of probiotics for the treatment of irritable bowel syndrome .World J Gastroenterol .", "label": "", "metadata": {}, "score": "50.432194"}
{"text": "2008 May 9 .McFarland LV , Dublin S. Meta - analysis of probiotics for the treatment of irritable bowel syndrome .World J Gastroenterol .", "label": "", "metadata": {}, "score": "50.432194"}
{"text": "2008 May 9 .McFarland LV , Dublin S. Meta - analysis of probiotics for the treatment of irritable bowel syndrome .World J Gastroenterol .", "label": "", "metadata": {}, "score": "50.432194"}
{"text": "Gas - related symptoms represent very common complaints in children .The reduction of gas production can be considered as a valuable target in controlling symptoms .", "label": "", "metadata": {}, "score": "50.57955"}
{"text": "Out of 7 patients with constipation - predominant IBS , 4 were responders , mostly due to a decrease in cramping but also due to some improvement with constipation and flatulence .", "label": "", "metadata": {}, "score": "50.644794"}
{"text": "Longstreth GF , et al .: Functional bowel disorders .Gastroenterology 2006 , 130 : 1480 - 1491 .PubMed View Article .Sandler RS , Stewart WF , Liberman JN , et al .", "label": "", "metadata": {}, "score": "50.65443"}
{"text": "McKee AM , Prior A , Whorwell PJ .Exclusion diets in irritable bowel syndrome : are they worthwhile ?J Clin Gastroenterol .Jones VA , McLaughlan P , Shorthouse M , et al .", "label": "", "metadata": {}, "score": "50.860184"}
{"text": "McKee AM , Prior A , Whorwell PJ .Exclusion diets in irritable bowel syndrome : are they worthwhile ?J Clin Gastroenterol .Jones VA , McLaughlan P , Shorthouse M , et al .", "label": "", "metadata": {}, "score": "50.860184"}
{"text": "McKee AM , Prior A , Whorwell PJ .Exclusion diets in irritable bowel syndrome : are they worthwhile ?J Clin Gastroenterol .Jones VA , McLaughlan P , Shorthouse M , et al .", "label": "", "metadata": {}, "score": "50.860184"}
{"text": "McKee AM , Prior A , Whorwell PJ .Exclusion diets in irritable bowel syndrome : are they worthwhile ?J Clin Gastroenterol .Jones VA , McLaughlan P , Shorthouse M , et al .", "label": "", "metadata": {}, "score": "50.860184"}
{"text": "218 - 227 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Clav\u00e9 , M. Acalovschi , J. K. Triantafillidis et al . , \" Randomised clinical trial : otilonium bromide improves frequency of abdominal pain , severity of distention and time to relapse in patients with irritable bowel syndrome , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "50.93144"}
{"text": "12 , pp .1311 - 1321 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. D. Dorn , T. J. Kaptchuk , J. B. Park et al . , \" A meta - analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome , \" Neurogastroenterology and Motility , vol .", "label": "", "metadata": {}, "score": "50.955345"}
{"text": "The FPS - R score improved more in the \u03b1 - galactosidase than placebo group , even if the difference was not statistically significant ( Table 3 ) .", "label": "", "metadata": {}, "score": "50.987957"}
{"text": "The FPS - R score improved more in the \u03b1 - galactosidase than placebo group , even if the difference was not statistically significant ( Table 3 ) .", "label": "", "metadata": {}, "score": "50.987957"}
{"text": "This product has been investigated in experimental visceral hypersensitivity models that showed a dose - dependent analgesic effect .It significantly decreased serotonin levels in serum and CRF concentrations in the brain .", "label": "", "metadata": {}, "score": "51.15026"}
{"text": "The significant decrease of FPS - R score occurring in the active group and the marginal change in the placebo group provides the evidence of the efficacy of \u03b1 - galactosidase .", "label": "", "metadata": {}, "score": "51.23157"}
{"text": "The significant decrease of FPS - R score occurring in the active group and the marginal change in the placebo group provides the evidence of the efficacy of \u03b1 - galactosidase .", "label": "", "metadata": {}, "score": "51.23157"}
{"text": "Spiller R , Aziz Q , Creed F , et al .: Guidelines on the irritable bowel syndrome : mechanisms and practical management .Gut 2007 , 56 : 1770 - 1798 .", "label": "", "metadata": {}, "score": "51.404556"}
{"text": "[PubMed ] [ DOI ] .Madisch A , Holtmann G , Plein K , Hotz J. Treatment of irritable bowel syndrome with herbal preparations : results of a double - blind , randomized , placebo - controlled , multi - centre trial .", "label": "", "metadata": {}, "score": "51.42571"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A controlled trial of psychological treatment for the irritable bowel syndrome .Gastroenterology .", "label": "", "metadata": {}, "score": "51.473797"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A controlled trial of psychological treatment for the irritable bowel syndrome .Gastroenterology .", "label": "", "metadata": {}, "score": "51.473797"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A controlled trial of psychological treatment for the irritable bowel syndrome .Gastroenterology .", "label": "", "metadata": {}, "score": "51.473797"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A controlled trial of psychological treatment for the irritable bowel syndrome .Gastroenterology .", "label": "", "metadata": {}, "score": "51.473797"}
{"text": "1910 - 1915 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Wilson , G. F. Longstreth , K. Knight et al . , \" Quality of life in managed care patients with irritable bowel syndrome , \" Managed Care Interface , vol .", "label": "", "metadata": {}, "score": "51.49685"}
{"text": "[PubMed ] [ Cross Ref ] .Jones M. Bloating and intestinal gas .Curr Treat Options Gastroenterol .doi : 10.1007/s11938 - 005 - 0024-x .", "label": "", "metadata": {}, "score": "51.51326"}
{"text": "Other medical treatment approaches for IBS include increased dietary fiber , drugs that reduce bowel spasm , and drugs to address constipation or diarrhea as needed .", "label": "", "metadata": {}, "score": "51.60222"}
{"text": "Other medical treatment approaches for IBS include increased dietary fiber , drugs that reduce bowel spasm , and drugs to address constipation or diarrhea as needed .", "label": "", "metadata": {}, "score": "51.60222"}
{"text": "Hypnotherapy has also been studied for IBS in children .76 Fifty - two children with IBS or functional ( unknown cause ) abdominal pain were randomized to hypnotherapy or standard care .", "label": "", "metadata": {}, "score": "51.62845"}
{"text": "Hypnotherapy has also been studied for IBS in children .76 Fifty - two children with IBS or functional ( unknown cause ) abdominal pain were randomized to hypnotherapy or standard care .", "label": "", "metadata": {}, "score": "51.62845"}
{"text": "Hypnotherapy has also been studied for IBS in children .76 Fifty - two children with IBS or functional ( unknown cause ) abdominal pain were randomized to hypnotherapy or standard care .", "label": "", "metadata": {}, "score": "51.62845"}
{"text": "Hypnotherapy has also been studied for IBS in children .76 Fifty - two children with IBS or functional ( unknown cause ) abdominal pain were randomized to hypnotherapy or standard care .", "label": "", "metadata": {}, "score": "51.62845"}
{"text": "The nepean dyspepsia index ( NDI ) total symptom score significantly decreased by 41 % after treatment .Similarly , there was 20 % improvement in the NDI total QOL score in the subset after treatment [ 23 ] .", "label": "", "metadata": {}, "score": "51.67427"}
{"text": "This study found benefits that persisted for an entire year after treatment stopped .15 In a review of 3 randomized trials , Lactobacillus rhamnosus GG was associated with improvement in symptoms , especially a reduction in abdominal pain , among 393 children with IBS .", "label": "", "metadata": {}, "score": "51.731766"}
{"text": "This study found benefits that persisted for an entire year after treatment stopped .15 In a review of 3 randomized trials , Lactobacillus rhamnosus GG was associated with improvement in symptoms , especially a reduction in abdominal pain , among 393 children with IBS .", "label": "", "metadata": {}, "score": "51.731766"}
{"text": "This study found benefits that persisted for an entire year after treatment stopped .15 In a review of 3 randomized trials , Lactobacillus rhamnosus GG was associated with improvement in symptoms , especially a reduction in abdominal pain , among 393 children with IBS .", "label": "", "metadata": {}, "score": "51.731766"}
{"text": "This study found benefits that persisted for an entire year after treatment stopped .15 In a review of 3 randomized trials , Lactobacillus rhamnosus GG was associated with improvement in symptoms , especially a reduction in abdominal pain , among 393 children with IBS .", "label": "", "metadata": {}, "score": "51.731766"}
{"text": "To insure the safety of this study , patients also received standard heart , renal , liver function laboratory tests and routine examination of blood , urine , and stools in the screen period and at the end of the treatment period ( week 4 ) .", "label": "", "metadata": {}, "score": "51.754696"}
{"text": "Guandalini S , Magazz\u00f9 G , Chiaro A , et al .VSL#3 improves symptoms in children with irritable bowel syndrome : a multicenter , randomized , placebo - controlled , double - blind , crossover study .", "label": "", "metadata": {}, "score": "51.914993"}
{"text": "Guandalini S , Magazz\u00f9 G , Chiaro A , et al .VSL#3 improves symptoms in children with irritable bowel syndrome : a multicenter , randomized , placebo - controlled , double - blind , crossover study .", "label": "", "metadata": {}, "score": "51.914993"}
{"text": "Guandalini S , Magazz\u00f9 G , Chiaro A , et al .VSL#3 improves symptoms in children with irritable bowel syndrome : a multicenter , randomized , placebo - controlled , double - blind , crossover study .", "label": "", "metadata": {}, "score": "51.914993"}
{"text": "Guandalini S , Magazz\u00f9 G , Chiaro A , et al .VSL#3 improves symptoms in children with irritable bowel syndrome : a multicenter , randomized , placebo - controlled , double - blind , crossover study .", "label": "", "metadata": {}, "score": "51.914993"}
{"text": "Gastroenterology 2006 , 130 : 1480 - 1491 .PubMed View Article .Grundmann O , Yoon SL : Complementary and alternative medicines in irritable bowel syndrome : An integrative view .", "label": "", "metadata": {}, "score": "51.973732"}
{"text": "Discussion .According to TCM theory , SQTX Granule has a regulating effect on abdominal pain , diarrhea and the syndrome of liver - spleen disharmony , which is similar to the symptoms of IBS - D. This study will provide objective evidence to evaluate the efficiency and safety of SQTX Granule in IBS - D treatment .", "label": "", "metadata": {}, "score": "51.981434"}
{"text": "The good tolerability was documented by adverse event recording during the study .About 6 % of patients reported adverse reactions with a probable or possible relationship to the test product .", "label": "", "metadata": {}, "score": "52.023453"}
{"text": "23 , no .5 , pp .878 - 884 , 1992 .View at Google Scholar .Unpublished Materials by H\u00fcbner24 GmbH .N. J. Talley , M. Verlinden , and M. Jones , \" Validity of a new quality of life scale for functional dyspepsia : a United States multicenter trial of the Nepean Dyspepsia index , \" American Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "52.12577"}
{"text": "No biomarkers have been found for IBS diagnosis [ 10 ] , so IBS is diagnosed by assessing symptoms , according to the Rome III criteria [ 11 , 12 ] .", "label": "", "metadata": {}, "score": "52.128216"}
{"text": "PubMed View Article .Irvine EJ , et al .: Design of treatment trials for functional gastrointestinal disorders .Gastroenterology 2006 , 130 : 1538 - 1551 .", "label": "", "metadata": {}, "score": "52.14469"}
{"text": "Diet was surveyed using a qualitative questionnaire at the beginning and end of the study .Patients were also weighed at the beginning and end .", "label": "", "metadata": {}, "score": "52.169983"}
{"text": "Conclusions .HM appears to be a promising , efficacious , and well - tolerated treatment for patients with IBS - D. Introduction .Irritable bowel syndrome ( IBS ) , which is defined as \" abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months \" [ 1 ] , is a common gastrointestinal ( GI ) disorder .", "label": "", "metadata": {}, "score": "52.220078"}
{"text": "PubMed View Article .Bensoussan A , Talley NJ , Hing M , Menzies R , Guo A , Ngu M : Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "52.25393"}
{"text": "Diagnosis of IBS - D is established according to the Rome III criteria [ 11 , 12 ] , mode listed in Table 2 .In pathophysiology research and clinical trials , a pain / discomfort frequency of at least two days a week during the screening evaluation is recommended for subject eligibility .", "label": "", "metadata": {}, "score": "52.25483"}
{"text": "The present study plays an important role in the development of safer effective alternatives for the management of IBS - D there is significant unmet clinical need .", "label": "", "metadata": {}, "score": "52.275032"}
{"text": "6 , pp .429 - 438 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Svedlund , I. Sjodin , and G. Dotevall , \" GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease , \" Digestive Diseases and Sciences , vol .", "label": "", "metadata": {}, "score": "52.296227"}
{"text": "In our study we could roughly regard the responses in obstipation , in which the mechanism of action of the product is unclear at least as a possible placebo - effect .", "label": "", "metadata": {}, "score": "52.453804"}
{"text": "Thus the condition belongs to a category of diseases that physicians call \" functional .\" This means that while the function of the bowel seems to have gone awry , no injury or disturbance of its structure can be discovered .", "label": "", "metadata": {}, "score": "52.60097"}
{"text": "Thus the condition belongs to a category of diseases that physicians call \" functional .\" This means that while the function of the bowel seems to have gone awry , no injury or disturbance of its structure can be discovered .", "label": "", "metadata": {}, "score": "52.60097"}
{"text": "The number of patients who showed reduction of the basal total IBS symptoms score in the peppermint oil group was greater than that in the placebo group [ 34 ] .", "label": "", "metadata": {}, "score": "52.604225"}
{"text": "Dig Dis Sci 2000 , 45 : 1166 - 1171 .PubMed View Article .Youssef NN , et al .: Quality of life for children with functional abdominal pain : a comparison study of patients ' and parents ' perceptions .", "label": "", "metadata": {}, "score": "52.69734"}
{"text": "Taking into account a drop - out of 15 % , the sample size needs to be 150 cases for each group .A total of 440 patients will be recruited in this trial , including 330 cases for the SQTX Granule group and 110 cases for the placebo group in a 3:1 ratio .", "label": "", "metadata": {}, "score": "52.797276"}
{"text": "[PubMed ] [ DOI ] .Gwee KA , Lu CL , Ghoshal UC .Epidemiology of irritable bowel syndrome in Asia : something old , something new , something borrowed .", "label": "", "metadata": {}, "score": "52.814697"}
{"text": "Moser G , Tr\u00e4gner S , Gajowniczek EE .Long - term success of GUT - directed group hypnosis for patients with refractory irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "53.165443"}
{"text": "Moser G , Tr\u00e4gner S , Gajowniczek EE .Long - term success of GUT - directed group hypnosis for patients with refractory irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "53.165443"}
{"text": "Moser G , Tr\u00e4gner S , Gajowniczek EE .Long - term success of GUT - directed group hypnosis for patients with refractory irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "53.165443"}
{"text": "Moser G , Tr\u00e4gner S , Gajowniczek EE .Long - term success of GUT - directed group hypnosis for patients with refractory irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "53.165443"}
{"text": "The effects were associated with a restoration of the disturbed acetylcholine - induced contraction , pathohistological protection and inhibition of tumor necrosis factor ( TNF)-\u03b1 [ 50 ] .", "label": "", "metadata": {}, "score": "53.209965"}
{"text": "J Clin Gastroenterol .Gawronska A , Dziechciarz P , Horvath A , et al .A randomized double - blind placebo - controlled trial of Lactobacillus GG for abdominal pain disorders in children .", "label": "", "metadata": {}, "score": "53.28025"}
{"text": "J Clin Gastroenterol .Gawronska A , Dziechciarz P , Horvath A , et al .A randomized double - blind placebo - controlled trial of Lactobacillus GG for abdominal pain disorders in children .", "label": "", "metadata": {}, "score": "53.28025"}
{"text": "J Clin Gastroenterol .Gawronska A , Dziechciarz P , Horvath A , et al .A randomized double - blind placebo - controlled trial of Lactobacillus GG for abdominal pain disorders in children .", "label": "", "metadata": {}, "score": "53.28025"}
{"text": "J Clin Gastroenterol .Gawronska A , Dziechciarz P , Horvath A , et al .A randomized double - blind placebo - controlled trial of Lactobacillus GG for abdominal pain disorders in children .", "label": "", "metadata": {}, "score": "53.28025"}
{"text": "The effect of HM was significantly greater than that of orally taking PB in ameliorating the symptoms of rugitus ( 0.38 versus 0.59 , . ) at the end of treatment period .", "label": "", "metadata": {}, "score": "53.332138"}
{"text": "Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome .Lancet .Waxman D. The irritable bowel : a pathological or psychological syndrome ?", "label": "", "metadata": {}, "score": "53.49264"}
{"text": "Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome .Lancet .Waxman D. The irritable bowel : a pathological or psychological syndrome ?", "label": "", "metadata": {}, "score": "53.49264"}
{"text": "Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome .Lancet .Waxman D. The irritable bowel : a pathological or psychological syndrome ?", "label": "", "metadata": {}, "score": "53.49264"}
{"text": "Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome .Lancet .Waxman D. The irritable bowel : a pathological or psychological syndrome ?", "label": "", "metadata": {}, "score": "53.49264"}
{"text": "PubMed View Article .Guandalini S , Magazz\u00f9 G , Chiaro A , et al .:VSL#3 improves symptoms in children with irritable bowel syndrome : a multicenter , randomized , placebo - controlled , double - blind , crossover study .", "label": "", "metadata": {}, "score": "53.531143"}
{"text": "Paineau D , Payen F , Panserieu S , et al .The effects of regular consumption of short - chain fructo - oligosaccharides on digestive comfort of subjects with minor functional bowel disorders .", "label": "", "metadata": {}, "score": "53.606403"}
{"text": "Paineau D , Payen F , Panserieu S , et al .The effects of regular consumption of short - chain fructo - oligosaccharides on digestive comfort of subjects with minor functional bowel disorders .", "label": "", "metadata": {}, "score": "53.606403"}
{"text": "Paineau D , Payen F , Panserieu S , et al .The effects of regular consumption of short - chain fructo - oligosaccharides on digestive comfort of subjects with minor functional bowel disorders .", "label": "", "metadata": {}, "score": "53.606403"}
{"text": "Paineau D , Payen F , Panserieu S , et al .The effects of regular consumption of short - chain fructo - oligosaccharides on digestive comfort of subjects with minor functional bowel disorders .", "label": "", "metadata": {}, "score": "53.606403"}
{"text": "PubMed Central PubMed View Article .Gastroenterology 2013 , 145 : 1253 - 1261 .PubMed View Article .Arebi N , Gurmany S , Bullas D , Hobson A , Stagg A , Kamm M : Review article : the psychoneuroimmunology of irritable bowel syndrome - an exploration of interactions between psychological , neurological and immunological observations .", "label": "", "metadata": {}, "score": "53.615475"}
{"text": "Overall , 62 per - protocol - patients were analyzed for efficacy ( see Figure 1 ) .Table 2 : Relative changes between V0 and V3 ( mean , standard deviation , minimum , maximum , responder frequency ) .", "label": "", "metadata": {}, "score": "53.61998"}
{"text": "These data may explain , at least in part , the clinically observed therapeutic efficacy of STW 5 in both hypotonic and spastic dysmotility symptoms of IBS [ 48 ] .", "label": "", "metadata": {}, "score": "53.687637"}
{"text": "Acknowledgment .This work is supported by Anton H\u00fcbner GmbH & Co. KG .References . A. Icks , B. Haastert , P. Enck , W. Rathmann , and G. Giani , \" Health - related quality of life in subjects with functional bowel disorders in Germany , \" Zeitschrift fur Gastroenterologie , vol .", "label": "", "metadata": {}, "score": "53.849094"}
{"text": "According to physician 's overall evaluation , children receiving \u03b1 - galactosidase had higher rates of improvement ( 67 % ) than placebo ( 52 % ) but the difference was not statistically significant .", "label": "", "metadata": {}, "score": "53.895176"}
{"text": "According to physician 's overall evaluation , children receiving \u03b1 - galactosidase had higher rates of improvement ( 67 % ) than placebo ( 52 % ) but the difference was not statistically significant .", "label": "", "metadata": {}, "score": "53.895176"}
{"text": "The flaxseed group had even further improvements in constipation and bloating while continuing their treatment in the 3 months after the double - blind study ended .", "label": "", "metadata": {}, "score": "53.949745"}
{"text": "The flaxseed group had even further improvements in constipation and bloating while continuing their treatment in the 3 months after the double - blind study ended .", "label": "", "metadata": {}, "score": "53.949745"}
{"text": "The flaxseed group had even further improvements in constipation and bloating while continuing their treatment in the 3 months after the double - blind study ended .", "label": "", "metadata": {}, "score": "53.949745"}
{"text": "The flaxseed group had even further improvements in constipation and bloating while continuing their treatment in the 3 months after the double - blind study ended .", "label": "", "metadata": {}, "score": "53.949745"}
{"text": "4 , pp .51 - 59 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. O. Quartero , V. Meineche - Schmidt , J. Muris , G. Rubin , and N. de Wit , \" Bulking agents , antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome , \" Cochrane Database of Systematic Reviews , vol .", "label": "", "metadata": {}, "score": "53.973465"}
{"text": "References .Guthrie E , Creed F , Dawson D , et al .A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome .", "label": "", "metadata": {}, "score": "54.01272"}
{"text": "PubMed View Article .Brandt LJ , Chey WD , Foxx - Orenstein AE , Schiller LR , Schoenfeld PS , Spiegel BM , Talley NJ , Quigley EM : An evidence - based position statement on the management of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "54.11365"}
{"text": "All data were evaluated in a descriptive manner .All data are presented as means \u00b1 SE .Changes in sum scores were analyzed with two - tailed , paired t -tests .", "label": "", "metadata": {}, "score": "54.134674"}
{"text": "[PubMed ] [ DOI ] .Duracinsky M , Chassany O. [ How can an effective drug to treat irritable bowel syndrome be successfully developed ? ]", "label": "", "metadata": {}, "score": "54.154762"}
{"text": "Horvath A , Dziechciarz P , Szajewska H. Meta - analysis : Lactobacillus rhamnosus GG for abdominal pain - related functional gastrointestinal disorders in childhood .", "label": "", "metadata": {}, "score": "54.171864"}
{"text": "Horvath A , Dziechciarz P , Szajewska H. Meta - analysis : Lactobacillus rhamnosus GG for abdominal pain - related functional gastrointestinal disorders in childhood .", "label": "", "metadata": {}, "score": "54.171864"}
{"text": "Horvath A , Dziechciarz P , Szajewska H. Meta - analysis : Lactobacillus rhamnosus GG for abdominal pain - related functional gastrointestinal disorders in childhood .", "label": "", "metadata": {}, "score": "54.171864"}
{"text": "Horvath A , Dziechciarz P , Szajewska H. Meta - analysis : Lactobacillus rhamnosus GG for abdominal pain - related functional gastrointestinal disorders in childhood .", "label": "", "metadata": {}, "score": "54.171864"}
{"text": "10 , pp .863 - 867 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Icks , B. Haastert , P. Enck , W. Rathmann , and G. Giani , \" Prevalence of functional bowel disorders and related health care seeking : a population - based study , \" Zeitschrift fur Gastroenterologie , vol .", "label": "", "metadata": {}, "score": "54.185364"}
{"text": "PubMed Central PubMed View Article .Drossman DA , Chang L , Bellamy N , Gallo - Torres HE , Lembo A , Mearin F , Norton NJ , Whorwell P : Severity in irritable bowel syndrome : a Rome Foundation Working Team report .", "label": "", "metadata": {}, "score": "54.202545"}
{"text": "Parents and/or patients recorded symptoms 3 times daily ( 7 - 8 am , 2 - 3 pm , 6 - 7 pm ) during the treatment .", "label": "", "metadata": {}, "score": "54.240097"}
{"text": "Parents and/or patients recorded symptoms 3 times daily ( 7 - 8 am , 2 - 3 pm , 6 - 7 pm ) during the treatment .", "label": "", "metadata": {}, "score": "54.240097"}
{"text": "[PubMed ] [ DOI ] .Ford AC , Brandt LJ , Young C , Chey WD , Foxx - Orenstein AE , Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "54.351784"}
{"text": "A detailed medical history may help physicians to recognize children in whom , based on the medical history , food appears to induce or favor gas - related symptoms .", "label": "", "metadata": {}, "score": "54.40921"}
{"text": "A detailed medical history may help physicians to recognize children in whom , based on the medical history , food appears to induce or favor gas - related symptoms .", "label": "", "metadata": {}, "score": "54.40921"}
{"text": "951 - 956 , 2007 .View at Google Scholar .C. Reimer , B. S\u00f8ndergaard , L. Hilsted , and P. Bytzer , \" Proton - pump inhibitor therapy induces acid - related symptoms in healthy volunteers after withdrawal of therapy , \" Gastroenterology , vol .", "label": "", "metadata": {}, "score": "54.42403"}
{"text": "[PubMed ] [ DOI ] .Hawrelak JA , Myers SP .Effects of two natural medicine formulations on irritable bowel syndrome symptoms : a pilot study .", "label": "", "metadata": {}, "score": "54.432922"}
{"text": "The trend for worse score along the day was common for both groups .The scores were lower with \u03b1 - galactosidase even if no difference was statistically significant .", "label": "", "metadata": {}, "score": "54.447964"}
{"text": "The trend for worse score along the day was common for both groups .The scores were lower with \u03b1 - galactosidase even if no difference was statistically significant .", "label": "", "metadata": {}, "score": "54.447964"}
{"text": "O'Sullivan MA , et al .Bacterial supplementaion in the irritable bowel syndrome .A randomized double - blind placebo - controlled crossover study .Digest Liver Dis .", "label": "", "metadata": {}, "score": "54.48761"}
{"text": "O'Sullivan MA , et al .Bacterial supplementaion in the irritable bowel syndrome .A randomized double - blind placebo - controlled crossover study .Digest Liver Dis .", "label": "", "metadata": {}, "score": "54.48761"}
{"text": "O'Sullivan MA , et al .Bacterial supplementaion in the irritable bowel syndrome .A randomized double - blind placebo - controlled crossover study .Digest Liver Dis .", "label": "", "metadata": {}, "score": "54.48761"}
{"text": "O'Sullivan MA , et al .Bacterial supplementaion in the irritable bowel syndrome .A randomized double - blind placebo - controlled crossover study .Digest Liver Dis .", "label": "", "metadata": {}, "score": "54.48761"}
{"text": "King TS , Elia M , Hunter JO .Abnormal colonic fermentation in irritable bowel syndrome .Lancet .Ballegaard M , Bjergstrom A , Brondum S , et al .", "label": "", "metadata": {}, "score": "54.54554"}
{"text": "King TS , Elia M , Hunter JO .Abnormal colonic fermentation in irritable bowel syndrome .Lancet .Ballegaard M , Bjergstrom A , Brondum S , et al .", "label": "", "metadata": {}, "score": "54.54554"}
{"text": "King TS , Elia M , Hunter JO .Abnormal colonic fermentation in irritable bowel syndrome .Lancet .Ballegaard M , Bjergstrom A , Brondum S , et al .", "label": "", "metadata": {}, "score": "54.54554"}
{"text": "King TS , Elia M , Hunter JO .Abnormal colonic fermentation in irritable bowel syndrome .Lancet .Ballegaard M , Bjergstrom A , Brondum S , et al .", "label": "", "metadata": {}, "score": "54.54554"}
{"text": "24 - 34 , 2004 .View at Google Scholar \u00b7 View at Scopus . D. A. Drossman , W. D. Chey , J. F. Johanson et al . , \" Clinical trial : lubiprostone in patients with constipation - associated irritable bowel syndrome - results of two randomized , placebo - controlled studies , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "54.5797"}
{"text": "Whorwell PJ .Use of hypnotherapy in gastrointestinal disease .Br J Hosp Med .Forbes A , Jackson S , Walter C , et al .", "label": "", "metadata": {}, "score": "54.752197"}
{"text": "Whorwell PJ .Use of hypnotherapy in gastrointestinal disease .Br J Hosp Med .Forbes A , Jackson S , Walter C , et al .", "label": "", "metadata": {}, "score": "54.752197"}
{"text": "Whorwell PJ .Use of hypnotherapy in gastrointestinal disease .Br J Hosp Med .Forbes A , Jackson S , Walter C , et al .", "label": "", "metadata": {}, "score": "54.752197"}
{"text": "Whorwell PJ .Use of hypnotherapy in gastrointestinal disease .Br J Hosp Med .Forbes A , Jackson S , Walter C , et al .", "label": "", "metadata": {}, "score": "54.752197"}
{"text": "Finally , although we instructed the parents of our patients to continue with their usual diet over the study period , the dietary habits of our children were not formally recorded in diary during the study .", "label": "", "metadata": {}, "score": "54.910606"}
{"text": "Finally , although we instructed the parents of our patients to continue with their usual diet over the study period , the dietary habits of our children were not formally recorded in diary during the study .", "label": "", "metadata": {}, "score": "54.910606"}
{"text": "Li Q , Liu F , et al .Treatment of constipation - predominant irritable bowel syndrome by focusing on the liver in terms of Traditional Chinese Medicine : a meta - analysis .", "label": "", "metadata": {}, "score": "54.933376"}
{"text": "Li Q , Liu F , et al .Treatment of constipation - predominant irritable bowel syndrome by focusing on the liver in terms of Traditional Chinese Medicine : a meta - analysis .", "label": "", "metadata": {}, "score": "54.933376"}
{"text": "Li Q , Liu F , et al .Treatment of constipation - predominant irritable bowel syndrome by focusing on the liver in terms of Traditional Chinese Medicine : a meta - analysis .", "label": "", "metadata": {}, "score": "54.933376"}
{"text": "Li Q , Liu F , et al .Treatment of constipation - predominant irritable bowel syndrome by focusing on the liver in terms of Traditional Chinese Medicine : a meta - analysis .", "label": "", "metadata": {}, "score": "54.933376"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.03822"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.03822"}
{"text": "Guthrie E , Creed F , Dawson D , et al .A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.03822"}
{"text": "Drouault - Holowacz S , Bieuvelet S , Burckel A , et al .A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.046394"}
{"text": "Drouault - Holowacz S , Bieuvelet S , Burckel A , et al .A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.046394"}
{"text": "Drouault - Holowacz S , Bieuvelet S , Burckel A , et al .A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.046394"}
{"text": "Drouault - Holowacz S , Bieuvelet S , Burckel A , et al .A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "55.046394"}
{"text": "The measurements that need to be performed at each visit are listed in Figure 2 .Study schedule for patients .After the enrolment and allocation , participants will receive the administration for four weeks and a follow - up of eight weeks .", "label": "", "metadata": {}, "score": "55.0563"}
{"text": "Lu WZ , Gwee KA , Moochhalla S , et al .Melatonin improves bowel symptoms in female patients with irritable bowel syndrome : a double - blind placebo - controlled study .", "label": "", "metadata": {}, "score": "55.1504"}
{"text": "Lu WZ , Gwee KA , Moochhalla S , et al .Melatonin improves bowel symptoms in female patients with irritable bowel syndrome : a double - blind placebo - controlled study .", "label": "", "metadata": {}, "score": "55.1504"}
{"text": "Lu WZ , Gwee KA , Moochhalla S , et al .Melatonin improves bowel symptoms in female patients with irritable bowel syndrome : a double - blind placebo - controlled study .", "label": "", "metadata": {}, "score": "55.1504"}
{"text": "Lu WZ , Gwee KA , Moochhalla S , et al .Melatonin improves bowel symptoms in female patients with irritable bowel syndrome : a double - blind placebo - controlled study .", "label": "", "metadata": {}, "score": "55.1504"}
{"text": "1991 ; 100 : A251 .Di Stefano M , Miceli E , Gotti S. et al .The effect of oral \u03b1 - galactosidase on intestinal gas production and gas - related symptoms .", "label": "", "metadata": {}, "score": "55.161564"}
{"text": "PubMed .Thompson WG , Irvine EJ , Pare P , Ferrazzi S , Rance L : Functional gastrointestinal disorders in Canada : first population - based survey using Rome II criteria with suggestions for improving the questionnaire .", "label": "", "metadata": {}, "score": "55.19605"}
{"text": "43 - 45 , 1996 .View at Google Scholar .E.-H. Zhou , H.-R. Liu , H.-G. Wu et al . , \" Herb - partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats , \" Neurological Research , vol .", "label": "", "metadata": {}, "score": "55.221546"}
{"text": "Schmulson M , Chang L : Review article : the treatment of functional abdominal bloating and distension .Aliment Pharmacol Ther 2011 , 33 : 1071 - 1086 .", "label": "", "metadata": {}, "score": "55.33205"}
{"text": "Nikfar S , Rahimi R , Rahimi F , et al .Efficacy of probiotics in irritable bowel syndrome : a meta - analysis of randomized , controlled trials .", "label": "", "metadata": {}, "score": "55.35898"}
{"text": "Nikfar S , Rahimi R , Rahimi F , et al .Efficacy of probiotics in irritable bowel syndrome : a meta - analysis of randomized , controlled trials .", "label": "", "metadata": {}, "score": "55.35898"}
{"text": "Nikfar S , Rahimi R , Rahimi F , et al .Efficacy of probiotics in irritable bowel syndrome : a meta - analysis of randomized , controlled trials .", "label": "", "metadata": {}, "score": "55.35898"}
{"text": "Nikfar S , Rahimi R , Rahimi F , et al .Efficacy of probiotics in irritable bowel syndrome : a meta - analysis of randomized , controlled trials .", "label": "", "metadata": {}, "score": "55.35898"}
{"text": "Brinkhaus B , Hentschel C , Von Keudell C , et al .Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome : a randomized , placebo - controlled , double - blind clinical trial .", "label": "", "metadata": {}, "score": "55.381462"}
{"text": "Brinkhaus B , Hentschel C , Von Keudell C , et al .Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome : a randomized , placebo - controlled , double - blind clinical trial .", "label": "", "metadata": {}, "score": "55.381462"}
{"text": "Brinkhaus B , Hentschel C , Von Keudell C , et al .Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome : a randomized , placebo - controlled , double - blind clinical trial .", "label": "", "metadata": {}, "score": "55.381462"}
{"text": "Brinkhaus B , Hentschel C , Von Keudell C , et al .Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome : a randomized , placebo - controlled , double - blind clinical trial .", "label": "", "metadata": {}, "score": "55.381462"}
{"text": "Adverse events .Adverse events will be recorded and graded in detail throughout the study .When a severe adverse event occurs , participants will be provided with every necessary treatment , and the event must be reported to the leader of the trial , ethics committees , sponsors and CFDA within 24 hours .", "label": "", "metadata": {}, "score": "55.4274"}
{"text": "PubMed View Article .Rahimi R , Abdollahi M : Herbal medicines for the management of irritable bowel syndrome : a comprehensive review .World J Gastroenterol 2012 , 18 : 589 - 600 .", "label": "", "metadata": {}, "score": "55.505753"}
{"text": "Decreasing and disappearing time of abdominal pain and diarrhea : .Safety outcome .Data management .After review by clinical inspectors , completed CRFs will be sent to a specified statistics centre , and data entry and management is completed by two individual data administrators to ensure the accuracy of the data .", "label": "", "metadata": {}, "score": "55.542324"}
{"text": "The most common reasons for study discontinuation were the lack of efficacy in three patients ( group FM : one patient ; group PB : two patients ) and AEs in two patients ( group HM : one patient ; group PB : one patient ) .", "label": "", "metadata": {}, "score": "55.671967"}
{"text": "PubMed View Article .Barbara G , Stanghellini V : Review biomarkers in IBS : when will they replace symptoms for diagnosis and management ?Gut 2009 , 58 : 1571 - 1575 .", "label": "", "metadata": {}, "score": "55.890022"}
{"text": "Drug tolerability was rated , and physical examinations were repeated .The remaining test drug was weighed as a measure of compliance .Evaluation Parameters .", "label": "", "metadata": {}, "score": "55.976814"}
{"text": "Only two patients were found to have light allergy during the study time and recovered without treatment .Our findings are consistent with the previous clinical trial [ 16 ] including 81 patients .", "label": "", "metadata": {}, "score": "56.006554"}
{"text": "Although IBS does not end up with the development of serious disease and associated mortality , it does have a significant negative impact on patients ' quality of life and social functioning [ 3 ] and can increase healthcare costs [ 4 ] .", "label": "", "metadata": {}, "score": "56.05449"}
{"text": "( The analogous problem in the stomach is called dyspepsia , and the two conditions frequently overlap . )Because the cause of IBS is not understood , conventional medical treatment of IBS is highly inadequate .", "label": "", "metadata": {}, "score": "56.062473"}
{"text": "( The analogous problem in the stomach is called dyspepsia , and the two conditions frequently overlap . )Because the cause of IBS is not understood , conventional medical treatment of IBS is highly inadequate .", "label": "", "metadata": {}, "score": "56.062473"}
{"text": "As a result , the best treatment is still not well defined [ 4 , 5 ] .Bloating is the sensation of trapped gas and tightness in the abdomen which is exacerbated by meals and fluctuates in intensity during the day .", "label": "", "metadata": {}, "score": "56.069527"}
{"text": "As a result , the best treatment is still not well defined [ 4 , 5 ] .Bloating is the sensation of trapped gas and tightness in the abdomen which is exacerbated by meals and fluctuates in intensity during the day .", "label": "", "metadata": {}, "score": "56.069527"}
{"text": "As a consequence , it is hoped that further studies can be carried out in this field .Conclusion .The present trial provided preliminary evidence that HM may be a promising , efficacious , and well - tolerated treatment for IBS - D patients .", "label": "", "metadata": {}, "score": "56.131477"}
{"text": "These data justify the differential effect of STW 5 which is a result of the combined actions of its individual components explaining the clinically observed therapeutic efficacy of STW 5 in both hypotonic and spastic dysmotility symptoms of IBS .", "label": "", "metadata": {}, "score": "56.180336"}
{"text": "The TCM diagnosis of liver - spleen disharmony and diarrhea syndrome is based on the Guidelines for Clinical Research of New Chinese Medicine [ 20 ] .", "label": "", "metadata": {}, "score": "56.213257"}
{"text": "2007 Aug 13 .[ Epub ahead of print ] .Van der Veek PP , Van Rood YR , Masclee AA .Clinical trial : short- and long - term benefit of relaxation training for irritable bowel syndrome .", "label": "", "metadata": {}, "score": "56.232075"}
{"text": "2007 Aug 13 .[ Epub ahead of print ] .Van der Veek PP , Van Rood YR , Masclee AA .Clinical trial : short- and long - term benefit of relaxation training for irritable bowel syndrome .", "label": "", "metadata": {}, "score": "56.232075"}
{"text": "2007 Aug 13 .[ Epub ahead of print ] .Van der Veek PP , Van Rood YR , Masclee AA .Clinical trial : short- and long - term benefit of relaxation training for irritable bowel syndrome .", "label": "", "metadata": {}, "score": "56.232075"}
{"text": "2007 Aug 13 .[ Epub ahead of print ] .Van der Veek PP , Van Rood YR , Masclee AA .Clinical trial : short- and long - term benefit of relaxation training for irritable bowel syndrome .", "label": "", "metadata": {}, "score": "56.232075"}
{"text": "IBS considerably reduces patients ' quality of life , interfering with their working ability and social activity , and it also results in a significant economic burden through decreased work productivity and increased healthcare costs [ 6 ] .", "label": "", "metadata": {}, "score": "56.280224"}
{"text": "doi : 10.1053/j.gastro.2005.11.058 .[PubMed ] [ Cross Ref ] .Spiller R , Aziz Q , Creed F. et al .Guidelines on the irritable bowel syndrome : mechanisms and practical management .", "label": "", "metadata": {}, "score": "56.28597"}
{"text": "Other criteria .Patients are determined as requiring withdrawal based on disease progression , allergic reactions , serious adverse events , or poor efficacy .Serious complications .", "label": "", "metadata": {}, "score": "56.293015"}
{"text": "Issa B , Wafaei NA , Whorwell PJ : Abdominal bloating and distension : what is the role of the microbiota .Dig Dis Sci 2012 , 57 : 4 - 8 .", "label": "", "metadata": {}, "score": "56.464905"}
{"text": "Agrawal A , Houghton LA , Morris J , et al .Clinical trial : the effects of a fermented milk product containing Bifidobacterium lactis DN-173 - 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation .", "label": "", "metadata": {}, "score": "56.522892"}
{"text": "Agrawal A , Houghton LA , Morris J , et al .Clinical trial : the effects of a fermented milk product containing Bifidobacterium lactis DN-173 - 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation .", "label": "", "metadata": {}, "score": "56.522892"}
{"text": "Agrawal A , Houghton LA , Morris J , et al .Clinical trial : the effects of a fermented milk product containing Bifidobacterium lactis DN-173 - 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation .", "label": "", "metadata": {}, "score": "56.522892"}
{"text": "Agrawal A , Houghton LA , Morris J , et al .Clinical trial : the effects of a fermented milk product containing Bifidobacterium lactis DN-173 - 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation .", "label": "", "metadata": {}, "score": "56.522892"}
{"text": "[PubMed ] [ DOI ] .Bensoussan A , Talley NJ , Hing M , Menzies R , Guo A , Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "56.529987"}
{"text": "Li Q , Yang GY , Liu JP : Syndrome differentiation in Chinese herbal medicine for irritable bowel syndrome : a literature review of randomized trials .", "label": "", "metadata": {}, "score": "56.543255"}
{"text": "PubMed View Article .Spiller R : New insights into bloating and abdominal distension : is it all outlet obstruction ?Am J Gastroenterol 2010 , 105 : 888 - 889 .", "label": "", "metadata": {}, "score": "56.797268"}
{"text": "Data were collected for the years 1966 to 2011 ( up to February ) .The search terms were : \" complementary and alternative medicine \" , \" plant \" , or \" herb \" and \" irritable bowel syndrome \" .", "label": "", "metadata": {}, "score": "56.806637"}
{"text": "329 - 341 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Simr\u00e9n , L. \u00d6hman , J. Olsson et al . , \" Clinical trial : the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - A randomized , double - blind , controlled study , \" Alimentary Pharmacology and Therapeutics , vol .", "label": "", "metadata": {}, "score": "56.9849"}
{"text": "Stevenson C , Blaauw R , et al .Randomized clinical trial : Effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome .Nutrition .", "label": "", "metadata": {}, "score": "57.034954"}
{"text": "Stevenson C , Blaauw R , et al .Randomized clinical trial : Effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome .Nutrition .", "label": "", "metadata": {}, "score": "57.034954"}
{"text": "Stevenson C , Blaauw R , et al .Randomized clinical trial : Effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome .Nutrition .", "label": "", "metadata": {}, "score": "57.034954"}
{"text": "Stevenson C , Blaauw R , et al .Randomized clinical trial : Effect of Lactobacillus plantarum 299v on symptoms of irritable bowel syndrome .Nutrition .", "label": "", "metadata": {}, "score": "57.034954"}
{"text": "2009 ; 104 : 1831 - 1843 ; quiz 1844 .[PubMed ] [ DOI ] .Rezaie A , Nikfar S , Abdollahi M. The place of antibiotics in management of irritable bowel syndrome : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "57.06864"}
{"text": "Figure 3 : Primary endpoint : changes of the GSRS total score from baseline to week 4 ( end of the treatment ) and week 8 ( follow - up period ) for the three groups in the FAS population .", "label": "", "metadata": {}, "score": "57.1348"}
{"text": "Schneider A , Enck P , Streitberger K , et al .Acupuncture treatment in irritable bowel syndrome .Gut .2005 Sep 8 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "57.138447"}
{"text": "Schneider A , Enck P , Streitberger K , et al .Acupuncture treatment in irritable bowel syndrome .Gut .2005 Sep 8 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "57.138447"}
{"text": "Schneider A , Enck P , Streitberger K , et al .Acupuncture treatment in irritable bowel syndrome .Gut .2005 Sep 8 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "57.138447"}
{"text": "Schneider A , Enck P , Streitberger K , et al .Acupuncture treatment in irritable bowel syndrome .Gut .2005 Sep 8 .[ Epub ahead of print ] .", "label": "", "metadata": {}, "score": "57.138447"}
{"text": "Choi CH , Jo SY , Park HJ , Chang SK , Byeon JS , Myung SJ .A randomized , double - blind , placebo - controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome : effect on quality of life .", "label": "", "metadata": {}, "score": "57.13944"}
{"text": "Choi CH , Jo SY , Park HJ , Chang SK , Byeon JS , Myung SJ .A randomized , double - blind , placebo - controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome : effect on quality of life .", "label": "", "metadata": {}, "score": "57.13944"}
{"text": "Choi CH , Jo SY , Park HJ , Chang SK , Byeon JS , Myung SJ .A randomized , double - blind , placebo - controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome : effect on quality of life .", "label": "", "metadata": {}, "score": "57.13944"}
{"text": "Choi CH , Jo SY , Park HJ , Chang SK , Byeon JS , Myung SJ .A randomized , double - blind , placebo - controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome : effect on quality of life .", "label": "", "metadata": {}, "score": "57.13944"}
{"text": "Neurogastroenterol Motil .Niv E , Naftali T , Hallak R , et al .The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind , placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "57.208836"}
{"text": "Neurogastroenterol Motil .Niv E , Naftali T , Hallak R , et al .The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind , placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "57.208836"}
{"text": "Neurogastroenterol Motil .Niv E , Naftali T , Hallak R , et al .The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind , placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "57.208836"}
{"text": "Neurogastroenterol Motil .Niv E , Naftali T , Hallak R , et al .The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome - a double blind , placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "57.208836"}
{"text": "The FPS - R has been shown to be reliable for assessment of the intensity of children 's pain age 4 or 5 onward [ 18 ] .", "label": "", "metadata": {}, "score": "57.210426"}
{"text": "The FPS - R has been shown to be reliable for assessment of the intensity of children 's pain age 4 or 5 onward [ 18 ] .", "label": "", "metadata": {}, "score": "57.210426"}
{"text": "Results .Patients in group HM and group FM had lower GSRS total score at week 4 ( . ) as compared with patients ' score in group PB .", "label": "", "metadata": {}, "score": "57.23061"}
{"text": "The number of included patients is limited and their age range is wide .All our patients meet Rome III criteria for IBS and the American College of Gastroenterology IBS Task Force recommends that further investigations are unnecessary in young patients without alarm features with the exception of celiac disease serology .", "label": "", "metadata": {}, "score": "57.35479"}
{"text": "The number of included patients is limited and their age range is wide .All our patients meet Rome III criteria for IBS and the American College of Gastroenterology IBS Task Force recommends that further investigations are unnecessary in young patients without alarm features with the exception of celiac disease serology .", "label": "", "metadata": {}, "score": "57.35479"}
{"text": "PubMed ] [ DOI ] .Grundmann O , Yoon SL .Irritable bowel syndrome : epidemiology , diagnosis and treatment : an update for health - care practitioners .", "label": "", "metadata": {}, "score": "57.36323"}
{"text": "2007 Apr 7 .[ Epub ahead of print ] .Guyonnet D , Chassany O , Ducrotte P , et al .Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health - related quality of life and symptoms in irritable bowel syndrome in adults in primary care : a multicentre , randomized , double - blind , controlled trial .", "label": "", "metadata": {}, "score": "57.460464"}
{"text": "2007 Apr 7 .[ Epub ahead of print ] .Guyonnet D , Chassany O , Ducrotte P , et al .Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health - related quality of life and symptoms in irritable bowel syndrome in adults in primary care : a multicentre , randomized , double - blind , controlled trial .", "label": "", "metadata": {}, "score": "57.460464"}
{"text": "2007 Apr 7 .[ Epub ahead of print ] .Guyonnet D , Chassany O , Ducrotte P , et al .Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health - related quality of life and symptoms in irritable bowel syndrome in adults in primary care : a multicentre , randomized , double - blind , controlled trial .", "label": "", "metadata": {}, "score": "57.460464"}
{"text": "2007 Apr 7 .[ Epub ahead of print ] .Guyonnet D , Chassany O , Ducrotte P , et al .Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health - related quality of life and symptoms in irritable bowel syndrome in adults in primary care : a multicentre , randomized , double - blind , controlled trial .", "label": "", "metadata": {}, "score": "57.460464"}
{"text": "Based on our study there is no safety issue related to the use of \u03b1 -galactosidase in children with bloating and gas - related symptoms .", "label": "", "metadata": {}, "score": "57.4625"}
{"text": "Based on our study there is no safety issue related to the use of \u03b1 -galactosidase in children with bloating and gas - related symptoms .", "label": "", "metadata": {}, "score": "57.4625"}
{"text": "Halpern GM , Prindiville T , Blankenburg M , et al .Treatment of irritable bowel syndrome with lacteol fort : a randomized , double - blind , cross - over trial .", "label": "", "metadata": {}, "score": "57.569508"}
{"text": "Halpern GM , Prindiville T , Blankenburg M , et al .Treatment of irritable bowel syndrome with lacteol fort : a randomized , double - blind , cross - over trial .", "label": "", "metadata": {}, "score": "57.569508"}
{"text": "Halpern GM , Prindiville T , Blankenburg M , et al .Treatment of irritable bowel syndrome with lacteol fort : a randomized , double - blind , cross - over trial .", "label": "", "metadata": {}, "score": "57.569508"}
{"text": "Halpern GM , Prindiville T , Blankenburg M , et al .Treatment of irritable bowel syndrome with lacteol fort : a randomized , double - blind , cross - over trial .", "label": "", "metadata": {}, "score": "57.569508"}
{"text": "Di Stefano M , Miceli E , Gotti S , et al .: The effect of oral \u03b1 - galactosidase on intestinal gas production and gas - related symptoms .", "label": "", "metadata": {}, "score": "57.575363"}
{"text": "J Pain .[PubMed ] [ DOI ] .Bijkerk CJ , de Wit NJ , Muris JW , Whorwell PJ , Knottnerus JA , Hoes AW .", "label": "", "metadata": {}, "score": "57.57908"}
{"text": "N Engl J Med .doi : 10.1056/NEJMoa1004409 .[PubMed ] [ Cross Ref ] .Schmulson M , Chang L. Review article : the treatment of functional abdominal bloating and distension .", "label": "", "metadata": {}, "score": "57.638676"}
{"text": "80 - 87 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Madish , S. Miehlke , and J. Labenz , \" Management of functional dyspepsia : unsolved problems and new perspectives , \" World Journal of Gastroenterology , vol .", "label": "", "metadata": {}, "score": "57.729755"}
{"text": "Secondary Endpoint .Figure 4 shows the changes in GSRS score for all seven IBS specific symptoms throughout the study time .There was significant relief of IBS specific symptoms from baseline to 4 and 8 weeks in all of the groups ( . )", "label": "", "metadata": {}, "score": "57.969814"}
{"text": "Drossman DA : The functional gastrointestinal disorders and the Rome III process .Gastroenterology 2006 , 130 : 1377 - 1390 .PubMed View Article .", "label": "", "metadata": {}, "score": "58.095573"}
{"text": "At the end of the trial , the peppermint oil group reported a more significant improvement in the change of symptom scale than the placebo group .", "label": "", "metadata": {}, "score": "58.155807"}
{"text": "Nowadays standard available therapies for IBS - D include antispasmodics , antidiarrhoeals , and 5-hydroxytryptamine 3 ( 5-HT3 ) receptor antagonist [ 6 ] .", "label": "", "metadata": {}, "score": "58.223316"}
{"text": "The animal experiment [ 17 ] reported that HM could decrease visceral hypersensitivity of rats .This indicated that moxibustoin on navel ( Shenque CV8 ) is better than orally taking PB in ameliorating GI symptom of IBS - D patients .", "label": "", "metadata": {}, "score": "58.266388"}
{"text": "Olesen M , Gudmand - Hoyer E. Related Articles , Links Efficacy , safety , and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "58.296078"}
{"text": "Olesen M , Gudmand - Hoyer E. Related Articles , Links Efficacy , safety , and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "58.296078"}
{"text": "Olesen M , Gudmand - Hoyer E. Related Articles , Links Efficacy , safety , and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "58.296078"}
{"text": "Olesen M , Gudmand - Hoyer E. Related Articles , Links Efficacy , safety , and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome .", "label": "", "metadata": {}, "score": "58.296078"}
{"text": "Despite all these distressing symptoms , in IBS , the intestines appear to be perfectly healthy when they are examined .Thus the condition belongs to a category of diseases that physicians call \" functional .", "label": "", "metadata": {}, "score": "58.320778"}
{"text": "Despite all these distressing symptoms , in IBS , the intestines appear to be perfectly healthy when they are examined .Thus the condition belongs to a category of diseases that physicians call \" functional .", "label": "", "metadata": {}, "score": "58.320778"}
{"text": "2008 ; 337 : a2313 .[PubMed ] [ DOI ] .Rahimi R , Nikfar S , Abdollahi M. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men : a meta - analysis of eight randomized , placebo - controlled , 12-week trials .", "label": "", "metadata": {}, "score": "58.342255"}
{"text": "PubMed View Article .Jerndal P , Ringstr\u00f6m G , Agerforz P , Karpefors M , Akkermans LM , Bayati A , Simr\u00e9n M : Gastrointestinal - specific anxiety : an important factor for severity of GI symptoms and quality of life in IBS .", "label": "", "metadata": {}, "score": "58.35041"}
{"text": "2009 ; 33 Suppl 1 : S26-S34 .[PubMed ] [ DOI ] .Wu JC .Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome : facts or myths ?", "label": "", "metadata": {}, "score": "58.463055"}
{"text": "Evidence of efficacy of IBS drug therapies with bulking agents , antispasmodics , and antidepressants is weak , particularly because of the problem of valid outcome measures [ 13 ] .", "label": "", "metadata": {}, "score": "58.783516"}
{"text": "Clinical trial : a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double - blind placebo - controlled study .Aliment Pharmacol Ther .", "label": "", "metadata": {}, "score": "58.826496"}
{"text": "Clinical trial : a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double - blind placebo - controlled study .Aliment Pharmacol Ther .", "label": "", "metadata": {}, "score": "58.826496"}
{"text": "Clinical trial : a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double - blind placebo - controlled study .Aliment Pharmacol Ther .", "label": "", "metadata": {}, "score": "58.826496"}
{"text": "Clinical trial : a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double - blind placebo - controlled study .Aliment Pharmacol Ther .", "label": "", "metadata": {}, "score": "58.826496"}
{"text": "Primary Endpoint .The GI symptom severity , as measured by the GSRS total score , was compared within - group and between - group .", "label": "", "metadata": {}, "score": "58.8464"}
{"text": "Results .Baseline Patient Characteristics .In our study , patients were mostly females ( 74.29 % ) and had a mean age of 25.7 years .", "label": "", "metadata": {}, "score": "58.898518"}
{"text": "Treatment assignments will not be revealed and are blinded to the patients and investigators ( including statisticians ) until the entire study is completed .For the first level of unblinding , before statistical analysis , the blind code will be disclosed to group A and group B. For the second level of unblinding , group A and group B will be disclosed to the test placebo groups in a summary meeting .", "label": "", "metadata": {}, "score": "59.12429"}
{"text": "The title and abstract of each article were examined to eliminate duplicates , reviews , studies examining functional bowel diseases other than IBS , and studies assessing complementary and alternative medicines other than herbs .", "label": "", "metadata": {}, "score": "59.13671"}
{"text": "Figure 1 shows the patient flow .After informed consent , eligible patients entered a baseline period of 1 week during which they recorded data on a daily basis in a questionnaire / diary provided at study entry by the physician .", "label": "", "metadata": {}, "score": "59.247383"}
{"text": "Figure 1 shows the patient flow .After informed consent , eligible patients entered a baseline period of 1 week during which they recorded data on a daily basis in a questionnaire / diary provided at study entry by the physician .", "label": "", "metadata": {}, "score": "59.247383"}
{"text": "Food allergies may play a role in IBS , and diets based on identifying and eliminating allergenic foods might offer some benefit .Hypnotherapy has shown some promise for IBS .", "label": "", "metadata": {}, "score": "59.282654"}
{"text": "Food allergies may play a role in IBS , and diets based on identifying and eliminating allergenic foods might offer some benefit .Hypnotherapy has shown some promise for IBS .", "label": "", "metadata": {}, "score": "59.282654"}
{"text": "Food allergies may play a role in IBS , and diets based on identifying and eliminating allergenic foods might offer some benefit .Hypnotherapy has shown some promise for IBS .", "label": "", "metadata": {}, "score": "59.282654"}
{"text": "Food allergies may play a role in IBS , and diets based on identifying and eliminating allergenic foods might offer some benefit .Hypnotherapy has shown some promise for IBS .", "label": "", "metadata": {}, "score": "59.282654"}
{"text": "What is more , compared to week 4 , GSRS specific score in Group HM remained stable in the follow - up period ( week 8) .", "label": "", "metadata": {}, "score": "59.31632"}
{"text": "Some herbal products have been shown to be helpful in treating gastrointestinal problems [ 11 ] , and some of these studies have been conducted in comparison with standard prokinetic drugs [ 12 ] .", "label": "", "metadata": {}, "score": "59.326736"}
{"text": "Because of various factors involved in its pathophysiology and disappointing results from conventional IBS medications , the treatment of IBS is challenging and use of complementary and alternative medicines especially herbal therapies is increasing .", "label": "", "metadata": {}, "score": "59.361652"}
{"text": "Patients .90 outpatients were included in the study ( 64 females , 26 males ; mean age 56.5 years ( range 19 - 72 ) ; mean body mass index 24.1 ( range 17.1 - 35.0 kg / m 2 ) ) .", "label": "", "metadata": {}, "score": "59.41211"}
{"text": "Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome .Dig Dis Sci .Kim HJ , Camilleri M , McKinzie S , et al .", "label": "", "metadata": {}, "score": "59.484398"}
{"text": "Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome .Dig Dis Sci .Kim HJ , Camilleri M , McKinzie S , et al .", "label": "", "metadata": {}, "score": "59.484398"}
{"text": "Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome .Dig Dis Sci .Kim HJ , Camilleri M , McKinzie S , et al .", "label": "", "metadata": {}, "score": "59.484398"}
{"text": "Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome .Dig Dis Sci .Kim HJ , Camilleri M , McKinzie S , et al .", "label": "", "metadata": {}, "score": "59.484398"}
{"text": "However , the studies are available only in adult populations .The aim of this study was to evaluate the efficacy and tolerability of \u03b1 - galactosidase in pediatric patients with predominant gas - related symptoms .", "label": "", "metadata": {}, "score": "59.523003"}
{"text": "However , the studies are available only in adult populations .The aim of this study was to evaluate the efficacy and tolerability of \u03b1 - galactosidase in pediatric patients with predominant gas - related symptoms .", "label": "", "metadata": {}, "score": "59.523003"}
{"text": "Symptom improvements after Mentha capsule were significantly better than after placebo .No significant side effect was seen in the Mentha group and peppermint oil was well tolerated [ 32 ] .", "label": "", "metadata": {}, "score": "59.542526"}
{"text": "Eight - week treatment of IBS patients with Curcuma longa extract tablet decreased IBS prevalence and abdominal pain / discomfort score significantly between baseline and after treatment .", "label": "", "metadata": {}, "score": "59.59213"}
{"text": "129 - 134 , 1988 .View at Google Scholar \u00b7 View at Scopus . E. Dimen\u00e4s , H. Glise , B. Hallerback , H. Hernqvist , J. Svedlund , and I. Wiklund , \" Quality of life in patients with upper gastrointestinal symptoms .", "label": "", "metadata": {}, "score": "59.597805"}
{"text": "The effect of \u03b1 -galactosidase on gas related symptoms does not appear to be long - lasting .The improvement observed at the end of treatment was not sustained after 2 weeks of follow - up but this is consistent with the mechanism of action of the enzyme .", "label": "", "metadata": {}, "score": "59.60083"}
{"text": "The effect of \u03b1 -galactosidase on gas related symptoms does not appear to be long - lasting .The improvement observed at the end of treatment was not sustained after 2 weeks of follow - up but this is consistent with the mechanism of action of the enzyme .", "label": "", "metadata": {}, "score": "59.60083"}
{"text": "First of all , the potential limitation of the study is that , as a pilot study , no power analysis was provided , which lowered the statistical power of the study to a certain extent .", "label": "", "metadata": {}, "score": "59.688644"}
{"text": "Therapeutic efficacy of a traditional Chinese medicine ( TCM )( Table 2 ) was investigated in patients with diarrhea - predominant IBS .There was no significant difference in the proportion of patients with global symptom improvement between the TCM and placebo groups .", "label": "", "metadata": {}, "score": "59.697582"}
{"text": "Gut .2002;50:A83 .Fireman Z , Segal A , Kopelman Y , et al .Acupuncture treatment for irritable bowel syndrome .A double - blind controlled study .", "label": "", "metadata": {}, "score": "59.742577"}
{"text": "Gut .2002;50:A83 .Fireman Z , Segal A , Kopelman Y , et al .Acupuncture treatment for irritable bowel syndrome .A double - blind controlled study .", "label": "", "metadata": {}, "score": "59.742577"}
{"text": "Gut .2002;50:A83 .Fireman Z , Segal A , Kopelman Y , et al .Acupuncture treatment for irritable bowel syndrome .A double - blind controlled study .", "label": "", "metadata": {}, "score": "59.742577"}
{"text": "Gut .2002;50:A83 .Fireman Z , Segal A , Kopelman Y , et al .Acupuncture treatment for irritable bowel syndrome .A double - blind controlled study .", "label": "", "metadata": {}, "score": "59.742577"}
{"text": "Gaylord SA , Palsson OS , Garland EL , et al .Mindfulness training reduces the severity of irritable bowel syndrome in women : results of a randomized controlled trial .", "label": "", "metadata": {}, "score": "59.85216"}
{"text": "Gaylord SA , Palsson OS , Garland EL , et al .Mindfulness training reduces the severity of irritable bowel syndrome in women : results of a randomized controlled trial .", "label": "", "metadata": {}, "score": "59.85216"}
{"text": "Gaylord SA , Palsson OS , Garland EL , et al .Mindfulness training reduces the severity of irritable bowel syndrome in women : results of a randomized controlled trial .", "label": "", "metadata": {}, "score": "59.85216"}
{"text": "Gaylord SA , Palsson OS , Garland EL , et al .Mindfulness training reduces the severity of irritable bowel syndrome in women : results of a randomized controlled trial .", "label": "", "metadata": {}, "score": "59.85216"}
{"text": "2007 Oct 6 .[ Epub ahead of print ] .Sinn DH , Song JH , Kim HJ , et al .Therapeutic effect of Lactobacillus acidophilus -SDC 2012 , 2013 in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "59.862778"}
{"text": "2007 Oct 6 .[ Epub ahead of print ] .Sinn DH , Song JH , Kim HJ , et al .Therapeutic effect of Lactobacillus acidophilus -SDC 2012 , 2013 in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "59.862778"}
{"text": "2007 Oct 6 .[ Epub ahead of print ] .Sinn DH , Song JH , Kim HJ , et al .Therapeutic effect of Lactobacillus acidophilus -SDC 2012 , 2013 in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "59.862778"}
{"text": "2007 Oct 6 .[ Epub ahead of print ] .Sinn DH , Song JH , Kim HJ , et al .Therapeutic effect of Lactobacillus acidophilus -SDC 2012 , 2013 in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "59.862778"}
{"text": "38 patients received continuous therapy for gastrointestinal symptoms : 12 patients took proton pump inhibitors , 8 took antacids , 4 took acid blockers , 4 took herbal medicines , and 10 others .", "label": "", "metadata": {}, "score": "59.901043"}
{"text": "Patients .90 outpatients of the ambulance of the Naturopathic Department with gastrointestinal complaints were included in this observational study .Patients suspected clinically to have organic problems were not included unless procedures for exclusion of organic problems were being performed .", "label": "", "metadata": {}, "score": "60.01097"}
{"text": "Lahmann C , R\u00f6hricht F , Sauer N. Functional relaxation as complementary therapy in irritable bowel syndrome : a randomized , controlled clinical trial .J Altern Complement Med .", "label": "", "metadata": {}, "score": "60.112537"}
{"text": "Lahmann C , R\u00f6hricht F , Sauer N. Functional relaxation as complementary therapy in irritable bowel syndrome : a randomized , controlled clinical trial .J Altern Complement Med .", "label": "", "metadata": {}, "score": "60.112537"}
{"text": "Lahmann C , R\u00f6hricht F , Sauer N. Functional relaxation as complementary therapy in irritable bowel syndrome : a randomized , controlled clinical trial .J Altern Complement Med .", "label": "", "metadata": {}, "score": "60.112537"}
{"text": "Lahmann C , R\u00f6hricht F , Sauer N. Functional relaxation as complementary therapy in irritable bowel syndrome : a randomized , controlled clinical trial .J Altern Complement Med .", "label": "", "metadata": {}, "score": "60.112537"}
{"text": "Acta Gastroenterol Latinoam .Spiller P. Review article : probiotics and prebiotics in irritable bowel syndrome ( IBS ) .Aliment Pharmacol Ther .2008 Jun 4 .", "label": "", "metadata": {}, "score": "60.304073"}
{"text": "Acta Gastroenterol Latinoam .Spiller P. Review article : probiotics and prebiotics in irritable bowel syndrome ( IBS ) .Aliment Pharmacol Ther .2008 Jun 4 .", "label": "", "metadata": {}, "score": "60.304073"}
{"text": "Acta Gastroenterol Latinoam .Spiller P. Review article : probiotics and prebiotics in irritable bowel syndrome ( IBS ) .Aliment Pharmacol Ther .2008 Jun 4 .", "label": "", "metadata": {}, "score": "60.304073"}
{"text": "Acta Gastroenterol Latinoam .Spiller P. Review article : probiotics and prebiotics in irritable bowel syndrome ( IBS ) .Aliment Pharmacol Ther .2008 Jun 4 .", "label": "", "metadata": {}, "score": "60.304073"}
{"text": "The severity of abdominal pain was reduced significantly in the peppermint group as compared to the placebo group .Furthermore , peppermint oil capsule significantly improved the QOL .", "label": "", "metadata": {}, "score": "60.44108"}
{"text": "There are different strategies that may reduce intestinal gas including active charcoal , simethicone etc .[ 9 , 10 ] .Recently , the use of antibiotics seems to provide significant relief of functional GI symptoms , bloating and abdominal pain , but the need for repeated treatment cycles may have an important impact on the intestinal bacterial flora [ 21 , 22 ] , especially in children .", "label": "", "metadata": {}, "score": "60.47185"}
{"text": "There are different strategies that may reduce intestinal gas including active charcoal , simethicone etc .[ 9 , 10 ] .Recently , the use of antibiotics seems to provide significant relief of functional GI symptoms , bloating and abdominal pain , but the need for repeated treatment cycles may have an important impact on the intestinal bacterial flora [ 21 , 22 ] , especially in children .", "label": "", "metadata": {}, "score": "60.47185"}
{"text": "Bittner AC , Croffut RM , Stranahan MC , et al .Prescript - Assist probiotic - prebiotic treatment for irritable bowel syndrome : a methodologically oriented , 2-week , randomized , placebo - controlled , double - blind clinical study .", "label": "", "metadata": {}, "score": "60.508816"}
{"text": "Bittner AC , Croffut RM , Stranahan MC , et al .Prescript - Assist probiotic - prebiotic treatment for irritable bowel syndrome : a methodologically oriented , 2-week , randomized , placebo - controlled , double - blind clinical study .", "label": "", "metadata": {}, "score": "60.508816"}
{"text": "Bittner AC , Croffut RM , Stranahan MC , et al .Prescript - Assist probiotic - prebiotic treatment for irritable bowel syndrome : a methodologically oriented , 2-week , randomized , placebo - controlled , double - blind clinical study .", "label": "", "metadata": {}, "score": "60.508816"}
{"text": "Bittner AC , Croffut RM , Stranahan MC , et al .Prescript - Assist probiotic - prebiotic treatment for irritable bowel syndrome : a methodologically oriented , 2-week , randomized , placebo - controlled , double - blind clinical study .", "label": "", "metadata": {}, "score": "60.508816"}
{"text": "Similar results were seen in another study as well .In a review of 19 randomized trials with 1,510 people , Chinese herbal medicine was associated with a greater cure rate , and reduced recurrence of constipation - dominant IBS compared to traditional Western treatments .", "label": "", "metadata": {}, "score": "60.51674"}
{"text": "Similar results were seen in another study as well .In a review of 19 randomized trials with 1,510 people , Chinese herbal medicine was associated with a greater cure rate , and reduced recurrence of constipation - dominant IBS compared to traditional Western treatments .", "label": "", "metadata": {}, "score": "60.51674"}
{"text": "Similar results were seen in another study as well .In a review of 19 randomized trials with 1,510 people , Chinese herbal medicine was associated with a greater cure rate , and reduced recurrence of constipation - dominant IBS compared to traditional Western treatments .", "label": "", "metadata": {}, "score": "60.51674"}
{"text": "Similar results were seen in another study as well .In a review of 19 randomized trials with 1,510 people , Chinese herbal medicine was associated with a greater cure rate , and reduced recurrence of constipation - dominant IBS compared to traditional Western treatments .", "label": "", "metadata": {}, "score": "60.51674"}
{"text": "This study has shown for the first time that pediatric patients with predominant gas - related symptoms had a better response than placebo in the short term use of oral \u03b1 -galactosidase .", "label": "", "metadata": {}, "score": "60.615078"}
{"text": "This study has shown for the first time that pediatric patients with predominant gas - related symptoms had a better response than placebo in the short term use of oral \u03b1 -galactosidase .", "label": "", "metadata": {}, "score": "60.615078"}
{"text": "This was a single center , randomized , double blind , placebo - controlled , parallel group study performed in tertiary care setting .Fifty two pediatric out patients ( 32 female ) with gas - related disturbances at least once per week over the last 12 weeks , were included in the study .", "label": "", "metadata": {}, "score": "60.61543"}
{"text": "This was a single center , randomized , double blind , placebo - controlled , parallel group study performed in tertiary care setting .Fifty two pediatric out patients ( 32 female ) with gas - related disturbances at least once per week over the last 12 weeks , were included in the study .", "label": "", "metadata": {}, "score": "60.61543"}
{"text": "[PubMed ] [ DOI ] .Mozaffari S , Rahimi R , Abdollahi M. Implications of melatonin therapy in irritable bowel syndrome : a systematic review .", "label": "", "metadata": {}, "score": "60.629513"}
{"text": "Efficacy Endpoints .Primary Efficacy Endpoint .The primary efficacy endpoint is the total score of gastrointestinal symptom rating Scale [ 14 ] ( GSRS total score ) .", "label": "", "metadata": {}, "score": "60.63584"}
{"text": "[PubMed ] .Issa B , Wafaei NA , Whorwell PJ .Abdominal bloating and distension : what is the role of the microbiota .", "label": "", "metadata": {}, "score": "60.705444"}
{"text": "Statistical Analysis .The primary efficacy variable was the changes from baseline in GSRS total score .As for secondary endpoints , the changes of the GSRS symptom specific scores from baseline were analyzed .", "label": "", "metadata": {}, "score": "60.781258"}
{"text": "Kajander K , Myllyluoma E , Rajilic - Stojanovic M , et al .Clinical trial : multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota .", "label": "", "metadata": {}, "score": "60.89182"}
{"text": "Kajander K , Myllyluoma E , Rajilic - Stojanovic M , et al .Clinical trial : multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota .", "label": "", "metadata": {}, "score": "60.89182"}
{"text": "Kajander K , Myllyluoma E , Rajilic - Stojanovic M , et al .Clinical trial : multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota .", "label": "", "metadata": {}, "score": "60.89182"}
{"text": "Kajander K , Myllyluoma E , Rajilic - Stojanovic M , et al .Clinical trial : multispecies probiotic supplementation alleviates the symptoms of IBS and stabilises intestinal microbiota .", "label": "", "metadata": {}, "score": "60.89182"}
{"text": "The comparison of effectiveness among three groups showed that at week 4 , there was more relief of symptoms of rugitus ( .Safety and Tolerability .", "label": "", "metadata": {}, "score": "60.89744"}
{"text": "In the present study , 285 patients were recruited , and 75 patients were excluded because they did not meet the inclusion criteria .In total , 210 patients ( FAS ) were randomized .", "label": "", "metadata": {}, "score": "60.90631"}
{"text": "Am J Gastroenterol .2012 Apr 10 .Lindfors P , Unge P , Arvidsson P , et al .Effects of gut - directed hypnotherapy on IBS in different clinical settings - results from two randomized , controlled trials .", "label": "", "metadata": {}, "score": "60.969368"}
{"text": "Am J Gastroenterol .2012 Apr 10 .Lindfors P , Unge P , Arvidsson P , et al .Effects of gut - directed hypnotherapy on IBS in different clinical settings - results from two randomized , controlled trials .", "label": "", "metadata": {}, "score": "60.969368"}
{"text": "Am J Gastroenterol .2012 Apr 10 .Lindfors P , Unge P , Arvidsson P , et al .Effects of gut - directed hypnotherapy on IBS in different clinical settings - results from two randomized , controlled trials .", "label": "", "metadata": {}, "score": "60.969368"}
{"text": "Am J Gastroenterol .2012 Apr 10 .Lindfors P , Unge P , Arvidsson P , et al .Effects of gut - directed hypnotherapy on IBS in different clinical settings - results from two randomized , controlled trials .", "label": "", "metadata": {}, "score": "60.969368"}
{"text": "Gut Pathog .[PubMed ] [ DOI ] .Rahimi R , Nikfar S , Rezaie A , Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome : a meta - analysis .", "label": "", "metadata": {}, "score": "61.08181"}
{"text": "Fifty - eight patients with IBS were randomized to receive Aloe vera or matching placebo for a month but no significant difference was found between Aloe and placebo groups [ 17 ] .", "label": "", "metadata": {}, "score": "61.110092"}
{"text": "177 - 183 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Malfertheimer , G. Holtmann , U. Peitz et al . , \" Guidelines of the German socieety of digestive and metabolic diseases for treatment of dyspepsia , \" Zeitschrift fur Gastroenterologie , vol .", "label": "", "metadata": {}, "score": "61.154556"}
{"text": "Probiotics .For example , in a 6-week , double - blind , placebo - controlled trial of 274 people with constipation - predominant IBS , in which constipation is a more significant symptom than diarrhea , use of a probiotic formula containing Bifidobacterium animalis significantly reduced discomfort and increased stool frequency .", "label": "", "metadata": {}, "score": "61.273216"}
{"text": "Probiotics .For example , in a 6-week , double - blind , placebo - controlled trial of 274 people with constipation - predominant IBS , in which constipation is a more significant symptom than diarrhea , use of a probiotic formula containing Bifidobacterium animalis significantly reduced discomfort and increased stool frequency .", "label": "", "metadata": {}, "score": "61.273216"}
{"text": "Probiotics .For example , in a 6-week , double - blind , placebo - controlled trial of 274 people with constipation - predominant IBS , in which constipation is a more significant symptom than diarrhea , use of a probiotic formula containing Bifidobacterium animalis significantly reduced discomfort and increased stool frequency .", "label": "", "metadata": {}, "score": "61.273216"}
{"text": "Probiotics .For example , in a 6-week , double - blind , placebo - controlled trial of 274 people with constipation - predominant IBS , in which constipation is a more significant symptom than diarrhea , use of a probiotic formula containing Bifidobacterium animalis significantly reduced discomfort and increased stool frequency .", "label": "", "metadata": {}, "score": "61.273216"}
{"text": "Whether there is curative effect of HM in ameliorating IBS symptoms remains unknown .Consequently , the aim of present trial is to explore the potential of HM to attenuate the symptoms of IBS - D. Methods .", "label": "", "metadata": {}, "score": "61.388443"}
{"text": "doi : 10.1023/A:1005554103531 .[PubMed ] [ Cross Ref ] .Youssef NN . et al .Quality of life for children with functional abdominal pain : a comparison study of patients ' and parents ' perceptions .", "label": "", "metadata": {}, "score": "61.481384"}
{"text": "doi : 10.1542/peds.2005 - 0114 .[PubMed ] [ Cross Ref ] .Spiller R. New insights into bloating and abdominal distension : is it all outlet obstruction ?", "label": "", "metadata": {}, "score": "61.506973"}
{"text": "In preclinical trials and toxicological studies , no evidence of toxic effects has been found with SQTX Granule .Pharmacologic experiments showed that it has the effects of inducing spasmolysis , analgesia and reducing diarrhea in rats with diarrhea caused by stress .", "label": "", "metadata": {}, "score": "61.575607"}
{"text": "75 In a second related trial , 48 patients were randomized to hypnotherapy with a less experienced psychologist or to a waiting list .In both trials , which lasted three months , those who received hypnotherapy showed an improvement in their IBS symptoms .", "label": "", "metadata": {}, "score": "61.63401"}
{"text": "75 In a second related trial , 48 patients were randomized to hypnotherapy with a less experienced psychologist or to a waiting list .In both trials , which lasted three months , those who received hypnotherapy showed an improvement in their IBS symptoms .", "label": "", "metadata": {}, "score": "61.63401"}
{"text": "75 In a second related trial , 48 patients were randomized to hypnotherapy with a less experienced psychologist or to a waiting list .In both trials , which lasted three months , those who received hypnotherapy showed an improvement in their IBS symptoms .", "label": "", "metadata": {}, "score": "61.63401"}
{"text": "75 In a second related trial , 48 patients were randomized to hypnotherapy with a less experienced psychologist or to a waiting list .In both trials , which lasted three months , those who received hypnotherapy showed an improvement in their IBS symptoms .", "label": "", "metadata": {}, "score": "61.63401"}
{"text": "However this is consistent with the mechanism of action of \u03b1 -galactosidase .The reduced formation of gas by colonic bacteria may have been expected to have other beneficial effects on distension of colon segments and abdomen .", "label": "", "metadata": {}, "score": "61.784557"}
{"text": "However this is consistent with the mechanism of action of \u03b1 -galactosidase .The reduced formation of gas by colonic bacteria may have been expected to have other beneficial effects on distension of colon segments and abdomen .", "label": "", "metadata": {}, "score": "61.784557"}
{"text": "97 - 103 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Spiller , Q. Aziz , F. Creed , et al . , \" Guidelines on the irritable bowel syndrome : mechanisms and practical management , \" Gut , vol .", "label": "", "metadata": {}, "score": "62.15894"}
{"text": "There is not much information about placebo response on gas related symptoms in children in literature .In our study , we did not see apparent difference in the placebo response between children of less and above 8 years .", "label": "", "metadata": {}, "score": "62.19374"}
{"text": "There is not much information about placebo response on gas related symptoms in children in literature .In our study , we did not see apparent difference in the placebo response between children of less and above 8 years .", "label": "", "metadata": {}, "score": "62.19374"}
{"text": "Statistical analysis will be conducted based on an intention - to - treat ( ITT ) principle .All subjects who were treated with at least one dose of the study drug and had at least one clinical observation after starting the treatment comprise FAS .", "label": "", "metadata": {}, "score": "62.196976"}
{"text": "Here are some directions for future researches : optimal treatment duration and follow - up period should be determined to investigate the possible mechanism of action of HM , based on time , in treating with IBS - D. The impact of HM on IBS - D patients ' overall satisfaction or QOL is needed , as well as the correlation between the dose of medicamental pulverata used in HM and the overall effect of HM therapy .", "label": "", "metadata": {}, "score": "62.208466"}
{"text": "[PubMed ] [ DOI ] .Darvish - Damavandi M , Nikfar S , Abdollahi M. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome .", "label": "", "metadata": {}, "score": "62.244698"}
{"text": "We designed this study to evaluate the efficacy and safety of Shun - Qi -Tong - Xie Granule ( SQTX Granule ) , a TCM treatment , in patients with IBS with diarrhea ( IBS - D ) .", "label": "", "metadata": {}, "score": "62.267235"}
{"text": "After exclusion of a somatic disorder , such chronic symptoms are usually categorized as either nonulcer dyspepsia ( NUD ) or irritable bowel syndrome ( IBS ) .", "label": "", "metadata": {}, "score": "62.354286"}
{"text": "[PubMed ] [ DOI ] .Nikfar S , Rahimi R , Rahimi F , Derakhshani S , Abdollahi M. Efficacy of probiotics in irritable bowel syndrome : a meta - analysis of randomized , controlled trials .", "label": "", "metadata": {}, "score": "62.521107"}
{"text": "2006 ; 13 Suppl 5 : 90 - 99 .[PubMed ] [ DOI ] .Michael S , Kelber O , Hauschildt S , Spanel - Borowski K , Nieber K. Inhibition of inflammation - induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6 .", "label": "", "metadata": {}, "score": "62.56697"}
{"text": "Misdiagnosis .Using forbidden drugs or treatments in the course of the trial .Taking no medication during the trial .No evaluable records after medication .", "label": "", "metadata": {}, "score": "62.84591"}
{"text": "According to TCM theory , one of the most important principles of diagnosis and treatment is symptom differentiation , which is based on four diagnostic methods ( inspection , listening and smelling , inquiry and palpation ) to collect clinical manifestations , including symptoms and TCM signs .", "label": "", "metadata": {}, "score": "62.879593"}
{"text": "[PubMed ] [ DOI ] .Ford AC , Talley NJ , Spiegel BM , Foxx - Orenstein AE , Schiller L , Quigley EM , Moayyedi P. Effect of fibre , antispasmodics , and peppermint oil in the treatment of irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "62.93681"}
{"text": "Oral \u03b1 -galactosidase was effective in the short - term treatment of gas - related symptoms in children who were referred to specialist care .Its use is also supported by non - toxicity , good tolerability and availability of the formulation in drops , suitable for pediatric patients .", "label": "", "metadata": {}, "score": "63.14011"}
{"text": "Oral \u03b1 -galactosidase was effective in the short - term treatment of gas - related symptoms in children who were referred to specialist care .Its use is also supported by non - toxicity , good tolerability and availability of the formulation in drops , suitable for pediatric patients .", "label": "", "metadata": {}, "score": "63.14011"}
{"text": "Concomitant treatments and forbidden drugs .Usage of any other Western medication or Chinese medicines that have similar effects to SQTX Granule , or may affect the analysis of the final results , is strictly prohibited .", "label": "", "metadata": {}, "score": "63.153275"}
{"text": "Nat Prod Res .[PubMed ] [ DOI ] Abstract .Background .Gas - related symptoms represent very common complaints in children .The reduction of gas production can be considered as a valuable target in controlling symptoms .", "label": "", "metadata": {}, "score": "63.643345"}
{"text": "A follow - up study found that these effects lasted for almost 5 years in about 2/3 of the children .Relaxation therapy may also be helpful .", "label": "", "metadata": {}, "score": "63.696762"}
{"text": "A follow - up study found that these effects lasted for almost 5 years in about 2/3 of the children .Relaxation therapy may also be helpful .", "label": "", "metadata": {}, "score": "63.696762"}
{"text": "A follow - up study found that these effects lasted for almost 5 years in about 2/3 of the children .Relaxation therapy may also be helpful .", "label": "", "metadata": {}, "score": "63.696762"}
{"text": "A follow - up study found that these effects lasted for almost 5 years in about 2/3 of the children .Relaxation therapy may also be helpful .", "label": "", "metadata": {}, "score": "63.696762"}
{"text": "This study was placebo - controlled , as currently there is no reference treatment for gas - related symptoms in FGID .The evidence of efficacy of antiflatulents such as simethicone and activated charcoal is weak , together with that of probiotics , such as different strains of Lactobacillus or Bifidobacterium spp .", "label": "", "metadata": {}, "score": "63.80652"}
{"text": "This study was placebo - controlled , as currently there is no reference treatment for gas - related symptoms in FGID .The evidence of efficacy of antiflatulents such as simethicone and activated charcoal is weak , together with that of probiotics , such as different strains of Lactobacillus or Bifidobacterium spp .", "label": "", "metadata": {}, "score": "63.80652"}
{"text": "doi : 10.1016/S0304 - 3959(01)00314 - 1 .[PubMed ] [ Cross Ref ] .Irvine EJ . et al .Design of treatment trials for functional gastrointestinal disorders .", "label": "", "metadata": {}, "score": "63.859795"}
{"text": "However , there were many biases in the trials , which makes outcomes less reliable .Other Proposed Natural Treatments .One study found evidence that pancreatic digestive enzymes ( including proteolytic enzymes plus other enzymes called lipases ) might be helpful for reducing the flare - up of IBS symptoms that may follow a fatty meal .", "label": "", "metadata": {}, "score": "63.86313"}
{"text": "However , there were many biases in the trials , which makes outcomes less reliable .Other Proposed Natural Treatments .One study found evidence that pancreatic digestive enzymes ( including proteolytic enzymes plus other enzymes called lipases ) might be helpful for reducing the flare - up of IBS symptoms that may follow a fatty meal .", "label": "", "metadata": {}, "score": "63.86313"}
{"text": "However , there were many biases in the trials , which makes outcomes less reliable .Other Proposed Natural Treatments .One study found evidence that pancreatic digestive enzymes ( including proteolytic enzymes plus other enzymes called lipases ) might be helpful for reducing the flare - up of IBS symptoms that may follow a fatty meal .", "label": "", "metadata": {}, "score": "63.86313"}
{"text": "However , there were many biases in the trials , which makes outcomes less reliable .Other Proposed Natural Treatments .One study found evidence that pancreatic digestive enzymes ( including proteolytic enzymes plus other enzymes called lipases ) might be helpful for reducing the flare - up of IBS symptoms that may follow a fatty meal .", "label": "", "metadata": {}, "score": "63.86313"}
{"text": "The treatment was administered at the beginning of each meal 3 times a day for 2 weeks .No medications were allowed for the duration of the study .", "label": "", "metadata": {}, "score": "63.934032"}
{"text": "The treatment was administered at the beginning of each meal 3 times a day for 2 weeks .No medications were allowed for the duration of the study .", "label": "", "metadata": {}, "score": "63.934032"}
{"text": "Tarpila S , Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [ abstract].Gastroenterology .1997;112:A836 .Smith MA , Youngs GR , Finn R. Food intolerance , atopy , and irritable bowel syndrome .", "label": "", "metadata": {}, "score": "63.98664"}
{"text": "Tarpila S , Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [ abstract].Gastroenterology .1997;112:A836 .Smith MA , Youngs GR , Finn R. Food intolerance , atopy , and irritable bowel syndrome .", "label": "", "metadata": {}, "score": "63.98664"}
{"text": "Tarpila S , Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [ abstract].Gastroenterology .1997;112:A836 .Smith MA , Youngs GR , Finn R. Food intolerance , atopy , and irritable bowel syndrome .", "label": "", "metadata": {}, "score": "63.98664"}
{"text": "Tarpila S , Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [ abstract].Gastroenterology .1997;112:A836 .Smith MA , Youngs GR , Finn R. Food intolerance , atopy , and irritable bowel syndrome .", "label": "", "metadata": {}, "score": "63.98664"}
{"text": "Niedzielin K , Kordecki H , Birkenfeld B. A controlled , double - blind , randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "64.00897"}
{"text": "Niedzielin K , Kordecki H , Birkenfeld B. A controlled , double - blind , randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "64.00897"}
{"text": "Niedzielin K , Kordecki H , Birkenfeld B. A controlled , double - blind , randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "64.00897"}
{"text": "Niedzielin K , Kordecki H , Birkenfeld B. A controlled , double - blind , randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "64.00897"}
{"text": "Significantly more Padma Lax patients than placebo patients rated the current treatment superior to previous therapies tried for IBS .Laboratory parameters displayed no clinically significant changes .", "label": "", "metadata": {}, "score": "64.13747"}
{"text": "L , J , Kelly P , et al .Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles .", "label": "", "metadata": {}, "score": "64.258675"}
{"text": "L , J , Kelly P , et al .Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles .", "label": "", "metadata": {}, "score": "64.258675"}
{"text": "L , J , Kelly P , et al .Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles .", "label": "", "metadata": {}, "score": "64.258675"}
{"text": "L , J , Kelly P , et al .Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles .", "label": "", "metadata": {}, "score": "64.258675"}
{"text": "[PubMed ] [ DOI ] .Rahimi R , Nikfar S , Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome : A meta - analysis of randomized controlled trials .", "label": "", "metadata": {}, "score": "64.54013"}
{"text": "Guglielmetti S , Mora D , Gschwender M , Popp K. Randomised clinical trial : Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "64.57345"}
{"text": "Guglielmetti S , Mora D , Gschwender M , Popp K. Randomised clinical trial : Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "64.57345"}
{"text": "Guglielmetti S , Mora D , Gschwender M , Popp K. Randomised clinical trial : Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "64.57345"}
{"text": "Guglielmetti S , Mora D , Gschwender M , Popp K. Randomised clinical trial : Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "64.57345"}
{"text": "Phytomedicine .2006 ; 13 Suppl 5 : 67 - 74 .[PubMed ] [ DOI ] .Schemann M , Michel K , Zeller F , Hohenester B , R\u00fchl A. Region - specific effects of STW 5 ( Iberogast ) and its components in gastric fundus , corpus and antrum .", "label": "", "metadata": {}, "score": "64.58876"}
{"text": "They also noted that 5HT 3 and 5-hydroxytryptamine 4 ( 5HT 4 ) agonists carry a possible risk of ischemic colitis and cardiovascular events , respectively , which may limit their utility [ 1 ] .", "label": "", "metadata": {}, "score": "64.610916"}
{"text": "41 Treatment with FOS at a dose of 20 g daily initially worsened symptoms , but over time this negative effect wore off .At no time in the study were clear benefits seen , however .", "label": "", "metadata": {}, "score": "64.86911"}
{"text": "41 Treatment with FOS at a dose of 20 g daily initially worsened symptoms , but over time this negative effect wore off .At no time in the study were clear benefits seen , however .", "label": "", "metadata": {}, "score": "64.86911"}
{"text": "41 Treatment with FOS at a dose of 20 g daily initially worsened symptoms , but over time this negative effect wore off .At no time in the study were clear benefits seen , however .", "label": "", "metadata": {}, "score": "64.86911"}
{"text": "41 Treatment with FOS at a dose of 20 g daily initially worsened symptoms , but over time this negative effect wore off .At no time in the study were clear benefits seen , however .", "label": "", "metadata": {}, "score": "64.86911"}
{"text": "According to the basic principles of TCM , IBS - D with liver - spleen disharmony is treated by relieving stagnation of liver qi , as well as improving the transportation function of the spleen .", "label": "", "metadata": {}, "score": "64.884735"}
{"text": "Aliment Pharmacol Ther .Bensoussan A , Talley NJ , Hing M , et al .Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "65.009415"}
{"text": "Aliment Pharmacol Ther .Bensoussan A , Talley NJ , Hing M , et al .Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "65.009415"}
{"text": "Aliment Pharmacol Ther .Bensoussan A , Talley NJ , Hing M , et al .Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "65.009415"}
{"text": "Aliment Pharmacol Ther .Bensoussan A , Talley NJ , Hing M , et al .Treatment of irritable bowel syndrome with Chinese herbal medicine : a randomized controlled trial .", "label": "", "metadata": {}, "score": "65.009415"}
{"text": "PubMed Central PubMed View Article .Magge SS , Wolf JL : Complementary and alternative medicine and mind - body therapies for treatment of irritable bowel syndrome in women .", "label": "", "metadata": {}, "score": "65.030624"}
{"text": "NY ) .[PubMed ] [ DOI ] .Davis K , Philpott S , Kumar D , Mendall M. Randomised double - blind placebo - controlled trial of aloe vera for irritable bowel syndrome .", "label": "", "metadata": {}, "score": "65.05505"}
{"text": "All patients have to give their written informed consent prior to enrolment .The study 's flow chart is shown in Figure 1 .Study flow chart .", "label": "", "metadata": {}, "score": "65.20502"}
{"text": "In this study , the number of activated mast cells was decreased in the TXYF group after treatment , showing a significant difference as compared with that before treatment as well as with that in the Myarisan group after treatment .", "label": "", "metadata": {}, "score": "65.29089"}
{"text": "Suarez F , Levitt MD , Adshead J , et al .Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal .", "label": "", "metadata": {}, "score": "65.320465"}
{"text": "Suarez F , Levitt MD , Adshead J , et al .Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal .", "label": "", "metadata": {}, "score": "65.320465"}
{"text": "Suarez F , Levitt MD , Adshead J , et al .Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal .", "label": "", "metadata": {}, "score": "65.320465"}
{"text": "Suarez F , Levitt MD , Adshead J , et al .Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal .", "label": "", "metadata": {}, "score": "65.320465"}
{"text": "Values of p - value smaller than 0.05 were considered statistically significant .Results .Fifty - two patients completed the trial ( 32 females , median age 8 yrs , range 4 - 17 yrs ) .", "label": "", "metadata": {}, "score": "65.33236"}
{"text": "Values of p - value smaller than 0.05 were considered statistically significant .Results .Fifty - two patients completed the trial ( 32 females , median age 8 yrs , range 4 - 17 yrs ) .", "label": "", "metadata": {}, "score": "65.33236"}
{"text": "Pimentel M , Lembo A , Chey WD , et al .:Rifaximin therapy for patients with irritable bowel syndrome without constipation .N Engl J Med 2011 , 364 : 22 - 32 .", "label": "", "metadata": {}, "score": "65.392105"}
{"text": "71A review of 6 trials with 255 patients found relaxation therapy had higher incidence of some improvement .In these trials , relaxation therapy was compared to a control group or usual care .", "label": "", "metadata": {}, "score": "65.40723"}
{"text": "71A review of 6 trials with 255 patients found relaxation therapy had higher incidence of some improvement .In these trials , relaxation therapy was compared to a control group or usual care .", "label": "", "metadata": {}, "score": "65.40723"}
{"text": "71A review of 6 trials with 255 patients found relaxation therapy had higher incidence of some improvement .In these trials , relaxation therapy was compared to a control group or usual care .", "label": "", "metadata": {}, "score": "65.40723"}
{"text": "71A review of 6 trials with 255 patients found relaxation therapy had higher incidence of some improvement .In these trials , relaxation therapy was compared to a control group or usual care .", "label": "", "metadata": {}, "score": "65.40723"}
{"text": "And finally , a 4-week randomized trial involving 122 people with IBS found evidence that B. bifidum improved symptoms and quality of life compared to placebo .", "label": "", "metadata": {}, "score": "65.47983"}
{"text": "And finally , a 4-week randomized trial involving 122 people with IBS found evidence that B. bifidum improved symptoms and quality of life compared to placebo .", "label": "", "metadata": {}, "score": "65.47983"}
{"text": "And finally , a 4-week randomized trial involving 122 people with IBS found evidence that B. bifidum improved symptoms and quality of life compared to placebo .", "label": "", "metadata": {}, "score": "65.47983"}
{"text": "And finally , a 4-week randomized trial involving 122 people with IBS found evidence that B. bifidum improved symptoms and quality of life compared to placebo .", "label": "", "metadata": {}, "score": "65.47983"}
{"text": "J Pediatr .Kline RM , Kline JJ , Di Palma J , et al .Enteric - coated , pH - dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children .", "label": "", "metadata": {}, "score": "65.481384"}
{"text": "J Pediatr .Kline RM , Kline JJ , Di Palma J , et al .Enteric - coated , pH - dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children .", "label": "", "metadata": {}, "score": "65.481384"}
{"text": "J Pediatr .Kline RM , Kline JJ , Di Palma J , et al .Enteric - coated , pH - dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children .", "label": "", "metadata": {}, "score": "65.481384"}
{"text": "J Pediatr .Kline RM , Kline JJ , Di Palma J , et al .Enteric - coated , pH - dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children .", "label": "", "metadata": {}, "score": "65.481384"}
{"text": "Digestion 1991 , 49 : 227 - 230 .PubMed View Article .Suarez FL , Furne J , Springfield J , Levitt MD : Failure of activated charcoal to reduce the release of gases produced by the colonic flora .", "label": "", "metadata": {}, "score": "65.57083"}
{"text": "[PubMed ] [ Cross Ref ] .Fink RN , Lembo AJ .Intestinal gas .Curr Treat Options Gastroenterol .2001 Aug ; 4 : 333 - 337 .", "label": "", "metadata": {}, "score": "65.628555"}
{"text": "Poor curative effect is found during the study .Significant deviation from the protocol .Flawed protocol .The sponsors decide to terminate the trial due to management or funding problems .", "label": "", "metadata": {}, "score": "65.76654"}
{"text": "26,36,57 One randomized trial involving 90 people with diarrhea - predominant IBS found Saccharomyces boulardii to be more effective than placebo at improving quality of life .", "label": "", "metadata": {}, "score": "65.857346"}
{"text": "26,36,57 One randomized trial involving 90 people with diarrhea - predominant IBS found Saccharomyces boulardii to be more effective than placebo at improving quality of life .", "label": "", "metadata": {}, "score": "65.857346"}
{"text": "26,36,57 One randomized trial involving 90 people with diarrhea - predominant IBS found Saccharomyces boulardii to be more effective than placebo at improving quality of life .", "label": "", "metadata": {}, "score": "65.857346"}
{"text": "26,36,57 One randomized trial involving 90 people with diarrhea - predominant IBS found Saccharomyces boulardii to be more effective than placebo at improving quality of life .", "label": "", "metadata": {}, "score": "65.857346"}
{"text": "CONCLUSION .In this paper , different herbal preparations investigated for the management of IBS and their possible mechanisms of action were reviewed .Among the single preparations , the most evidence for efficacy in IBS patients was found for essential oil of Mentha piperita .", "label": "", "metadata": {}, "score": "65.936615"}
{"text": "So far , the present study is the largest multicenter ( 3 centers ) RCT with HM in IBS - D. Our results demonstrated that herb - partitioned moxibustion should be significantly better than orally taking pinaverium bromide in improving the GI symptoms of IBS - D. However , there was no significant difference between herb - partitioned moxibustion and farina - partitioned moxibustion .", "label": "", "metadata": {}, "score": "66.09561"}
{"text": "Lim B , Manheimer E , Lao L , et al .Acupuncture for treatment of irritable bowel syndrome .Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111 .", "label": "", "metadata": {}, "score": "66.11286"}
{"text": "Lim B , Manheimer E , Lao L , et al .Acupuncture for treatment of irritable bowel syndrome .Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111 .", "label": "", "metadata": {}, "score": "66.11286"}
{"text": "Lim B , Manheimer E , Lao L , et al .Acupuncture for treatment of irritable bowel syndrome .Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111 .", "label": "", "metadata": {}, "score": "66.11286"}
{"text": "Lim B , Manheimer E , Lao L , et al .Acupuncture for treatment of irritable bowel syndrome .Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111 .", "label": "", "metadata": {}, "score": "66.11286"}
{"text": "Both treatments were well tolerated .No adverse effects were reported during the study .Discussion .This randomized placebo - controlled study provides evidence that oral \u03b1 - galactosidase can improve gas - related symptoms in children and adolescents .", "label": "", "metadata": {}, "score": "66.151855"}
{"text": "Both treatments were well tolerated .No adverse effects were reported during the study .Discussion .This randomized placebo - controlled study provides evidence that oral \u03b1 - galactosidase can improve gas - related symptoms in children and adolescents .", "label": "", "metadata": {}, "score": "66.151855"}
{"text": "Statistical analysis .All characteristics were summarized by usual descriptive statistics such as mean and standard deviation for continuous variables and rates for categorical variables .", "label": "", "metadata": {}, "score": "66.19408"}
{"text": "Statistical analysis .All characteristics were summarized by usual descriptive statistics such as mean and standard deviation for continuous variables and rates for categorical variables .", "label": "", "metadata": {}, "score": "66.19408"}
{"text": "Grigoleit HG , Grigoleit P. Peppermint oil in irritable bowel syndrome .Phytomedicine .Kim HJ , Vazquez Roque MI , Camilleri M , et al .", "label": "", "metadata": {}, "score": "66.262344"}
{"text": "Grigoleit HG , Grigoleit P. Peppermint oil in irritable bowel syndrome .Phytomedicine .Kim HJ , Vazquez Roque MI , Camilleri M , et al .", "label": "", "metadata": {}, "score": "66.262344"}
{"text": "Grigoleit HG , Grigoleit P. Peppermint oil in irritable bowel syndrome .Phytomedicine .Kim HJ , Vazquez Roque MI , Camilleri M , et al .", "label": "", "metadata": {}, "score": "66.262344"}
{"text": "Grigoleit HG , Grigoleit P. Peppermint oil in irritable bowel syndrome .Phytomedicine .Kim HJ , Vazquez Roque MI , Camilleri M , et al .", "label": "", "metadata": {}, "score": "66.262344"}
{"text": "We used the FPS - R scale in order to measure the overall degree of discomfort associated with gas - related symptoms in everyday life .", "label": "", "metadata": {}, "score": "66.5092"}
{"text": "We used the FPS - R scale in order to measure the overall degree of discomfort associated with gas - related symptoms in everyday life .", "label": "", "metadata": {}, "score": "66.5092"}
{"text": "6 , pp .841 - 851 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. L. van Tilburg , O. S. Palsson , R. L. Levy et al . , \" Complementary and alternative medicine use and cost in functional bowel disorders : a six month prospective study in a large HMO , \" BMC Complementary and Alternative Medicine , vol . 8 , article 46 , 2008 .", "label": "", "metadata": {}, "score": "66.83936"}
{"text": "In addition , IBS - related stools improved in form or appearance in the TXNG group in comparison to the placebo group .The stool frequency was significantly decreased in the TXNG group compared with the placebo group .", "label": "", "metadata": {}, "score": "66.85777"}
{"text": "Am J Gastroenterol .[PubMed ] [ DOI ] .Wan H , Chen Y. Effects of antidepressive treatment of Saint John 's wort extract related to autonomic nervous function in women with irritable bowel syndrome .", "label": "", "metadata": {}, "score": "66.86354"}
{"text": "There were no statistically significant differences between the mono - extract group and the placebo group [ 44 ] .Different mechanisms have been proposed for the efficacy of STW 5 in IBS .", "label": "", "metadata": {}, "score": "67.02698"}
{"text": "Gastroenterology .doi : 10.1053/j.gastro.2004.11.050 .[PubMed ] [ Cross Ref ] .Guandalini S , Magazz\u00f9 G , Chiaro A. et al .", "label": "", "metadata": {}, "score": "67.1255"}
{"text": "Scand J Gastroenterol .[PubMed ] [ DOI ] .Zaidi SF , Yamada K , Kadowaki M , Usmanghani K , Sugiyama T. Bactericidal activity of medicinal plants , employed for the treatment of gastrointestinal ailments , against Helicobacter pylori .", "label": "", "metadata": {}, "score": "67.128006"}
{"text": "J Gastroenterol Hepatol .Nash P , Gould SR , Barnardo DE .Peppermint oil does not relieve the pain of irritable bowel syndrome .Br J Clin Pract .", "label": "", "metadata": {}, "score": "67.19361"}
{"text": "J Gastroenterol Hepatol .Nash P , Gould SR , Barnardo DE .Peppermint oil does not relieve the pain of irritable bowel syndrome .Br J Clin Pract .", "label": "", "metadata": {}, "score": "67.19361"}
{"text": "J Gastroenterol Hepatol .Nash P , Gould SR , Barnardo DE .Peppermint oil does not relieve the pain of irritable bowel syndrome .Br J Clin Pract .", "label": "", "metadata": {}, "score": "67.19361"}
{"text": "J Gastroenterol Hepatol .Nash P , Gould SR , Barnardo DE .Peppermint oil does not relieve the pain of irritable bowel syndrome .Br J Clin Pract .", "label": "", "metadata": {}, "score": "67.19361"}
{"text": "However , we can blind the patients between group HM and group FM .The evaluators , data collectors , and data statisticians were all blinded to treatment arm assignments .", "label": "", "metadata": {}, "score": "67.442566"}
{"text": "PubMed View Article .Saps M , et al .: Multicenter , randomized , placebo - controlled trial of amitriptyline in children with functional gastrointestinal disorders .", "label": "", "metadata": {}, "score": "67.469604"}
{"text": "The results of this study will provide evidence regarding the value of SQTX Granule as an intervention for IBS - D. Methods / design .Design .", "label": "", "metadata": {}, "score": "67.63253"}
{"text": "CS is the head of the Pediatric Gastroenterology Unit , approved the study design and strongly revised a draft of the paper .Guarantor of the article : CS .", "label": "", "metadata": {}, "score": "67.638855"}
{"text": "It is currently unknown , however , which gastrointestinal symptoms respond best to silica gel and whether acute or chronic symptoms may be influenced by this treatment .", "label": "", "metadata": {}, "score": "67.81634"}
{"text": "Due to disappointing results with conventional IBS treatments , complementary and alternative medicines are becoming attractive options for many patients [ 16 ] .In the present paper , management of IBS by herbal medicines and their modes of action have been evaluated in detail .", "label": "", "metadata": {}, "score": "68.195496"}
{"text": "B. Uehleke designed the study , performed the statistical evaluation and wrote the manuscript with the assistance of M. Ortiz .M. Ortiz was a studying physician and handled most of the patients .", "label": "", "metadata": {}, "score": "68.213745"}
{"text": "Dig Dis Sci .Shinozaki M , Kanazawa M , Kano M , Endo Y , Nakaya N , Hongo M , Fukudo S. Effect of autogenic training on general improvement in patients with irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "68.21417"}
{"text": "Dig Dis Sci .Shinozaki M , Kanazawa M , Kano M , Endo Y , Nakaya N , Hongo M , Fukudo S. Effect of autogenic training on general improvement in patients with irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "68.21417"}
{"text": "Dig Dis Sci .Shinozaki M , Kanazawa M , Kano M , Endo Y , Nakaya N , Hongo M , Fukudo S. Effect of autogenic training on general improvement in patients with irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "68.21417"}
{"text": "Dig Dis Sci .Shinozaki M , Kanazawa M , Kano M , Endo Y , Nakaya N , Hongo M , Fukudo S. Effect of autogenic training on general improvement in patients with irritable bowel syndrome : a randomized controlled trial .", "label": "", "metadata": {}, "score": "68.21417"}
{"text": "Lancet .Parker TJ , Naylor SJ , Riordan AM , et al .Management of patients with food intolerance in irritable bowel syndrome : the development and use of an exclusion diet .", "label": "", "metadata": {}, "score": "68.22853"}
{"text": "Lancet .Parker TJ , Naylor SJ , Riordan AM , et al .Management of patients with food intolerance in irritable bowel syndrome : the development and use of an exclusion diet .", "label": "", "metadata": {}, "score": "68.22853"}
{"text": "Lancet .Parker TJ , Naylor SJ , Riordan AM , et al .Management of patients with food intolerance in irritable bowel syndrome : the development and use of an exclusion diet .", "label": "", "metadata": {}, "score": "68.22853"}
{"text": "Lancet .Parker TJ , Naylor SJ , Riordan AM , et al .Management of patients with food intolerance in irritable bowel syndrome : the development and use of an exclusion diet .", "label": "", "metadata": {}, "score": "68.22853"}
{"text": "A recent systematic review and meta - analysis of acupuncture for IBS found that patients reported greater benefits from acupuncture than from pharmacological therapies [ 10 ] .", "label": "", "metadata": {}, "score": "68.25307"}
{"text": "Obviously the same effect could be obtained by selecting foods which do not contain those specific non - absorbable oligosaccharides .However this selection is not easy and may lead to the elimination of healthy food ( cereals , legumes and vegetables ) .", "label": "", "metadata": {}, "score": "68.35854"}
{"text": "Obviously the same effect could be obtained by selecting foods which do not contain those specific non - absorbable oligosaccharides .However this selection is not easy and may lead to the elimination of healthy food ( cereals , legumes and vegetables ) .", "label": "", "metadata": {}, "score": "68.35854"}
{"text": "The primary endpoint was the reduction in global distress measured by the Faces Pain Scale - Revised ( FPS - R ) at the end of treatment compared to baseline .", "label": "", "metadata": {}, "score": "68.404724"}
{"text": "The primary endpoint was the reduction in global distress measured by the Faces Pain Scale - Revised ( FPS - R ) at the end of treatment compared to baseline .", "label": "", "metadata": {}, "score": "68.404724"}
{"text": "J Pediatr Gastroenterol Nutr . doi : 10.1097/MPG.0b013e3181ca4d95 .[PubMed ] [ Cross Ref ] .Ganiats TG , Norcross WA , Halverson AL .", "label": "", "metadata": {}, "score": "68.45293"}
{"text": "Parents were instructed to continue with their usual diet over the study period in order to avoid any possible impact from a change of diet to the study results .", "label": "", "metadata": {}, "score": "68.52165"}
{"text": "Parents were instructed to continue with their usual diet over the study period in order to avoid any possible impact from a change of diet to the study results .", "label": "", "metadata": {}, "score": "68.52165"}
{"text": "PubMed View Article . O'MahonyL , McCarthy J , Kelly P , et al .: Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles .", "label": "", "metadata": {}, "score": "68.55526"}
{"text": "At the end of the treatment , the medicamental pulverata was sealed with adhesive tape and was washed clean 2 days later .The treatment ( both in group HM and group FM ) was performed twice a week and lasted for 4 weeks ( treatment period ) .", "label": "", "metadata": {}, "score": "68.57329"}
{"text": "All patients gave written informed consent .In order to insure the quality of this trial , treatment was performed by trained and certified clinicians who have the Chinese medicine practitioner license from the Ministry of Health of the People 's Republic of China .", "label": "", "metadata": {}, "score": "68.713326"}
{"text": "Especially in some of the subgroups , small sample sizes are further limiting factors in this pilot study .Further investigation in controlled studies will be necessary to evaluate the effect of Silicea Gastrointestinal Gel on specific functional gastrointestinal syndromes .", "label": "", "metadata": {}, "score": "69.0114"}
{"text": "Moxibustion in the management of irritable bowel syndrome : Systematic review and meta - analysis .BMC Complement Altern Med .The term IBS is used to describe chronic colon problems that occur in the absence of an identifiable medical cause .", "label": "", "metadata": {}, "score": "69.02978"}
{"text": "The reduction in proportion of patients with relevant symptoms is the secondary outcome measure .The study protocol was defined in accordance with the Declaration of Helsinki and approved by the ethical committee of the University Hospital Umberto I in Rome .", "label": "", "metadata": {}, "score": "69.11283"}
{"text": "The reduction in proportion of patients with relevant symptoms is the secondary outcome measure .The study protocol was defined in accordance with the Declaration of Helsinki and approved by the ethical committee of the University Hospital Umberto I in Rome .", "label": "", "metadata": {}, "score": "69.11283"}
{"text": "CC , BG and AM designed the study .CS is the head of the Pediatric Gastroenterology Unit , approved the study design and strongly revised a draft of the paper .", "label": "", "metadata": {}, "score": "69.172935"}
{"text": "C - IBS and DA - IBS formulations .The efficacy and tolerability of C - IBS ( Table 2 ) , a formula designed to treat constipation - predominant IBS , and DA - IBS , a formula designed to treat diarrhea - predominant and alternating bowel habit IBS , were evaluated in an uncontrolled study .", "label": "", "metadata": {}, "score": "69.249245"}
{"text": "Adverse events ( AEs ) were also recorded by clinicians during the treatment period , such as skin burn related to moxibustion therapy ( the dropped ashes from the burning moxa cone ) and infection caused by burn or allergy caused by the medicamental pulverata .", "label": "", "metadata": {}, "score": "69.25007"}
{"text": "2008 Sep 17 .Ford AC , Talley NJ , Spiegel BM , et al .Effect of fibre , antispasmodics , and peppermint oil in the treatment of irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "69.37426"}
{"text": "2008 Sep 17 .Ford AC , Talley NJ , Spiegel BM , et al .Effect of fibre , antispasmodics , and peppermint oil in the treatment of irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "69.37426"}
{"text": "2008 Sep 17 .Ford AC , Talley NJ , Spiegel BM , et al .Effect of fibre , antispasmodics , and peppermint oil in the treatment of irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "69.37426"}
{"text": "2008 Sep 17 .Ford AC , Talley NJ , Spiegel BM , et al .Effect of fibre , antispasmodics , and peppermint oil in the treatment of irritable bowel syndrome : systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "69.37426"}
{"text": "At the beginning of treatment , patients were advised to take two 15 mL spoonfuls of gastrointestinal gel dissolved in water or tea 3 times daily at least 2 hours after the last meal or before lunch , dinner , and bedtime , respectively , breakfast .", "label": "", "metadata": {}, "score": "69.40494"}
{"text": "J. C. Boyer , R. Magous , M. O. Christen , J. L. Balmes , and J. P. Bali , \" Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide , \" Cell Calcium , vol .", "label": "", "metadata": {}, "score": "69.42625"}
{"text": "The statistical analysis will be performed using the SAS 8.1 software ( SAS , Cary , NC , USA ) .Baseline differences among the groups will be assessed with the use of the one - factor analysis of variance or the Mann - Whitney U- test for measurement data and the \u03c7 2 test or the Wilcoxon test for enumeration data .", "label": "", "metadata": {}, "score": "69.44716"}
{"text": "42 , pp .6577 - 6581 , 2005 .View at Google Scholar \u00b7 View at Scopus .J. Melzer , F. Iten , J. Reichling , and R. Saller , \" Iberis amara L. and Iberogast - results of a systematic review concerning functional dyspepsia , \" Journal of Herbal Pharmacotherapy , vol .", "label": "", "metadata": {}, "score": "69.64415"}
{"text": "This study is a phase III clinical trial and has been authorised by the CFDA ( Approval Number 2007 L02218 ) .In addition , the study is registered with the Chinese Clinical Trial Registry ( ChiCTR - TRC-14004241 ) .", "label": "", "metadata": {}, "score": "69.70009"}
{"text": "A randomised , multi - centre , double - blind , placebo - controlled , superiority , phase III clinical trial will be helpful for further clarification of these results .", "label": "", "metadata": {}, "score": "69.70568"}
{"text": "Studies indicate an improvement both in the abdominal complaints and the quality of life in IBS patients adopting CAM treatment , which includes dietary supplements , TCM , acupuncture , moxibustion and botanicals [ 13 - 16 ] .", "label": "", "metadata": {}, "score": "69.81583"}
{"text": "Symptomatology , quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy .Aliment Pharmacol Ther .Rees WD , Evans BK , Rhodes J. Treating irritable bowel syndrome with peppermint oil .", "label": "", "metadata": {}, "score": "69.90413"}
{"text": "Symptomatology , quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy .Aliment Pharmacol Ther .Rees WD , Evans BK , Rhodes J. Treating irritable bowel syndrome with peppermint oil .", "label": "", "metadata": {}, "score": "69.90413"}
{"text": "Symptomatology , quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy .Aliment Pharmacol Ther .Rees WD , Evans BK , Rhodes J. Treating irritable bowel syndrome with peppermint oil .", "label": "", "metadata": {}, "score": "69.90413"}
{"text": "Symptomatology , quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy .Aliment Pharmacol Ther .Rees WD , Evans BK , Rhodes J. Treating irritable bowel syndrome with peppermint oil .", "label": "", "metadata": {}, "score": "69.90413"}
{"text": "2390 - 2397 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Affiliated with .Abstract .Background .Irritable bowel syndrome ( IBS ) is a common gastrointestinal functional disorder with no effective therapy .", "label": "", "metadata": {}, "score": "69.96175"}
{"text": "doi : 10.1053/j.gastro.2011.12.043 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Saps M. et al .Multicenter , randomized , placebo - controlled trial of amitriptyline in children with functional gastrointestinal disorders .", "label": "", "metadata": {}, "score": "70.11701"}
{"text": "Dew MJ , Evans BK , Rhodes J. Peppermint oil for the irritable bowel syndrome : a multicentre trial .Br J Clin Pract .Lawson MJ , Knight RE , Tran K , et al .", "label": "", "metadata": {}, "score": "70.12964"}
{"text": "Dew MJ , Evans BK , Rhodes J. Peppermint oil for the irritable bowel syndrome : a multicentre trial .Br J Clin Pract .Lawson MJ , Knight RE , Tran K , et al .", "label": "", "metadata": {}, "score": "70.12964"}
{"text": "Dew MJ , Evans BK , Rhodes J. Peppermint oil for the irritable bowel syndrome : a multicentre trial .Br J Clin Pract .Lawson MJ , Knight RE , Tran K , et al .", "label": "", "metadata": {}, "score": "70.12964"}
{"text": "Dew MJ , Evans BK , Rhodes J. Peppermint oil for the irritable bowel syndrome : a multicentre trial .Br J Clin Pract .Lawson MJ , Knight RE , Tran K , et al .", "label": "", "metadata": {}, "score": "70.12964"}
{"text": "PubMed View Article .Hicks CL , et al .:The faces pain scale - revised : toward a common metric in pediatric pain measurement .", "label": "", "metadata": {}, "score": "70.147804"}
{"text": "PubMed ] [ Cross Ref ] .Friis H , Bod'e S , Rumessen JJ .et al .Effect of simethicone on lactulose - induced H2 production and gastrointestinal symptoms .", "label": "", "metadata": {}, "score": "70.208305"}
{"text": "No significant changes were observed between \u03b1 -galactosidase and placebo for the \" physician 's overall evaluation \" at end of treatment and at follow - up .", "label": "", "metadata": {}, "score": "70.23308"}
{"text": "No significant changes were observed between \u03b1 -galactosidase and placebo for the \" physician 's overall evaluation \" at end of treatment and at follow - up .", "label": "", "metadata": {}, "score": "70.23308"}
{"text": "Priobiotics were associated with fewer global symptoms , abdominal pain , bloating , and flatulence when compared to placebo .There were no differences found in urgency - related symptoms .", "label": "", "metadata": {}, "score": "70.43863"}
{"text": "Priobiotics were associated with fewer global symptoms , abdominal pain , bloating , and flatulence when compared to placebo .There were no differences found in urgency - related symptoms .", "label": "", "metadata": {}, "score": "70.43863"}
{"text": "Priobiotics were associated with fewer global symptoms , abdominal pain , bloating , and flatulence when compared to placebo .There were no differences found in urgency - related symptoms .", "label": "", "metadata": {}, "score": "70.43863"}
{"text": "Priobiotics were associated with fewer global symptoms , abdominal pain , bloating , and flatulence when compared to placebo .There were no differences found in urgency - related symptoms .", "label": "", "metadata": {}, "score": "70.43863"}
{"text": "Both treatments were given as drops or tablets according to body weight : 4 or 8 drops were administered to children with body weight lower than 20 kg and to children with body weight between 20 and 40 kg , respectively .", "label": "", "metadata": {}, "score": "70.624054"}
{"text": "Both treatments were given as drops or tablets according to body weight : 4 or 8 drops were administered to children with body weight lower than 20 kg and to children with body weight between 20 and 40 kg , respectively .", "label": "", "metadata": {}, "score": "70.624054"}
{"text": "Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances : a randomised double blind placebo controlled study .Gut .2005 May 24 .", "label": "", "metadata": {}, "score": "70.79825"}
{"text": "Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances : a randomised double blind placebo controlled study .Gut .2005 May 24 .", "label": "", "metadata": {}, "score": "70.79825"}
{"text": "Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances : a randomised double blind placebo controlled study .Gut .2005 May 24 .", "label": "", "metadata": {}, "score": "70.79825"}
{"text": "Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances : a randomised double blind placebo controlled study .Gut .2005 May 24 .", "label": "", "metadata": {}, "score": "70.79825"}
{"text": "Curr Treat Options Gastroenterol 2005 , 8 : 311 - 318 .PubMed View Article .Friis H , Bod'e S , Rumessen JJ , et al .", "label": "", "metadata": {}, "score": "70.85796"}
{"text": "Similar analytic results of PP population and FAS population were detected .Here we are going to introduce the analytic results of FAS population .Figure 2 : Flow chart of the trial .", "label": "", "metadata": {}, "score": "71.02325"}
{"text": "74In the 5 trials that included real versus sham acupuncture , there were no significant differences between the two treatment groups on IBS symptoms .", "label": "", "metadata": {}, "score": "71.02725"}
{"text": "74In the 5 trials that included real versus sham acupuncture , there were no significant differences between the two treatment groups on IBS symptoms .", "label": "", "metadata": {}, "score": "71.02725"}
{"text": "74In the 5 trials that included real versus sham acupuncture , there were no significant differences between the two treatment groups on IBS symptoms .", "label": "", "metadata": {}, "score": "71.02725"}
{"text": "74In the 5 trials that included real versus sham acupuncture , there were no significant differences between the two treatment groups on IBS symptoms .", "label": "", "metadata": {}, "score": "71.02725"}
{"text": "[PubMed ] [ DOI ] .Bundy R , Walker AF , Middleton RW , Booth J. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults : a pilot study .", "label": "", "metadata": {}, "score": "71.06763"}
{"text": "RJL participated in the statistical design and helped in the design of the study .BS and YC helped to draft the manuscript .JG was the general supervisor for this research and participated in the critical revision of the manuscript .", "label": "", "metadata": {}, "score": "71.0807"}
{"text": "In a double - blind , placebo - controlled , multicentre trial , STW 5-II , another formula composed of 6 of 9 herbal extracts used in STW 5 , and a preparation containing only one of 9 herbal extracts ( extract of Iberis amara ) were compared with placebo .", "label": "", "metadata": {}, "score": "71.13837"}
{"text": "Another , Lotronex , was temporarily withdrawn , and then re - approved , but only under strict limitations .Other medical treatment approaches for IBS include increased dietary fiber , drugs that reduce bowel spasm , and drugs to address constipation or diarrhea as needed .", "label": "", "metadata": {}, "score": "71.16655"}
{"text": "Another , Lotronex , was temporarily withdrawn , and then re - approved , but only under strict limitations .Other medical treatment approaches for IBS include increased dietary fiber , drugs that reduce bowel spasm , and drugs to address constipation or diarrhea as needed .", "label": "", "metadata": {}, "score": "71.16655"}
{"text": "A randomised , double - blinded , placebo - controlled , multi - centre , superiority clinical trial to evaluate the efficacy and safety of SQTX Granule is proposed .", "label": "", "metadata": {}, "score": "71.18909"}
{"text": "PubMed ] [ DOI ] .Liu JH , Chen GH , Yeh HZ , Huang CK , Poon SK .Enteric - coated peppermint - oil capsules in the treatment of irritable bowel syndrome : a prospective , randomized trial .", "label": "", "metadata": {}, "score": "71.193954"}
{"text": "To evaluate the efficacy and tolerability of \u03b1 - galactosidase in the treatment of gas - related symptoms in pediatric patients .Methods .Single center , randomized , double - blind , placebo - controlled , parallel group study performed in tertiary care setting .", "label": "", "metadata": {}, "score": "71.258286"}
{"text": "To evaluate the efficacy and tolerability of \u03b1 - galactosidase in the treatment of gas - related symptoms in pediatric patients .Methods .Single center , randomized , double - blind , placebo - controlled , parallel group study performed in tertiary care setting .", "label": "", "metadata": {}, "score": "71.258286"}
{"text": "Moxibustion in the management of irritable bowel syndrome : Systematic review and meta - analysis .BMC Complement Altern Med .Sponsored by iHerb .Com Positively the best overall value for natural products !", "label": "", "metadata": {}, "score": "71.26532"}
{"text": "PubMed View Article .Evid Based Complement Alternat Med 2013 , 2013 : 605460 .PubMed Central PubMed .Merat S , Khalili S , Mostajabi P , Ghorbani A , Ansari R , Malekzadeh R : The effect of enteric - coated , delayed - release peppermint oil on irritable bowel syndrome .", "label": "", "metadata": {}, "score": "71.30852"}
{"text": "STW 5 has also controlled visceral hypersensitivity by reducing intestinal afferent sensitivity to mechanical and chemical stimuli in the upper gastrointestinal tract in male Wistar rats .", "label": "", "metadata": {}, "score": "71.62022"}
{"text": "Another study showed that Hypericum perforatum can improve the psychologic symptoms and the ANS reactivity to stress and relieve intestinal symptoms in women with IBS .", "label": "", "metadata": {}, "score": "71.6762"}
{"text": "[PubMed ] [ DOI ] .Cooke C , Carr I , Abrams K , Mayberry J. Arrowroot as a treatment for diarrhoea in irritable bowel syndrome patients : a pilot study .", "label": "", "metadata": {}, "score": "71.81691"}
{"text": "J Appl Physiol .[PubMed ] [ DOI ] .Carrasco FR , Schmidt G , Romero AL , Sartoretto JL , Caparroz - Assef SM , Bersani - Amado CA , Cuman RK .", "label": "", "metadata": {}, "score": "71.90496"}
{"text": "Lactobacillus plantarum 299v failed to provide significant improvements in abdominal pain , bloating , or quality of life when compared to placebo in a randomized trial with 81 adults over an 8 week period .", "label": "", "metadata": {}, "score": "72.13762"}
{"text": "Lactobacillus plantarum 299v failed to provide significant improvements in abdominal pain , bloating , or quality of life when compared to placebo in a randomized trial with 81 adults over an 8 week period .", "label": "", "metadata": {}, "score": "72.13762"}
{"text": "Lactobacillus plantarum 299v failed to provide significant improvements in abdominal pain , bloating , or quality of life when compared to placebo in a randomized trial with 81 adults over an 8 week period .", "label": "", "metadata": {}, "score": "72.13762"}
{"text": "Lactobacillus plantarum 299v failed to provide significant improvements in abdominal pain , bloating , or quality of life when compared to placebo in a randomized trial with 81 adults over an 8 week period .", "label": "", "metadata": {}, "score": "72.13762"}
{"text": "Br J Nutr .[PubMed ] [ DOI ] .Emend\u00f6rfer F , Emend\u00f6rfer F , Bellato F , Noldin VF , Cechinel - Filho V , Yunes RA , Delle Monache F , Cardozo AM .", "label": "", "metadata": {}, "score": "72.144775"}
{"text": "PubMed View Article .McFarland LV : State - of - the - art of irritable bowel syndrome and inflammatory bowel disease research in 2008 .", "label": "", "metadata": {}, "score": "72.174675"}
{"text": "doi : 10.1159/000200726 .[PubMed ] [ Cross Ref ] .Suarez FL , Furne J , Springfield J , Levitt MD .Failure of activated charcoal to reduce the release of gases produced by the colonic flora .", "label": "", "metadata": {}, "score": "72.22847"}
{"text": "Silicea Gastrointestinal Gel seems suitable beyond infectious acute gastrointestinal disorders .Responses are relevant for chronic functional disorders , but it remains unclear , how much of that might be placebo - effect .", "label": "", "metadata": {}, "score": "72.30299"}
{"text": "Randomization and Blinding .Randomization was performed by an independent statistician through generating allocation numbers based on a random number creation system .The patients were randomly assigned in each center using a blocked randomization , and the block size is 16 .", "label": "", "metadata": {}, "score": "72.86359"}
{"text": "However , it seems there are many other herbal preparations such as those proposed in traditional medicine of different countries that could be studied and investigated for their efficacy in management of IBS .", "label": "", "metadata": {}, "score": "72.88779"}
{"text": "Further investigation showed that this effect may be mediated by kappa - opioid receptors and \u03b1 ( 2)-adrenoceptors in the central nervous system [ 39 ] .", "label": "", "metadata": {}, "score": "72.93675"}
{"text": "[PubMed ] [ DOI ] .Kline RM , Kline JJ , Di Palma J GJ .Enteric - coated , pH - dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children .", "label": "", "metadata": {}, "score": "73.06575"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .DNG and OS designed the study and wrote the manuscript .MS and FF followed - up patients .", "label": "", "metadata": {}, "score": "73.131424"}
{"text": "Additionally , patients with diseases that might have influenced symptoms and pregnant or nursing women were not included .Medication .Silicic acid is an inert adsorption agent that has been used for many years in the treatment of gastrointestinal disorders .", "label": "", "metadata": {}, "score": "73.18013"}
{"text": "Indeed , the human intestine does not contain the enzyme required to digest NDO and their consequent incomplete digestion produces increased bacterial fermentation generating hydrogen , methane and carbon dioxide [ 13 - 15 ] .", "label": "", "metadata": {}, "score": "73.34108"}
{"text": "Indeed , the human intestine does not contain the enzyme required to digest NDO and their consequent incomplete digestion produces increased bacterial fermentation generating hydrogen , methane and carbon dioxide [ 13 - 15 ] .", "label": "", "metadata": {}, "score": "73.34108"}
{"text": "Chin J Integr Med .[PubMed ] [ DOI ] .Hu X , Xu D , Zhao Y , Yang X , Meng J , Shen H , Guo J. The Alleviating Pain Effect of Aqueous Extract from Tong - Xie - Yao - Fang , on Experimental Visceral Hypersensitivity and Its Mechanism .", "label": "", "metadata": {}, "score": "73.57504"}
{"text": "There is evidence in modern phytotherapy for the beneficial effects of these plants in IBS .Boswellia carterii has shown anti - inflammatory [ 60 , 61 ] and immunomodulatory activity [ 62 ] .", "label": "", "metadata": {}, "score": "73.76397"}
{"text": "[PubMed ] [ DOI ] .Hawrelak JA , Cattley T , Myers SP .Essential oils in the treatment of intestinal dysbiosis : A preliminary in vitro study .", "label": "", "metadata": {}, "score": "73.86657"}
{"text": "The numbers are kept in opaque sealed envelopes .The double levels of blinding are sealed separately , and given to the leader and the sponsor of the clinical research .", "label": "", "metadata": {}, "score": "73.90584"}
{"text": "Randomised placebo controlled trial .BMJ .2009 ; 339 : b3154 .[PubMed ] [ DOI ] .Vejdani R , Shalmani HR , Mir - Fattahi M , Sajed - Nia F , Abdollahi M , Zali MR , Mohammad Alizadeh AH , Bahari A , Amin G. The efficacy of an herbal medicine , Carmint , on the relief of abdominal pain and bloating in patients with irritable bowel syndrome : a pilot study .", "label": "", "metadata": {}, "score": "73.935715"}
{"text": "Objective .To explore the efficacy of Herb - partitioned moxibustion in treating IBS - D patients .Method .210 IBS - D patients were randomly assigned on a . basis to group HM , group FM , or group PB for 4-week treatment .", "label": "", "metadata": {}, "score": "74.032486"}
{"text": "doi : 10.1053/j.gastro.2009.06.060 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Hicks CL . et al .The faces pain scale - revised : toward a common metric in pediatric pain measurement .", "label": "", "metadata": {}, "score": "74.05594"}
{"text": "Principal Proposed Natural Treatments .Peppermint .Peppermint oil is widely used for IBS , and the evidence suggests that it is probably useful .A majority of placebo - controlled studies have found peppermint oil to be more effective than placebo . 7 - 12,34,49,64,67 However , most of these studies are small .", "label": "", "metadata": {}, "score": "74.057014"}
{"text": "Principal Proposed Natural Treatments .Peppermint .Peppermint oil is widely used for IBS , and the evidence suggests that it is probably useful .A majority of placebo - controlled studies have found peppermint oil to be more effective than placebo . 7 - 12,34,49,64,67 However , most of these studies are small .", "label": "", "metadata": {}, "score": "74.057014"}
{"text": "Principal Proposed Natural Treatments .Peppermint .Peppermint oil is widely used for IBS , and the evidence suggests that it is probably useful .A majority of placebo - controlled studies have found peppermint oil to be more effective than placebo . 7 - 12,34,49,64,67 However , most of these studies are small .", "label": "", "metadata": {}, "score": "74.057014"}
{"text": "Principal Proposed Natural Treatments .Peppermint .Peppermint oil is widely used for IBS , and the evidence suggests that it is probably useful .A majority of placebo - controlled studies have found peppermint oil to be more effective than placebo . 7 - 12,34,49,64,67 However , most of these studies are small .", "label": "", "metadata": {}, "score": "74.057014"}
{"text": "2008 Nov 13;337:a2313 .Lembo AJ , Conboy L , Kelley JM , et al .A treatment trial of acupuncture in IBS patients .", "label": "", "metadata": {}, "score": "74.14534"}
{"text": "2008 Nov 13;337:a2313 .Lembo AJ , Conboy L , Kelley JM , et al .A treatment trial of acupuncture in IBS patients .", "label": "", "metadata": {}, "score": "74.14534"}
{"text": "2008 Nov 13;337:a2313 .Lembo AJ , Conboy L , Kelley JM , et al .A treatment trial of acupuncture in IBS patients .", "label": "", "metadata": {}, "score": "74.14534"}
{"text": "2008 Nov 13;337:a2313 .Lembo AJ , Conboy L , Kelley JM , et al .A treatment trial of acupuncture in IBS patients .", "label": "", "metadata": {}, "score": "74.14534"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Pediatric Gastroenterology and Liver Unit , Sapienza - University of Rome .Department of Medical Science , University of Bologna .", "label": "", "metadata": {}, "score": "74.16844"}
{"text": "Fumaria officinalis .The efficacy of Fumaria officinalis , because of its antispasmodic activity , has been investigated in IBS patients .In the randomized , double - blind , placebo - controlled trial , IBS - related pain decreased more in the fumitory group compared to the placebo group .", "label": "", "metadata": {}, "score": "74.2858"}
{"text": "Revision Information .This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "74.294945"}
{"text": "Revision Information .This content is reviewed regularly and is updated when new and relevant evidence is made available .This information is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "74.294945"}
{"text": "[PubMed ] [ DOI ] .Merat S , Khalili S , Mostajabi P , Ghorbani A , Ansari R , Malekzadeh R. The effect of enteric - coated , delayed - release peppermint oil on irritable bowel syndrome .", "label": "", "metadata": {}, "score": "74.296555"}
{"text": "They are not intended to diagnose , treat , cure , or prevent any disease .Read More", "label": "", "metadata": {}, "score": "74.46708"}
{"text": "Moxibustion in the management of irritable bowel syndrome : Systematic review and meta - analysis .BMC Complement Altern Med .Quick Links Patients & Visitors --Classes & Events --Locations --Patient Information --Pay Bill Online --Site Map --Registration Health Info --For Physicians --For Employees --Careers --Patient Portal --Health Library --Video Library The term IBS is used to describe chronic colon problems that occur in the absence of an identifiable medical cause .", "label": "", "metadata": {}, "score": "74.47145"}
{"text": "The dosage , duration and name of any concomitant treatment or medication must be recorded carefully in the CRFs .Test drugs .The test drugs are SQTX Granule and placebo , which are indistinguishable from the actual medication .", "label": "", "metadata": {}, "score": "74.54018"}
{"text": "Intervention .Patients are administered SQTX Granule or placebo in one bag ( 0.5 g per bag ) dissolved in warm water three times daily for 28 days .", "label": "", "metadata": {}, "score": "74.56333"}
{"text": "28,35,54,62 One such combination , called VSL#3 , contains B. longum , B. infantis , L. acidophilus , L. plantarum , L. casei , L. bulgaricus , and Streptococcus thermophilus .", "label": "", "metadata": {}, "score": "74.654976"}
{"text": "28,35,54,62 One such combination , called VSL#3 , contains B. longum , B. infantis , L. acidophilus , L. plantarum , L. casei , L. bulgaricus , and Streptococcus thermophilus .", "label": "", "metadata": {}, "score": "74.654976"}
{"text": "28,35,54,62 One such combination , called VSL#3 , contains B. longum , B. infantis , L. acidophilus , L. plantarum , L. casei , L. bulgaricus , and Streptococcus thermophilus .", "label": "", "metadata": {}, "score": "74.654976"}
{"text": "28,35,54,62 One such combination , called VSL#3 , contains B. longum , B. infantis , L. acidophilus , L. plantarum , L. casei , L. bulgaricus , and Streptococcus thermophilus .", "label": "", "metadata": {}, "score": "74.654976"}
{"text": "A bowl made by dough with a hole ( diameter 2 cm , depth 2 cm ) in the middle was placed on patient ' navel .", "label": "", "metadata": {}, "score": "74.78256"}
{"text": "In another study , the effectiveness of an enteric - coated peppermint oil capsule was evaluated in patients with IBS in whom small intestinal bacterial overgrowth , lactose intolerance and celiac disease were excluded .", "label": "", "metadata": {}, "score": "74.940636"}
{"text": "Outcome assessment .Primary outcome .Scores of IBS - quality of life rating scale ( IBS - QOL ) rating scale [ 21 ] .", "label": "", "metadata": {}, "score": "74.98063"}
{"text": "Special thanks to all the patients who participated in this study .Competing interests .The authors declare that they have no competing interests .Authors ' contributions .", "label": "", "metadata": {}, "score": "75.32119"}
{"text": "Biomed Imaging Interv J 2008 , 4 : e5 .PubMed Central PubMed .Zhen XY : Guidelines for Clinical Research of New Chinese Medicine .", "label": "", "metadata": {}, "score": "76.056946"}
{"text": "We used Wilcoxon rank - sum test in between - group comparisons while the Wilcoxon 's sign rank test was used in within - group comparisons .", "label": "", "metadata": {}, "score": "76.07493"}
{"text": "Acupuncture has been proposed as a treatment for IBS .However , a number of studies , including 2 systematic reviews , have not found strong evidence to support the use of acupuncture for this condition .", "label": "", "metadata": {}, "score": "76.09222"}
{"text": "Acupuncture has been proposed as a treatment for IBS .However , a number of studies , including 2 systematic reviews , have not found strong evidence to support the use of acupuncture for this condition .", "label": "", "metadata": {}, "score": "76.09222"}
{"text": "Acupuncture has been proposed as a treatment for IBS .However , a number of studies , including 2 systematic reviews , have not found strong evidence to support the use of acupuncture for this condition .", "label": "", "metadata": {}, "score": "76.09222"}
{"text": "Acupuncture has been proposed as a treatment for IBS .However , a number of studies , including 2 systematic reviews , have not found strong evidence to support the use of acupuncture for this condition .", "label": "", "metadata": {}, "score": "76.09222"}
{"text": "Tong - Xie - Yao - Fang ( TXYF ) is a prescription in TCM , prepared from four herbs ( Table 2 ) .A study was done to compare the efficacy of this formulation with Myarisan , a probiotic formulation , in treating diarrhea - predominant IBS .", "label": "", "metadata": {}, "score": "76.1978"}
{"text": "[PubMed ] [ DOI ] .Brinkhaus B , Hentschel C , Von Keudell C , Schindler G , Lindner M , St\u00fctzer H , Kohnen R , Willich SN , Lehmacher W , Hahn EG .", "label": "", "metadata": {}, "score": "76.21837"}
{"text": "[PubMed ] [ DOI ] .Krueger D , Gruber L , Buhner S , Zeller F , Langer R , Seidl S , Michel K , Schemann M. The multi - herbal drug STW 5 ( Iberogast ) has prosecretory action in the human intestine .", "label": "", "metadata": {}, "score": "76.236946"}
{"text": "Moxibustion in the management of irritable bowel syndrome : Systematic review and meta - analysis .BMC Complement Altern Med .Please be aware that this information is provided to supplement the care provided by your physician .", "label": "", "metadata": {}, "score": "76.302246"}
{"text": "Flatulence or gas build up in the intestine is typically caused by the fermentation of undigested food and may cause voluntary or involuntary passing of gas [ 6 ] .", "label": "", "metadata": {}, "score": "76.405945"}
{"text": "Flatulence or gas build up in the intestine is typically caused by the fermentation of undigested food and may cause voluntary or involuntary passing of gas [ 6 ] .", "label": "", "metadata": {}, "score": "76.405945"}
{"text": "Written informed consent will be obtained from each patient .Recruitment .Each centre will recruit 55 patients through posters in local hospitals .Sample size calculation .", "label": "", "metadata": {}, "score": "76.42883"}
{"text": "Cynara scolymus .Cynara scolymus was demonstrated to have both preventive and curative roles in IBS .The leaf extract of Cynara scolymus was evaluated in healthy volunteers suffering concomitant dyspepsia and showed a 26.4 % fall in IBS incidence after treatment .", "label": "", "metadata": {}, "score": "76.4427"}
{"text": "There are different strategies that may reduce intestinal gas .Current approaches are based on dietary changes and life - style factors ; administration of simethicone ; activated charcoal and probiotics [ 7 - 12 ] .", "label": "", "metadata": {}, "score": "76.49081"}
{"text": "There are different strategies that may reduce intestinal gas .Current approaches are based on dietary changes and life - style factors ; administration of simethicone ; activated charcoal and probiotics [ 7 - 12 ] .", "label": "", "metadata": {}, "score": "76.49081"}
{"text": "Enteric - coated peppermint - oil capsules in the treatment of irritable bowel syndrome : a prospective , randomized trial .J Gastroenterol .Kline RM , Kline JJ , Di Palma J , et al .", "label": "", "metadata": {}, "score": "76.53076"}
{"text": "Enteric - coated peppermint - oil capsules in the treatment of irritable bowel syndrome : a prospective , randomized trial .J Gastroenterol .Kline RM , Kline JJ , Di Palma J , et al .", "label": "", "metadata": {}, "score": "76.53076"}
{"text": "Enteric - coated peppermint - oil capsules in the treatment of irritable bowel syndrome : a prospective , randomized trial .J Gastroenterol .Kline RM , Kline JJ , Di Palma J , et al .", "label": "", "metadata": {}, "score": "76.53076"}
{"text": "Enteric - coated peppermint - oil capsules in the treatment of irritable bowel syndrome : a prospective , randomized trial .J Gastroenterol .Kline RM , Kline JJ , Di Palma J , et al .", "label": "", "metadata": {}, "score": "76.53076"}
{"text": "Am J Gastroenterol .[PubMed ] [ DOI ] .Zhanghua Yixue Zazhi .[PubMed ] [ DOI ] .Pan F , Zhang T , Zhang YH , Xu JJ , Chen FM .", "label": "", "metadata": {}, "score": "76.79714"}
{"text": "Fink RN , Lembo AJ : Intestinal gas .Curr Treat Options Gastroenterol .2001 Aug , 4 : 333 - 337 .PubMed View Article .", "label": "", "metadata": {}, "score": "76.883865"}
{"text": "The extracts of Angelica sinensis root , Matricaria recutita flower and Glycyrrhiza uralensis root mimicked the inhibitory effects in the proximal stomach whereas the extracts of Chelidonium majus , Melissa officinalis leaf , Carum carvi fruit and Iberis amara increased motility of the proximal stomach .", "label": "", "metadata": {}, "score": "76.93475"}
{"text": "All of the drugs provided by the pharmaceutical company will be numbered with a label according to the randomisation schedule .Blinding .This trial is a double - blind trial .", "label": "", "metadata": {}, "score": "77.06441"}
{"text": "[PubMed ] [ DOI ] .Magalh\u00e3es CB , Riva DR , DePaula LJ , Brando - Lima A , Koatz VL , Leal - Cardoso JH , Zin WA , Faffe DS .", "label": "", "metadata": {}, "score": "77.26305"}
{"text": "Shun - Qi -Tong - Xie Granule .TCM : .Traditional Chinese medicine .TXYF : .Tong - Xie - Yao - Fang .", "label": "", "metadata": {}, "score": "77.51139"}
{"text": "The most predominant effect of peppermint oil was reduction in the severity of abdominal pain .No side effects were reported by either the investigator or patients during the 2-week study period [ 35 ] .", "label": "", "metadata": {}, "score": "77.514496"}
{"text": "Aim .To investigate efficacy and tolerability of Silicea Gastrointestinal Gel in patients with gastrointestinal disorders .Methods .Open , prospective pivotal phase IV study with oral Silicea Gastrointestinal Gel over 6 weeks .", "label": "", "metadata": {}, "score": "78.01717"}
{"text": "Navel ( Shenque CV8 ) is closed to large intestine and small intestine in anatomical position .What is more , it is also associated with spleen , large intestine , and small intestine according to meridian theory .", "label": "", "metadata": {}, "score": "78.03809"}
{"text": "Because the cause of IBS is not understood , conventional medical treatment of IBS is highly inadequate .One drug that had shown promise , Zelnorm , was withdrawn from the market for safety issues .", "label": "", "metadata": {}, "score": "78.24182"}
{"text": "Because the cause of IBS is not understood , conventional medical treatment of IBS is highly inadequate .One drug that had shown promise , Zelnorm , was withdrawn from the market for safety issues .", "label": "", "metadata": {}, "score": "78.24182"}
{"text": "The present study was a multicenter ( 3 centers ) , randomized , controlled trial ( Figure 1 ) .Patient Selection .Patients were recruited from the outpatients of Affiliated Hospital of Shandong University of Traditional Chinese Medicine , Qilu Hospital Affiliated to Shandong University and Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medicine University , between October 2008 and January 2011 .", "label": "", "metadata": {}, "score": "78.313324"}
{"text": "There are conflicting results for the efficacy of Hypericum perforatum in IBS .Among compound preparations , most studies had been performed with STW 5 , a formula containing hydroethanolic extract of 9 herbs .", "label": "", "metadata": {}, "score": "78.59287"}
{"text": "29 Treatment consisted of 5 capsules 3 times daily , taken for 16 weeks .The results showed that both forms of active treatment were superior to placebo , significantly reducing IBS symptoms .", "label": "", "metadata": {}, "score": "78.65161"}
{"text": "29 Treatment consisted of 5 capsules 3 times daily , taken for 16 weeks .The results showed that both forms of active treatment were superior to placebo , significantly reducing IBS symptoms .", "label": "", "metadata": {}, "score": "78.65161"}
{"text": "29 Treatment consisted of 5 capsules 3 times daily , taken for 16 weeks .The results showed that both forms of active treatment were superior to placebo , significantly reducing IBS symptoms .", "label": "", "metadata": {}, "score": "78.65161"}
{"text": "29 Treatment consisted of 5 capsules 3 times daily , taken for 16 weeks .The results showed that both forms of active treatment were superior to placebo , significantly reducing IBS symptoms .", "label": "", "metadata": {}, "score": "78.65161"}
{"text": "Studies from Asia suggest higher prevalence of IBS in more developed countries such as Singapore ( 8.6 % ) and Japan ( 9.8 % ) compared with India with the lowest prevalence ( 4.2 % ) [ 3 ] .", "label": "", "metadata": {}, "score": "78.77311"}
{"text": "Relevant binding capacity was found for staphylococcal enterotoxin C1 and bacteria ( E. coli ) , which was comparable to that of activated carbon , and was not affected by acidic pH [ 14 ] .", "label": "", "metadata": {}, "score": "78.86482"}
{"text": "This is particularly remarkable since most of the patients reported a long history of gastrointestinal complaints resistant to many other therapies .It is also notable that this relief was due to treatment with this rather simple medicinal device silica gel .", "label": "", "metadata": {}, "score": "78.89276"}
{"text": "2006 ; 13 Suppl 5 : 51 - 55 .[PubMed ] [ DOI ] .M\u00fcller MH , Liu CY , Glatzle J , Weiser D , Kelber O , Enck P , Grundy D , Kreis ME .", "label": "", "metadata": {}, "score": "79.61604"}
{"text": "[PubMed ] [ DOI ] .Costabile A , Kolida S , Klinder A , Gietl E , B\u00e4uerlein M , Frohberg C , Landsch\u00fctze V , Gibson GR .", "label": "", "metadata": {}, "score": "79.68068"}
{"text": "The voucher specimens were deposited in Shandong University of Traditional Chinese Medicine .The voucher specimen number of the herbs was 080916 .The herbs were mixed in proportions ( seen Table 1 ) and were shattered into medicamental pulverata by pulverizer .", "label": "", "metadata": {}, "score": "79.85405"}
{"text": "2009 ; 21 : 1203-e110 .[PubMed ] [ DOI ] .Simmen U , Kelber O , Okpanyi SN , Jaeggi R , Bueter B , Weiser D. Binding of STW 5 ( Iberogast ) and its components to intestinal 5-HT , muscarinic M3 , and opioid receptors .", "label": "", "metadata": {}, "score": "80.00227"}
{"text": "The silica gel structure binds water and is not affected in the upper intestinal tract .Furthermore silicic acid could provide local protection to the gastrointestinal mucous membrane .", "label": "", "metadata": {}, "score": "80.567314"}
{"text": "[PubMed ] [ DOI ] .Saito YA , Rey E , Almazar - Elder AE , Harmsen WS , Zinsmeister AR , Locke GR , Talley NJ .", "label": "", "metadata": {}, "score": "80.81761"}
{"text": "With a stratified block randomisation method , a 440-case randomisation arrangement was carried out by an independent statistician according to the sequence generated with SAS software ; this lists a serial number from 001 to 440 corresponding to consecutive allocation ( with a randomisation scheme ) .", "label": "", "metadata": {}, "score": "81.11163"}
{"text": "Life Sci .[PubMed ] [ DOI ] .Bundy R , Walker AF , Middleton RW , Marakis G , Booth JC .Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia : a subset analysis .", "label": "", "metadata": {}, "score": "81.299545"}
{"text": "Biol Pharm Bull .[PubMed ] [ DOI ] .Rahimi R , Nikfar S , Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors : a meta - analysis .", "label": "", "metadata": {}, "score": "81.47852"}
{"text": "Scandinavian Journal of Gastroenterology , vol .28 , no . 8 , pp .681 - 687 , 1993 .View at Google Scholar \u00b7 View at Scopus . H. G. Wu , J. H. Wang , H. P. Chen , et al . , \" Exploration of efficacy and immunological mechanism for IBS treated by herb - partition moxibustion , \" Zhong Guo Zhen Jiu , vol .", "label": "", "metadata": {}, "score": "81.69807"}
{"text": "The efficacy of seed from Plantago psyllium in IBS was determined during a randomized controlled trial .The proportion of responders was significantly greater in the Plantago group than in the placebo group during the first month and the second month of treatment .", "label": "", "metadata": {}, "score": "81.71997"}
{"text": "One in vitro , 3 in vivo and 23 human studies were included and systematically reviewed .The majority of studies are about essential oil of Menta piperita as a single preparation and STW 5 as a compound preparation .", "label": "", "metadata": {}, "score": "81.95456"}
{"text": "[PubMed ] [ DOI ] .Walker AF , Middleton RW , Petrowicz O. Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post - marketing surveillance study .", "label": "", "metadata": {}, "score": "82.06398"}
{"text": "A Chinese herbal medicine .A randomized , double - blind , placebo - controlled trial was conducted to determine whether a Chinese herbal medicine ( CHM ) is of any benefit in the treatment of IBS .", "label": "", "metadata": {}, "score": "82.077736"}
{"text": "[PubMed ] [ DOI ] .Pittler MH , Ernst E. Peppermint oil for irritable bowel syndrome : a critical review and metaanalysis .Am J Gastroenterol .", "label": "", "metadata": {}, "score": "82.197426"}
{"text": "Thus , Curcuma xanthorriza did not show any therapeutic benefit over placebo in patients with IBS [ 19 ] .Thus , the species of Curcuma used is an important factor in determining its efficacy in IBS .", "label": "", "metadata": {}, "score": "82.310135"}
{"text": "[PubMed ] [ DOI ] .Sallon S , Ben - Arye E , Davidson R , Shapiro H , Ginsberg G , Ligumsky M. A novel treatment for constipation - predominant irritable bowel syndrome using Padma Lax , a Tibetan herbal formula .", "label": "", "metadata": {}, "score": "82.666046"}
{"text": "The prosecretory effect is due to increased epithelial chloride fluxes via cystic fibrosis transmembrane conductance regulator and calcium dependent chloride channels [ 45 ] .STW 5 was studied in vitro for binding affinities to serotonin ( 5-HT3 and 5-HT4 ) and muscarinic ( M3 ) receptors of the intestine that play central roles in the etiology of IBS .", "label": "", "metadata": {}, "score": "82.8073"}
{"text": "Chinese herbs have been used for a long time with good effects and few adverse events ; however , a randomised , double - blind , placebo - controlled trial is still necessary to prove the efficacy and safety of any medication .", "label": "", "metadata": {}, "score": "82.88852"}
{"text": "[PubMed ] [ DOI ] .Rahimi R , Shams - Ardekani MR , Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease .", "label": "", "metadata": {}, "score": "83.187294"}
{"text": "This pilot study gives direction to future research .Conclusion .Silicea Gastrointestinal Gel might be suitable for uses extending beyond treatment of acute gastrointestinal disorders caused by pathogens .", "label": "", "metadata": {}, "score": "83.93525"}
{"text": "[PubMed ] [ DOI ] .Logan AC , Beaulne TM .The treatment of small intestinal bacterial overgrowth with enteric - coated peppermint oil : a case report .", "label": "", "metadata": {}, "score": "84.31947"}
{"text": "In addition , the herbs used in our study were aimed to ameliorate symptoms of IBS - D in different aspects .Some of them are characterized with the nature of aromatic and warm character , such as Dingxiang and Shexiang , which can motivate the penetration of herbs .", "label": "", "metadata": {}, "score": "84.59044"}
{"text": "4 , pp .432 - 442 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Silicea Gastrointestinal Gel Improves Gastrointestinal Disorders : A Non - Controlled , Pilot Clinical Study .", "label": "", "metadata": {}, "score": "84.87094"}
{"text": "Antimicrobial properties were reported for Cuminum cyminum [ 70 ] and Cucurbita pepo [ 71 ] .However , more studies are required to get more conclusive results about the efficacy of these herbs in IBS .", "label": "", "metadata": {}, "score": "84.90369"}
{"text": "STW 5 .STW 5 ( Iberogast ) , a formula composed of hydroethanolic extracts of nine herbs , has been prepared for functional gastrointestinal disorders like IBS and its efficacy and mechanisms of action were investigated in several studies .", "label": "", "metadata": {}, "score": "85.00953"}
{"text": "PubMed View Article .Ganiats TG , Norcross WA , Halverson AL , et al .: Does beano prevent gas ?A double - blind crossover study of oral alfa - galactosidase to treat dietary oligosaccharide intolerance .", "label": "", "metadata": {}, "score": "85.04683"}
{"text": "The medicamental pulverata was replaced by farina ( only contained flour , about 8 - 10 g ) in group FM .Then a burning moxa cone ( diameter 2 cm , height 2 cm ) was put on the medicamental pulverata and changed till it burned out .", "label": "", "metadata": {}, "score": "85.09199"}
{"text": "2005 Jul 26 .[ Epub ahead of print ] .Nickolay K. Double blind trial of metoclopramide and Iberogast \u00ae in functional gastroenterology .Gastro Entero Hepatologie .", "label": "", "metadata": {}, "score": "85.21222"}
{"text": "2005 Jul 26 .[ Epub ahead of print ] .Nickolay K. Double blind trial of metoclopramide and Iberogast \u00ae in functional gastroenterology .Gastro Entero Hepatologie .", "label": "", "metadata": {}, "score": "85.21222"}
{"text": "2005 Jul 26 .[ Epub ahead of print ] .Nickolay K. Double blind trial of metoclopramide and Iberogast \u00ae in functional gastroenterology .Gastro Entero Hepatologie .", "label": "", "metadata": {}, "score": "85.21222"}
{"text": "2005 Jul 26 .[ Epub ahead of print ] .Nickolay K. Double blind trial of metoclopramide and Iberogast \u00ae in functional gastroenterology .Gastro Entero Hepatologie .", "label": "", "metadata": {}, "score": "85.21222"}
{"text": "The authors thank the research staff at Qilu Hospital Affiliated to Shandong University ( Yan - qing Li ) and Affiliated Hospital of Shandong University of Traditional Chinese Medicine ( Xiu - ying Wang and Zhi - qun Cao ) .", "label": "", "metadata": {}, "score": "85.86481"}
{"text": "J Pharm Pharmacol .[PubMed ] [ DOI ] .Friedman M , Henika PR , Mandrell RE .Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni , Escherichia coli , Listeria monocytogenes , and Salmonella enterica .", "label": "", "metadata": {}, "score": "86.073685"}
{"text": "Ltd , Xi'an , China .This funding source is providing test drugs , but it had no role in the design of this study and does not have any responsibility for analyses , interpretation of the data or the decision to submit results .", "label": "", "metadata": {}, "score": "86.137085"}
{"text": "Hypericum perforatum is a popular herbal medicine for the treatment of depression and it may be beneficial in the management of IBS by modulating psychological stress and serotonin [ 27 ] .", "label": "", "metadata": {}, "score": "86.375626"}
{"text": "Chinese Herbal Medicine .Chinese herbal medicine is traditionally practiced in a highly individualized way , with herbal formulas tailored to the exact details of each person 's case .", "label": "", "metadata": {}, "score": "87.13205"}
{"text": "Chinese Herbal Medicine .Chinese herbal medicine is traditionally practiced in a highly individualized way , with herbal formulas tailored to the exact details of each person 's case .", "label": "", "metadata": {}, "score": "87.13205"}
{"text": "Chinese Herbal Medicine .Chinese herbal medicine is traditionally practiced in a highly individualized way , with herbal formulas tailored to the exact details of each person 's case .", "label": "", "metadata": {}, "score": "87.13205"}
{"text": "Chinese Herbal Medicine .Chinese herbal medicine is traditionally practiced in a highly individualized way , with herbal formulas tailored to the exact details of each person 's case .", "label": "", "metadata": {}, "score": "87.13205"}
{"text": "2004 ; 20 Suppl 2 : 1 - 9 .[PubMed ] [ DOI ] .Karantanos T , Markoutsaki T , Gazouli M , Anagnou NP , Karamanolis DG .", "label": "", "metadata": {}, "score": "87.32657"}
{"text": "doi : 10.1136/gut.2007.119446 .[ PMC free article ] [ PubMed ] [ Cross Ref ] .Pimentel M , Lembo A , Chey WD . et al .", "label": "", "metadata": {}, "score": "87.51115"}
{"text": "For example , people receiving acupuncture treatments reported more symptom relief compared to those receiving psychotherapy or medication .A review of 11 low - quality randomized trials compared moxibustion or moxibustion with acupuncture to drug therapy .", "label": "", "metadata": {}, "score": "88.49109"}
{"text": "For example , people receiving acupuncture treatments reported more symptom relief compared to those receiving psychotherapy or medication .A review of 11 low - quality randomized trials compared moxibustion or moxibustion with acupuncture to drug therapy .", "label": "", "metadata": {}, "score": "88.49109"}
{"text": "For example , people receiving acupuncture treatments reported more symptom relief compared to those receiving psychotherapy or medication .A review of 11 low - quality randomized trials compared moxibustion or moxibustion with acupuncture to drug therapy .", "label": "", "metadata": {}, "score": "88.49109"}
{"text": "For example , people receiving acupuncture treatments reported more symptom relief compared to those receiving psychotherapy or medication .A review of 11 low - quality randomized trials compared moxibustion or moxibustion with acupuncture to drug therapy .", "label": "", "metadata": {}, "score": "88.49109"}
{"text": "CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY .Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition .", "label": "", "metadata": {}, "score": "88.57301"}
{"text": "Ethics .This work has been carried out in accordance with the Declaration of Helsinki ( 2000 ) of the World Medical Association .Since this was an observational study of an over - the - counter product , ethics committee approval was not necessary .", "label": "", "metadata": {}, "score": "88.777405"}
{"text": "[PubMed ] [ DOI ] .Ammon HP , Wahl MA .Pharmacology of Curcuma longa .Planta Med .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "88.79636"}
{"text": "Because of multifactorial nature of the pathophysiology of IBS , it seems that compound preparations can be more efficacious than single ones .Despite the wide prevalence of IBS , there are few studies on the use of herbal medicine in IBS and most studies in this area have focused on the use of peppermint oil and STW 5 ; while it seems that more effective herbal preparations can be found .", "label": "", "metadata": {}, "score": "88.822266"}
{"text": "One double - blind study failed to find either the herb fumitory or an herbal relative of turmeric helpful for IBS .The prebiotic supplement fructo - oligosaccharides has been advocated as a treatment for IBS .", "label": "", "metadata": {}, "score": "88.882126"}
{"text": "One double - blind study failed to find either the herb fumitory or an herbal relative of turmeric helpful for IBS .The prebiotic supplement fructo - oligosaccharides has been advocated as a treatment for IBS .", "label": "", "metadata": {}, "score": "88.882126"}
{"text": "One double - blind study failed to find either the herb fumitory or an herbal relative of turmeric helpful for IBS .The prebiotic supplement fructo - oligosaccharides has been advocated as a treatment for IBS .", "label": "", "metadata": {}, "score": "88.882126"}
{"text": "One double - blind study failed to find either the herb fumitory or an herbal relative of turmeric helpful for IBS .The prebiotic supplement fructo - oligosaccharides has been advocated as a treatment for IBS .", "label": "", "metadata": {}, "score": "88.882126"}
{"text": "This indicated that the herbs played an important role in the maintenance of curative effect .HM is one kind of moxibustion therapies , which combines all the functions of moxibustion , acupoints and herbs .", "label": "", "metadata": {}, "score": "88.90365"}
{"text": "Phytomedicine .2006 ; 13 Suppl 5 : 100 - 106 .[PubMed ] [ DOI ] .Ammon HP , Kelber O , Okpanyi SN .", "label": "", "metadata": {}, "score": "88.937225"}
{"text": "Both of them indicated the superiority of traditional Chinese medicine ( TCM ) in treating IBS .Moxibustion therapy , which is used to treat diseases not less than acupuncture in China , is one of the three major therapies just as important as acupuncture and traditional Chinese herbal medicine , but less attention is paid to moxibustion therapy than acupuncture nowadays .", "label": "", "metadata": {}, "score": "89.02861"}
{"text": "[PubMed ] [ DOI ] .Leung WK , Wu JC , Liang SM , Chan LS , Chan FK , Xie H , Fung SS , Hui AJ , Wong VW , Che CT .", "label": "", "metadata": {}, "score": "89.68062"}
{"text": "The food enzyme , \u03b1 -galactosidase , derived from Aspergillus niger mold , acts in the gastrointestinal tract by breaking down specific non - absorbable oligosaccharides before they are metabolized by colonic bacteria [ 13 ] .", "label": "", "metadata": {}, "score": "89.695786"}
{"text": "The food enzyme , \u03b1 -galactosidase , derived from Aspergillus niger mold , acts in the gastrointestinal tract by breaking down specific non - absorbable oligosaccharides before they are metabolized by colonic bacteria [ 13 ] .", "label": "", "metadata": {}, "score": "89.695786"}
{"text": "This was also true for extracts of some constituents of this compound formula including Mentha piperita leaf , Matricaria recutita flower and Glycyrrhiza uralensis root .", "label": "", "metadata": {}, "score": "90.15957"}
{"text": "No differences were found with respect to QOL [ 40 ] .COMPOUND PREPARATIONS .Preparations containing more than one herb are discussed below and summarized in Table 2 .", "label": "", "metadata": {}, "score": "90.31282"}
{"text": "Nat Prod Commun .[PubMed ] [ DOI ] .Badr SE , Shaaban M , Elkholy YM , Helal MH , Hamza AS , Masoud MS , El Safty MM .", "label": "", "metadata": {}, "score": "90.43976"}
{"text": "Tong - xie - ning .Tong - xie - ning ( TXNG ) is a traditional Chinese medicine composed of four different herbs .The efficacy of this preparation was evaluated in diarrhea predominant - IBS patients by a prospective , randomized , double - blind , placebo - controlled trial .", "label": "", "metadata": {}, "score": "90.8518"}
{"text": "Flaxseeds .In a double - blind study , 55 people with chronic constipation caused by IBS received either ground flaxseed or psyllium seed ( a well - known treatment for constipation ) daily for 3 months .", "label": "", "metadata": {}, "score": "91.02342"}
{"text": "Flaxseeds .In a double - blind study , 55 people with chronic constipation caused by IBS received either ground flaxseed or psyllium seed ( a well - known treatment for constipation ) daily for 3 months .", "label": "", "metadata": {}, "score": "91.02342"}
{"text": "Flaxseeds .In a double - blind study , 55 people with chronic constipation caused by IBS received either ground flaxseed or psyllium seed ( a well - known treatment for constipation ) daily for 3 months .", "label": "", "metadata": {}, "score": "91.02342"}
{"text": "Flaxseeds .In a double - blind study , 55 people with chronic constipation caused by IBS received either ground flaxseed or psyllium seed ( a well - known treatment for constipation ) daily for 3 months .", "label": "", "metadata": {}, "score": "91.02342"}
{"text": "Visual Analogue Scale .Declarations .Acknowledgements .The study is financially supported by Shaanxi Bosen Biological Pharmaceutical Group Co.Ltd , Xi'an , China .", "label": "", "metadata": {}, "score": "91.02431"}
{"text": "[PubMed ] [ DOI ] .Cappello G , Spezzaferro M , Grossi L , Manzoli L , Marzio L. Peppermint oil ( Mintoil ) in the treatment of irritable bowel syndrome : a prospective double blind placebo - controlled randomized trial .", "label": "", "metadata": {}, "score": "91.27061"}
{"text": "[PubMed ] [ DOI ] .Fan AY , Lao L , Zhang RX , Wang LB , Lee DY , Ma ZZ , Zhang WY , Berman B. Effects of an acetone extract of Boswellia carterii Birdw .", "label": "", "metadata": {}, "score": "91.27738"}
{"text": "[PubMed ] [ DOI ] .Badria FA , Mikhaeil BR , Maatooq GT , Amer MM .Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood .", "label": "", "metadata": {}, "score": "91.47121"}
{"text": "Maranta arundinacea .The efficacy of powdered root of Maranta arundinacea ( Arrowroot ) was assessed in patients with diarrhea predominant - IBS .It reduced diarrhea with a long - term effect on constipation .", "label": "", "metadata": {}, "score": "91.816574"}
{"text": "doi : 10.1111/j.1572 - 0241.1999.00798.x .[PubMed ] [ Cross Ref ] . O'MahonyL , McCarthy J , Kelly P. et al .", "label": "", "metadata": {}, "score": "92.32132"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' contributions .DNG and OS designed the study and wrote the manuscript .", "label": "", "metadata": {}, "score": "92.335556"}
{"text": "PubMed ] [ DOI ] .Ali BH , Blunden G. Pharmacological and toxicological properties of Nigella sativa .Phytother Res .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "92.87635"}
{"text": "Dig Dis Sci .2006 Jul 26 .[ Epub ahead of print ] .Saha L , Malhotra S , Rana S , et al .", "label": "", "metadata": {}, "score": "93.164795"}
{"text": "Dig Dis Sci .2006 Jul 26 .[ Epub ahead of print ] .Saha L , Malhotra S , Rana S , et al .", "label": "", "metadata": {}, "score": "93.164795"}
{"text": "Dig Dis Sci .2006 Jul 26 .[ Epub ahead of print ] .Saha L , Malhotra S , Rana S , et al .", "label": "", "metadata": {}, "score": "93.164795"}
{"text": "Dig Dis Sci .2006 Jul 26 .[ Epub ahead of print ] .Saha L , Malhotra S , Rana S , et al .", "label": "", "metadata": {}, "score": "93.164795"}
{"text": "Ethics .The trial protocol is conducted in accordance with the Good Clinical Practice Guidelines and the Declaration of Helsinki ( 2008 ) [ 19 ] .", "label": "", "metadata": {}, "score": "93.32916"}
{"text": "Silicic acid is also extremely hygroscopic ; therefore also water molecules bind to the primary hydrophilic adsorption sites .This enables silica gel to have very large surface areas .", "label": "", "metadata": {}, "score": "93.359985"}
{"text": "The authors declare that they have no conflict of interests .Authors ' Contribution .Yu - xia Ma and Xiao Liu and their affiliations contribute equally to this paper .", "label": "", "metadata": {}, "score": "93.42325"}
{"text": "J Altern Complement Med .[PubMed ] [ DOI ] .Banno N , Akihisa T , Yasukawa K , Tokuda H , Tabata K , Nakamura Y , Nishimura R , Kimura Y , Suzuki T. Anti - inflammatory activities of the triterpene acids from the resin of Boswellia carteri .", "label": "", "metadata": {}, "score": "93.90207"}
{"text": "PubMed ] .Solomons N. et al .Orally - ingested , microbial alpha - galactosidases produce effective in vivo , intraintestinal digestion of the Bean oligosaccharide , raffinose .", "label": "", "metadata": {}, "score": "93.97096"}
{"text": "100 mL of the silicon gel contain 3.5 g silicon dioxide ( silica ) .The silicon dioxide is mixed with water to form a gel .", "label": "", "metadata": {}, "score": "94.79457"}
{"text": "Does beano prevent gas ?A double - blind crossover study of oral alfa - galactosidase to treat dietary oligosaccharide intolerance .J Fam Pract .", "label": "", "metadata": {}, "score": "95.53549"}
{"text": "PubMed .Solomons N , et al .: Orally - ingested , microbial alpha - galactosidases produce effective in vivo , intraintestinal digestion of the Bean oligosaccharide , raffinose .", "label": "", "metadata": {}, "score": "95.655876"}
{"text": "[PubMed ] [ DOI ] .Kaur G , Hamid H , Ali A , Alam MS , Athar M. Antiinflammatory evaluation of alcoholic extract of galls of Quercus infectoria .", "label": "", "metadata": {}, "score": "96.01113"}
{"text": "Eugenia caryophyllata has anti - inflammatory [ 64 ] , immunomodulatory [ 65 ] , and antimicrobial [ 66 ] properties .Gall of Quercus infectoria possesses anti - inflammatory [ 67 ] and antibacterial [ 68 ] activity .", "label": "", "metadata": {}, "score": "96.01941"}
{"text": "PubMed Central PubMed .Commission SP : Pharmacopoeia of the People 's Republic of China .9th edition .Beijing : China Medical Science Press ; 2010 .", "label": "", "metadata": {}, "score": "96.67279"}
{"text": "Padma Lax .Padma Lax , a complex Tibetan herbal formula ( Table 2 ) , was evaluated for safety and effectiveness in treating constipation - predominant IBS in a 3-mo double - blind randomized pilot study .", "label": "", "metadata": {}, "score": "97.07201"}
{"text": "Peer reviewer : Mauro Bortolotti , MD , Professor , Department of Internal Medicine and Gastroenterology , University of Bologna , Via Massarenti 48 , Bologna 40138 , Italy .", "label": "", "metadata": {}, "score": "99.76006"}
{"text": "Correspondence to : Mohammad Abdollahi , Professor , Faculty of Pharmacy , Pharmaceutical Sciences Research Center , Endocrinology and Metabolism Research Institute , Tehran University of Medical Sciences , Tehran 1417614411 , Iran . mohammad.abdollahi@utoronto.ca .", "label": "", "metadata": {}, "score": "101.39067"}
{"text": "Carmint .Carmint is an Iranian herbal medicine containing total extracts of Melissa officinalis , Mentha spicata , and Coriandrum sativum .Thirty - two IBS patients randomly received either carmint or placebo , plus loperamide or psyllium ( based on their predominant bowel function ) , for 8 wk .", "label": "", "metadata": {}, "score": "101.44968"}
{"text": "[PubMed ] [ DOI ] .Grigoleit HG , Grigoleit P. Pharmacology and preclinical pharmacokinetics of peppermint oil .Phytomedicine .[PubMed ] [ DOI ] .", "label": "", "metadata": {}, "score": "102.04112"}
{"text": "View at Google Scholar .R. Kugelmeier , Vergleichende Untersuchungen \u00fcber die Adsorption von Makromolek\u00fclen und Bakterien an por\u00f6se Kiesels\u00e4uren , Ph.D. dissertation , Technische Universit\u00e4t Bonn , Bonn , Germany , 1980 .", "label": "", "metadata": {}, "score": "102.81027"}
{"text": "Mohammad Abdollahi , Professor , Faculty of Pharmacy , Pharmaceutical Sciences Research Center , Endocrinology and Metabolism Research Institute , Tehran University of Medical Sciences , Tehran 1417614411 , Iran . mohammad.abdollahi@utoronto.ca .", "label": "", "metadata": {}, "score": "103.649216"}
{"text": "Received : June 7 , 2011 Revised : August 21 , 2011 Accepted : October 28 , 2011 Published online : February 21 , 2012 .", "label": "", "metadata": {}, "score": "104.143936"}
{"text": "Luckily , Dr. Cynthia Chandler , a volunteer at our Medical Center of Lewisville , has the cure - a four - legged , furry ... .", "label": "", "metadata": {}, "score": "106.136505"}
{"text": "Cappello G , Spezzaferro M , Grossi L , et al .Peppermint oil ( Mintoil \u00ae ) in the treatment of irritable bowel syndrome : a prospective double blind placebo - controlled randomized trial .", "label": "", "metadata": {}, "score": "106.39614"}
{"text": "Cappello G , Spezzaferro M , Grossi L , et al .Peppermint oil ( Mintoil \u00ae ) in the treatment of irritable bowel syndrome : a prospective double blind placebo - controlled randomized trial .", "label": "", "metadata": {}, "score": "106.39614"}
{"text": "Cappello G , Spezzaferro M , Grossi L , et al .Peppermint oil ( Mintoil \u00ae ) in the treatment of irritable bowel syndrome : a prospective double blind placebo - controlled randomized trial .", "label": "", "metadata": {}, "score": "106.39614"}
{"text": "Cappello G , Spezzaferro M , Grossi L , et al .Peppermint oil ( Mintoil \u00ae ) in the treatment of irritable bowel syndrome : a prospective double blind placebo - controlled randomized trial .", "label": "", "metadata": {}, "score": "106.39614"}
{"text": "Nihon Rinsho .[PubMed ] [ DOI ] .Zhang XJ , Li Z , Leung WM , Liu L , Xu HX , Bian ZX .", "label": "", "metadata": {}, "score": "107.12265"}
{"text": "Paeonia lactiflora .The root of Paeonia lactiflora is used in many herbal preparations for IBS .Paeoniflorin ( PF ) is one of the principle active ingredients of the root of Paeonia lactiflora .", "label": "", "metadata": {}, "score": "110.74855"}
{"text": "[PubMed ] [ DOI ] .Vermani A. Screening of Quercus infectoria gall extracts as anti - bacterial agents against dental pathogens .Indian J Dent Res .", "label": "", "metadata": {}, "score": "111.59982"}
{"text": "doi : 10.1111/j.1365 - 2036.2011.04637.x .[PubMed ] [ Cross Ref ] Received 9 October 2013 ; Accepted 15 November 2013 .Academic Editor : Pinar Atukeren .", "label": "", "metadata": {}, "score": "116.883575"}
{"text": "PubMed View Article .Copyright .\u00a9 Wang et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "119.30315"}
{"text": "Mentha \u00d7 piperita .The evidence for the efficacy of essential oil of Mentha \u00d7 piperita ( peppermint oil ) in IBS seems to be more than other herbal preparations [ 9 , 31 ] .", "label": "", "metadata": {}, "score": "120.0509"}
{"text": "Pre - publication history .Copyright .\u00a9 Di Nardo et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd. Abstract .", "label": "", "metadata": {}, "score": "122.40826"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "124.59523"}
{"text": "Academic Editor : C. M. Wilcox .Copyright \u00a9 2012 B. Uehleke et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "140.56775"}
